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Succinate dehydrogenase (SDH, also known as complex II) is a protein complex 
located in the inner mitochondrial membrane. SDH has dual roles as a part of both the 
citric acid cycle and the electron transport chain required for aerobic respiration in 
eukaryotes. In the past two decades, the structure of SDH has been extensively studied. 
The tetrameric complex consists of SDHA, SDHB, SDHC and SDHD (Sdh1, Sdh2, Sdh3 
and Sdh4 in yeast) and contains five cofactors: one flavin adenine dinucleotide, three Fe-
S clusters and one heme b. Mutations in SDH subunit genes are associated with various 
human diseases. Recently, interest has been refocused on SDH by discovery of SDH 
assembly factors, SDHAF1 and SDHAF2. However, the mechanism for SDH assembly 
was still poorly understood. The fact that SDH consists of four subunits and five 
cofactors supports the idea that maturation of SDH would require several assembly 
factors, as is the case for other electron transport chain complex I, III and IV. SDH-
deficient gastrointestinal stromal tumors and neuroblastomas associated with SDH 
deficiency without mutations in genes encoding SDH subunits or two aforementioned 
assembly factors also suggest additional unknown SDH assembly factors. 
In this study, we focus on understanding the mechanism for maturation of the Fe-
S cluster subunit of SDH, Sdh2. We discovered a novel SDH assembly factor, Sdh7, and 
characterized its function. We also revealed the molecular function of Sdh6, a yeast 
ortholog of human SDHAF1, whose mutations were shown to result in SDH deficiency 
 
iv 
through an unknown mechanism. We demonstrate that Sdh6 and Sdh7 impart protection 
for the Fe-S cluster subunit of SDH against reactive oxygen species under oxidative 
stress conditions during SDH assembly. We also propose that a sequence variant of 
SDHAF3, a yeast ortholog of Sdh7, could be a pathogenic allele that enhances 
predisposition to endocrine-related tumors. Lastly, we elucidate the function of Nfu1 in 
Fe-S cluster delivery to target proteins including Sdh2. 
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One of the key biological processes in mitochondria in eukaryotic cells is 
generating energy for cells. The main metabolic pathway in mitochondria to produce 
energy in the form of ATP, a major energy currency in cells, consists of the citric acid 
cycle, the electron transport chain (ETC) and ATP synthase. Mitochondria are subcellular 
organelles compartmentalized by two double layer membranes. Their compartments 
consist of the matrix, inner mitochondrial membrane (IMM), intermembrane space (IMS) 
and outer mitochondrial membrane (OMM) from inside to outside. The citric acid cycle 
functions in the matrix. It generates ATP and reduces electron carriers in the forms of 
NADH and FADH2 through oxidation of acetyl-CoA derived from glycolysis, fatty acid 
oxidation and amino acid metabolism. The ETC is composed of complex I 
(NADH:ubiquinone oxidoreductase), complex II (succinate dehydrogenase), complex III 
(ubiquinol-cytochrome c reductase) and complex IV (cytochrome c oxidase), all of which 
are embedded in the IMM. The oxidation of NADH and FADH2 is coupled to generating 
a proton gradient across the IMM by the ETC. ATP synthase subsequently produces ATP 
using the proton gradient. The key feature of ETC complexes and ATP synthase is that 
they are membrane-embedded protein complexes composed of multiple subunits and 
redox cofactors. Therefore, biogenesis of these complexes would be expected to 




Mitochondria have their own genome (mitochondrial DNA) encoding 13 proteins, 
22 tRNAs and two ribosomal RNAs in humans. Therefore, in order to accommodate ~ 
1500 proteins within mitochondria, cells adopted machineries to mediate import of 
mitochondrial proteins from the cytosol. Nuclear DNA-encoded precursors of 
mitochondrial proteins are translated in the cytosol, and then translocated into 
mitochondria through the mitochondrial protein import pathway mainly composed of the 
translocase of the outer membrane (TOM complex) and the translocase of the inner 
membrane (TIM complex). Interestingly, complex I, complex III, complex IV and ATP 
synthase consist of subunits encoded by both mitochondrial DNA and nuclear DNA. 
Therefore, one could expect a tight regulation that couples translation of subunits 
encoded by mitochondrial DNA to availability of other subunits imported from the 
cytosol. The translocation of many precursors is directed by mitochondrial targeting 
sequences at their N-termini; therefore, the early step of mitochondrial protein maturation 
in mitochondria often involves peptidases that cleave off mitochondrial targeting 
sequences, as well as chaperones to stabilize imported precursors prior to their folding. 
Protein folding of hydrophobic subunits and insertion into the IMM is another key 
step for assembly of the ETC complexes. This step often appears to be coupled with the 
mitochondrial protein import as is the case for concurrent folding of many IMM proteins 
that are laterally transferred from the translocase of the inner membrane to the IMM. In 
the case of mitochondrial DNA encoded subunits of complex IV, Cox1, Cox2 and Cox3, 
a specialized insertase Oxa1 mediates membrane insertion of these proteins from the 
matrix. It is of particular interest that the Rieske subunit of complex III (Rip1), which has 
a α-helical transmembrane domain, is folded and matured with a [2Fe-2S] cluster in the 
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matrix, and then inserted into a complex III assembly intermediate in the IMM. It has 
been shown that a specialized translocase, Bcs1, is required for insertion of folded and 
mature Rip1. 
Semi-assembled intermediates would be prone to aggregation as many subunits of 
ETC complexes are hydrophobic. A dedicated chaperone may be required to stabilize 
assembly intermediates and subunits. It has been shown that Mzm1 is a complex III 
assembly factor stabilizing mature Rip1 in the matrix prior to its translocation to the IMM 
via Bcs1. 
Redox cofactors such as copper centers, iron-sulfur clusters and hemes are 
indispensible components for redox chemistry and electron transport within the ETC 
complexes. These redox cofactors are oxidative damage-prone entities or pro-oxidants 
when they are exposed to solvent. In addition, assembly intermediates with redox 
cofactors can generate reactive oxygen species (ROS) as they may not be able to 
complete their electron transport to physiologically ideal electron carriers. Therefore, 
specialized factors would be required for shielding redox cofactors during assembly 
processes and/or preventing assembly intermediate with cofactors from unwanted partial 
redox reactions. 
In the last decade, the mechanism for complex III and complex IV assembly has 
been extensively studied, especially with respect to the discovery of dedicated assembly 
factors. In addition, it has been shown that not only mutations in genes encoding 
subunits, but also mutations in genes encoding assembly factors of complex III and IV 
are associated with human pathology such as neurodegenerative diseases and cancers. 
However, little was known about SDH assembly and its implication in human diseases. 
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Succinate dehydrogenase (SDH, aka complex II) is a tetrameric complex 
responsible for oxidation of succinate to fumarate in the citric acid cycle. SDH also 
constitutes a part of the ETC as it catalyzes the reduction of ubiquinone using electrons 
derived from succinate oxidation. Compared to the other ETC complexes, all four 
subunits of SDH are encoded in nuclear DNA. However, considering that SDH is a 
membrane-embedded protein complex composed of multiple subunits and redox 
cofactors, SDH assembly should also be a process regulated and mediated by assembly 
factors as is the case for the other ETC complexes. Indeed, interest has been refocused on 
SDH biogenesis as mutations in two novel SDH assembly factors were linked to infantile 
leukoencephalopathy and paraganglioma with SDH deficiency. 
In this study, I took comprehensive approaches covering proteomics, genetics, 
biochemistry and molecular biology to understand mechanism of SDH assembly and 
iron-sulfur cluster delivery in yeast and mammalian cells as model organisms. In addition, 
the physiological importance of a novel SDH assembly factor SDHAF3 was also 
examined in a multicellular animal model, fruit flies, and mutations in SDHAF3 were 
screened in the context of human endocrine-related tumors. Chapter 1 reviews our current 
understanding of SDH assembly in great detail, with a summary of up-to-date published 
studies. Chapter 2 describes a study that further revealed the mechanism of Sdh1 (the 
flavin adenine dinucleotide subunit of SDH) maturation. In Chapter 3 and 4, function of 
novel SDH assembly factors and their physiological importance is discussed regarding 
our novel findings during a course of this study. Lastly, the mechanism for iron-sulfur 
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Abstract
Succinate dehydrogenase (or complex II; SDH) is a heterotetrameric protein complex that links
the tribarboxylic acid cycle with the electron transport chain. SDH is composed of four nuclear-
encoded subunits that must translocate independently to the mitochondria and assemble into
a mature protein complex embedded in the inner mitochondrial membrane. Recently, it has
become clear that failure to assemble functional SDH complexes can result in cancer and
neurodegenerative syndromes. The effort to thoroughly elucidate the SDH assembly pathway
has resulted in the discovery of four subunit-specific assembly factors that aid in the maturation
of individual subunits and support the assembly of the intact complex. This review will focus on
these assembly factors and assess the contribution of each factor to the assembly of SDH.
Finally, we propose a model of the SDH assembly pathway that incorporates all extant data.
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Electron transport chain complex assembly
Mitochondrial ATP synthesis is dependent on the concerted
efforts of the electron transport chain (ETC), which couples
the generation of an electrochemical gradient to the oxidation
of NADH and FADH2 and the reduction of oxygen to water.
The ETC is composed of four multimeric complexes and two
mobile electron carriers (coenzyme Q and cytochrome c), all
of which are embedded in or associated with the inner
mitochondrial membrane (IMM). Electrons derived from the
oxidation of NADH by complex I or succinate from the
tricarboxylic acid (TCA) cycle by complex II (succinate
dehydrogenase; SDH) are passed along the ETC, coupled
with the pumping of protons and establishment of the proton
gradient across the IMM. In the end, controlled flow of
protons down this electrochemical gradient is utilized by
complex V (ATP synthase) to catalyze ATP synthesis.
The assembly of the ETC complexes presents the cell with
the problem of coordinating the synthesis and stepwise
interactions of individual subunits, transcribed and translated
from two distinct genomes in two distinct compartments, into
intricate membrane bound complexes. This problem is
exacerbated by the nature of the ETC complexes themselves.
First, some subunits are embedded in the IMM and, therefore,
are hydrophobic and prone to aggregation prior to and during
assembly. Furthermore, the complexes contain redox-active
cofactors that can perform inappropriate and deleterious
reactions when they are not properly secluded within the
native complex. As a result, a number of dedicated factors
assist the assembly of these complexes by facilitating cofactor
insertion, preventing non-productive interactions and stabiliz-
ing assembly intermediates (Diaz et al., 2011; Fernandez-
Vizarra et al., 2009). While mammalian ETC complexes I, III
and IV contain 44, 11 and 14 subunits, respectively, and
include proteins encoded by both mitochondrial and nuclear
genomes, complex II or SDH, is the product of just four
nuclear-encoded genes. Despite this somewhat simple qua-
ternary structure, it has been made clear recently that SDH,
like all ETC complexes, requires assembly factors for its
biogenesis.
Succinate dehydrogenase and human disease
The critical role of SDH in mitochondrial metabolism has
long been appreciated, however, it has more recently emerged
that mutations affecting SDH cause a number of human
diseases (Hoekstra & Bayley, 2013; Rutter et al., 2010;
Table 1). Interestingly, loss of function mutations in SDH core
subunits do not cause a single, common pathology, but rather
lead to a variety of disease phenotypes that can be grouped
into two categories – cancer and neurodegeneration. With
respect to SDH-deficient cancers and other tumor syndromes,
mutations in the core subunits are most commonly associated
with paraganglioma, pheochromocytoma, renal cell carcin-
oma (RCC) and WT gastrointestinal stromal tumors (WT-
GIST). Paragangliomas are neuro-endocrine tumors that
occur in cells of the neural crest and tend to be co-localized
with oxygen sensing tissues such as the carotid body, while
pheochromocytomas represent a related class of tumors that
affect the adrenal gland. These two tumors are most
Address for correspondence: Jared Rutter, Department of Biochemistry,





commonly associated with mutations in SDHB, SDHC and
SDHD, however SDHA mutations have recently been
implicated in rare cases (Astuti et al., 2001; Baysal, 2000;
Burnichon et al., 2010; Peczkowska et al., 2008). Mutations
in SDHA, SDHB and SDHC have also been associated with
WT-GIST, a mesenchymal tumor of the digestive tract
(Janeway et al., 2011; Pantaleo et al., 2011, 2014). Finally,
the link between RCC and SDH dysfunction is supported by
the discovery of two families with inherited renal cell tumor
syndromes resulting from germline mutations in SDHB
(Vanharanta et al., 2004). Taken together, it is clear that
normal SDH activity serves to suppress tumors in humans. In
addition to the cancers described above, defects in SDH
activity also cause a variety of neurodegenerative disorders. In
fact, the classical presentation of patients with mutations
in SDHA is Leigh Syndrome, an early-onset, progressive
neurodegenerative disorder (Bourgeron et al., 1995).
SDHA mutations have also been associated with milder
forms of atrophy and myopathy (Bourgeron et al., 1995;
Horva´th et al., 2006). Although mutations in SDHC are rarely,
if ever, associated with neurologic disorders, SDHB mutations
have been shown to cause infantile leukodystrophy (Alston
et al., 2012) and SDHD mutations have recently been
identified in patients with progressive encephalomyopathy
(Jackson et al., 2014). Therefore, SDH activity not only
suppresses tumors but also supports normal neurologic
development and function. While it is fascinating that
mutations in all four subunits of SDH have been found to
cause one of the diseases described above, it is perhaps even
more interesting that numerous patients present with disease
accompanied by a loss of SDH activity, but have no mutations
of any of the core subunits (Jain-Ghai et al., 2013). These
genetic observations clearly implicate additional auxiliary
factors in the maintenance of cellular SDH activity.
Furthermore, this supports the notion that a thorough
characterization of the SDH assembly pathway will ultimately
lead to the discovery of new human disease alleles in the
genes that encode SDH assembly factors.
Enzymology and structure of succinate
dehydrogenase
Eukaryotic SDH is a heterotetrameric complex composed of
four nuclear-encoded subunits (Sun et al., 2005; Figure 1).
SDH is unique amongst eukaryotic ETC complexes in that it
functions as part of both the TCA cycle and the ETC and thus
couples two of the primary energy-harvesting pathways
within the cell. In addition to this distinction, SDH is the
only ETC complex that does not pump protons across the
IMM nor does it contain any proteins encoded by the
mitochondrial genome. In the context of the TCA cycle, SDH
catalyzes the oxidation of succinate to fumarate and uses the
electrons derived from this oxidation to catalyze the reduction
of ubiquinione to ubiquinol. These electrons are passed to
Complex III and then Complex IV, thereby contributing to the
establishment of the electrochemical gradient across the IMM
in support of ATP synthesis. The structure of SDH can be
characterized as a hydrophilic head that protrudes into the
Figure 1. Porcine succinate dehydrogenase
(PDB accession number: 1ZOY) embedded
in the mitochondrial inner membrane. SdhA
(purple ribbon); SdhB (blue ribbon); SdhC
(green ribbon); SdhD (brown ribbon); FAD
(green stick); FeS centers, [2Fe–2S],
[4Fe–4S], [3Fe–4S] from the bottom (red and
yellow sphere); Ubiquinone in the QP site
(red stick); Heme b (blue stick). (see
colour version of this figure at www.
informahealthcare.com/bmg).


















SDH6 SDHAF1 Infantile Leukodystrophy
SDH7 SDHAF3 N/A
SDH8 SDHAF4 N/A




mitochondrial matrix attached to the IMM by a hydrophobic
membrane anchor (Sun et al., 2005; Yankovskaya et al., 2003;
Figure 1).
The membrane anchor domain of SDH consists of Sdh3
(SDHC in mammals) and Sdh4 (SDHD; Sun et al., 2005;
Yankovskaya et al., 2003) and serves as the site of ubiquinone
binding to connect this hydrophobic mobile electron carrier to
the hydrophilic domain of SDH (Figure 1). The hydrophilic
domain represents the catalytic core of SDH and is composed
of Sdh1 (SDHA in mammals) and Sdh2 (SDHB), each of
which contain the redox-active cofactors that facilitate the
transfer of electrons from succinate to ubiquinone (Sun et al.,
2005; Yankovskaya et al., 2003; Figure 1). Sdh1 contains a
covalently bound FAD cofactor adjacent to the succinate-
binding site (Figure 1). Sdh2 harbors the three Fe–S centers
that mediate electron transfer from the flavin cofactor to the
ubiquinone (Figure 1). The Fe–S clusters of Sdh2, which
consist of a 2Fe–2S center adjacent to the FAD site of Sdh1,
followed by a 4Fe–4S and finally a 3Fe–4S center proximal to
the ubiquinone binding site, serve essentially as a wire used to
transfer electrons through the complex (Figure 1). In addition
to its important role in the process of electron transfer, Sdh2
also serves as the interface linking the catalytic Sdh1 subunit
to the membrane bound Sdh3 and Sdh4 subunits (Sun et al.,
2005; Yankovskaya et al., 2003). Interestingly, recent reports
indicate that soluble Sdh1–Sdh2 dimers exist in the absence
of one or both of the membrane anchors (Kim et al., 2012).
This suggests that Sdh1 and Sdh2 are likely to dimerize prior
to membrane association, rather than sequentially docking
onto the membrane anchor.
The SDH enzymatic reaction begins with the binding of
succinate to the open state of Sdh1, which undergoes a
conformational change bringing succinate into close proxim-
ity with the covalently bound FAD cofactor. Oxidation of
succinate is coupled to the two-electron reduction of FAD.
Since the Fe–S centers of SDH are single electron carriers,
two successive single electron transfer steps are required to
re-oxidize FADH2 back to FAD. In the end, the two electrons
gained from the oxidation of succinate are used to reduce
ubiquinone to ubiquinol, which passes the electrons on to
Complex III.
Assembly of SDH
Until recent years, the process of SDH assembly remained
highly enigmatic and was primarily focused on the core SDH
subunits themselves (Cecchini et al., 2002; Lemire &
Oyedotun, 2002). Our newfound understanding of this process
has been facilitated by the discovery of proteins dedicated to
the maturation of individual subunits and the assembly of the
holo-complex. Importantly, the discovery of these factors has
revealed that SDH assembly is a tightly coordinated process
in which the concerted functions of core subunits, dedicated
assembly factors and other ancillary factors must coordinate
their various activities to achieve the step-wise assembly of
this membrane bound complex. Based on the knowledge
gained in recent years, it is possible to organize the process of
SDH assembly into discrete, subunit-specific events. These
events, which include cofactor insertion, stabilization of sub-
complex assembly intermediates and prevention of
deleterious solvent interactions, result in the maturation of
individual subunits and support the complete assembly of
SDH. In the subsequent sections, we will review the current
understanding of the SDH assembly pathway focusing, in
particular, on the factors that facilitate this process (Figure 3).
Sdh1 – the catalytic subunit
Architecture of Sdh1
Sdh1 catalyzes the oxidation of succinate to fumarate. The
crystal structure of porcine SDH has revealed that mammalian
SDHA assumes a Rossmann-type fold with four distinct
domains – an FAD binding domain (residues 52–267 and
355–439; human sequence), a capping domain (residues 268–
354), a helical domain (residues 440–537) and a C-terminal
domain (residues 548–616). The structure indicates the
presence of a covalent bond between FAD and His99
(His90 in yeast) with the FAD being further coordinated by
a number of additional residues, which form a well-ordered
hydrogen bonding network (Sun et al., 2005; Figure 1).
In addition to the native SDH, a co-crystal structure of SDH
bound to a competitive inhibitor, 3-nitropropionic acid (NPA)
was also determined and facilitated the mapping of the
putative succinate binding site, which, as expected, is directly
adjacent to the FAD. While the precise mechanism for
succinate oxidation by Sdh1 has not yet been elucidated, these
studies have provided valuable information as to the residues
involved in this reaction. The structure demonstrates that
the nitryl group of NPA interacts with the FMN group of FAD
as well as the main chain of Glu261 and the side chains
of Thr260 and His248 while the NPA carboxyl group is
anchored by the amide of Glu246, the guanidinium group
of Arg403 and the imidazole of His359 (Sun et al., 2005).
Biosynthesis and delivery of FAD
FAD is an essential cofactor of Sdh1 and the flavinylation of
Sdh1 is dependent on adequate FAD levels in the mitochon-
drial matrix. Therefore, the synthesis and maintenance of
free FAD pools in this compartment plays a vital role in
the maturation of Sdh1 (Kim & Winge, 2013). In yeast, the
biosynthesis of FAD and its delivery to mitochondria is
dependent on the activities of three proteins – riboflavin
kinase (Fmn1), FAD synthetase (Fad1) and a putative
mitochondrial FAD transporter (Flx1). FAD is derived from
dietary riboflavin (vitamin B2) and its conversion requires the
activities of two ATP-dependent enzymes, Fmn1 and Fad1.
Fmn1, the riboflavin kinase, phosphorylates the tricyclic
isoalloxazine ring yielding flavin mononucleotide (FMN;
Santos et al., 2000). Although a number of enzymes within
the cell use FMN as a cofactor, the majority of FMN is
subsequently adenylated and converted to FAD by the FAD
synthetase, Fad1 (Wu et al., 1995).
Flx1 belongs to the eukaryotic superfamily of IMM carriers
and has been described as a putative IMM FAD carrier, but the
published literature disagrees as to the exact molecular
function of Flx1 (Bafunno et al., 2004; Tzagoloff et al.,
1996). At any rate, cells lacking Flx1 exhibit low matrix FAD
concentrations and reduced activity of two matrix flavo-
proteins, SDH and lipoamide dehydrogenase, due to a defect in




flavinylation of these two enzymes (Kim et al., 2012;
Tzagoloff et al., 1996). Therefore, while there is no known
direct link between Flx1 and Sdh1, it is clear that Flx1 plays an
important role in Sdh1 cofactor insertion as Sdh1 flavinylation
is severely compromised in flx1D cells. This decrease in
flavinylation also leads to the destabilization of Sdh1.
Interestingly, the flx1D defect in Sdh1 flavinylation can be
suppressed by the overexpression of Fad1 or Sdh5, a dedicated
SDH assembly factor that will be discussed in significant
detail in the subsequent section (Hao et al., 2009).
It is important to note that in mammalian cells, it is not clear
whether an Flx1 ortholog is required for SDH maturation. The
mammalian ortholog of the FAD1 gene, FLAD1, yields two
transcripts encoding two isoforms of FAD synthetase, one of
which is cytosolic and the other has a mitochondrial targeting
motif (Torchetti et al., 2010). Thus, mammalian cells might
synthesize FAD within the mitochondrial matrix perhaps
making any IMM carrier dispensable.
Sdh1 cofactor insertion
The first known step in the maturation of Sdh1, which is
imported into the mitochondrial matrix as an apo-protein, is
the insertion and covalent attachment of its FAD cofactor
(Robinson et al., 1994). Interestingly, succinate appears to be
an important allosteric effector of this process as it and
several other TCA cycle intermediates stimulate flavinylation
significantly in vitro (Brandsch & Bichler, 1989). Unlike
some bacterial Sdh1 orthologs, eukaryotic Sdh1 is not
competent to become flavinylated in the absence of other
proteins, which is typically interpreted to mean that the
flavinylation of Sdh1 is not autocatalytic (Kounosu, 2014;
Robinson & Lemire, 1996). As a result, simply maintaining
matrix FAD pools is not sufficient for Sdh1 flavinylation.
Early studies focused on this process revealed that there likely
exists a protein in the mitochondrial matrix required for
flavinylation of Sdh1 as the degree to which Sdh1 can be
flavinylated in vitro is proportional to the concentration of
isolated matrix fraction used in the assay (Robinson &
Lemire, 1996). This insight was subsequently validated by the
discovery of Sdh5.
Yeast Sdh5 was discovered in the course of studying
a collection of uncharacterized mitochondrial proteins with
a high degree of conservation throughout eukaryotes
(Hao et al., 2009). Deletion of SDH5 in yeast prevented
respiratory dependent growth and caused a dramatic reduction
in oxygen consumption – two phenotypes indicative of a
strong respiratory deficiency. In an attempt to better under-
stand this phenotype, an unbiased tandem affinity purification
was performed and it identified Sdh1 as the sole binding
partner of Sdh5. This result, consistent with a clear respira-
tory deficiency, strongly implicated Sdh5 in the maintenance
of SDH activity. This connection with SDH was further
strengthened by the observation that yeast cells lacking Sdh5
exhibited a complete loss of SDH activity and, in this regard,
essentially mirrored an sdh1D deletion strain. Despite these
phenotypic similarities, however, Sdh1 protein was still
clearly detectable, albeit at reduced levels, in an sdh5D
mutant strain and, interestingly, the SDH complex remained
intact (Hao et al., 2009; Kim et al., 2012).
Based on the above evidence, it is clear that Sdh5 is
required for maintaining SDH activity and that this function is
mediated through a direct physical interaction with Sdh1.
These data raised the possibility that the primary defect in
sdh5D cells might be failure to covalently flavinylate Sdh1,
resulting in a catalytically dead subunit. Indeed, direct
interrogation of Sdh1 flavinylation revealed a complete
failure to form the covalent bond between Sdh1 His90
and the FAD cofactor. This finding is consistent with
related studies that demonstrate flavinylation-deficient Sdh1
His90Ser mutants assemble into a catalytically inactive
SDH complex as do sdh5D mutants (Hao et al., 2009;
Robinson et al., 1994).
It is clear that Sdh5 is required for Sdh1 flavinylation but
through what mechanism? The first important clues resulted
from further interrogation of the nature of the Sdh1–Sdh5
interaction. BN-PAGE experiments demonstrated that Sdh5 is
not a member of the SDH holo-complex but rather migrates to
an approximate molecular weight of 90 kDa, consistent with
an Sdh1–Sdh5 dimer. Further investigation of this interaction
revealed that the formation of this complex is important in
maintaining the stability of both proteins. The steady-state
levels of Sdh1 are !50% reduced in an sdh5D mutant strain.
Conversely, deletion of SDH1 causes a near complete
destabilization of Sdh5, a result that strongly implicates
Sdh5 as a dedicated factor whose sole purpose is to act on
Sdh1. While Sdh1 protein is required to maintain the stability
of Sdh5, this relationship is not dependent on Sdh1 being
competent for flavinylation as substitution of Sdh1 His90 with
a Ser residue does not lead to destabilization of Sdh5. It is
important to note that only a minor fraction of Sdh1 in the
matrix is in association with Sdh5 at any given time.
Furthermore, deletion of SDH2 causes the steady-state level
of Sdh5 to increase, most likely due to an increase in the
fraction of Sdh1 that is bound to Sdh5. As this complex exists
independent of all other SDH subunits and accumulates in
strains that prevent SDH assembly, it is clear that the actions
of Sdh5 and the process of flavinylation are early steps in the
SDH assembly pathway (Hao et al., 2009; Kim et al., 2012).
Further insights into the role of Sdh5 in Sdh1 flavinylation
came from structural characterization of yeast Sdh5 by NMR
(Eletsky et al., 2012). No FAD was detected in purified
samples of Sdh5, nor did the addition of FAD to purified Sdh5
cause any perturbation in Sdh5 chemical shifts, suggesting
that Sdh5 does not act as a delivery vehicle that brings FAD to
apo-Sdh1 (Eletsky et al., 2012). The NMR studies revealed
that the Sdh5 core assumes a compact 5 a-helical bundle and
revealed a concentrated patch of conserved residues on the
surface of these a-helices, which is theorized to be the Sdh1
binding site (Eletsky et al., 2012)
While it is not yet possible to define the precise
mechanism by which Sdh5 supports Sdh1 flavinylation,
there is sufficient data to hypothesize as to the role of Sdh5
in this process. Biochemical studies have demonstrated that
Sdh5 does not directly bind FAD, thus it seems unlikely that
Sdh5 plays a role in physically delivering FAD to Sdh1.
While the Sdh1 binding site on Sdh5 has been defined in the
above NMR-based study, the region of Sdh1 that binds Sdh5
remains unknown. This information would provide insight
into the role of Sdh5 in Sdh1 flavinylation, but for now we are




forced to theorize as to such details. It seems likely that Sdh5
binds adjacent to the FAD binding site on apo-Sdh1, which
could serve one or more of many possible roles. First, it could
facilitate the non-covalent insertion of FAD into the pocket,
which would enable subsequent autocatalytic covalent
flavinylation. Second, Sdh5 could act as a chaperone for
unflavinylated apo-Sdh1, thus supporting flavinylation by
stabilizing apo-Sdh1 in a flavinylation-competent conform-
ation. Finally, it is possible that Sdh5 might participate
directly in the covalent flavinylation reaction by providing
catalytic residues to this active site. Regardless of the precise
mechanism, it is clear that Sdh5 specifically binds to apo-
Sdh1 and is required for its covalent flavinylation (Figure 3).
Sdh8 is a chaperone for flavinylated Sdh1
Following Sdh5-dependent covalent flavinylation, Sdh1 is
destined to form a soluble dimer with Sdh2; however, there
remains a population of Sdh1 that exists in an unbound state
free from any other core subunits in the mitochondrial matrix.
It is likely that Sdh1 is present in excess to other core SDH
subunits within the mitochondrial matrix as deletion of Sdh1
destabilizes the remaining core subunits, Sdh2, Sdh3 and
Sdh4, while Sdh1 protein levels are maintained, albeit at a
reduced level, upon deletion of any of the other core subunits.
This free, flavinylated Sdh1 appears to be maintained in a
soluble, assembly-competent state by a newly discovered,
subunit-specific chaperone, Sdh8 (Figure 3).
SDH8 is conserved throughout eukaryotes and encodes a
small protein that is localized to the mitochondrial matrix
(Van Vranken et al., 2014). Yeast cells lacking Sdh8 exhibit
slow growth on non-fermentable carbon sources but are still
respiratory competent. The first observation that suggested a
role for Sdh8 in SDH assembly or activity was its
metabolomics phenotype. Yeast cells and Drosophila mutants
lacking Sdh8 (or its ortholog) exhibit a significant but subtle
block in the TCA cycle centered at SDH (i.e. an accumulation
of succinate and a depletion of fumarate and malate, the two
TCA cycle intermediates downstream of SDH). It is important
to note that the magnitude of succinate accumulation is much
less than a mutant lacking one of the four core subunits or
Sdh5, which exhibits a complete loss of SDH activity.
Consistent with this finding, sdh8D mutant yeast maintain
approximately 40% of wild-type SDH activity and abundance
of SDH holo-complexes. Interestingly, deletion of the
Drosophila ortholog, dSdhaf4, causes a much more severe
phenotype. These mutants accumulate significantly more
succinate and have a !90% decrease in SDH activity, while
assembled SDH complexes are nearly undetectable. Thus,
while Sdh8 clearly supports SDH biogenesis, it does not
appear to be absolutely required for assembling functional
SDH complexes as some level of SDH activity is maintained
in organisms lacking Sdh8 or its orthologs (Van Vranken
et al., 2014).
While metabolomics clearly implicated Sdh8 in enabling
SDH activity, the first evidence as to its particular function
came when Sdh1 was discovered to be its primary binding
partner. Further interrogation of the specificity of this
interaction revealed that Sdh8 bound to Sdh1 independent
of any other SDH core subunits and importantly, Sdh5. In
addition, it was determined that the Sdh1–Sdh8 interaction
depends on covalent flavinylation of Sdh1, as Sdh8 fails to
interact with Sdh1 in an sdh5D background and also fails to
interact with two covalent flavinylation-deficient Sdh1
mutants (H90S and H90A). BN-PAGE analysis further
confirmed that Sdh8 is not associated with the SDH
Figure 2. Iron-sulfur cluster synthesis and delivery to Sdh2. The tan box depicts the de novo synthesis of 2Fe–2S clusters within the ISU complex.
Clusters are formed on the Isu1 scaffold protein with sulfide ions provided by the Nfs1 cysteine desulfurase and Yah1 ferredoxin. It is not clear how
ferrous ions are delivered to the ISU complex. The preformed 2Fe–2S cluster is released from the scaffold complex through the actions of Hsp70 (Ssq1)
and DnaJ (Jac1) to a transfer complex consisting of GSH-bound Grx5. The GSH–Grx5 delivers 2Fe–2S clusters to the ISA complex for the subsequent
4Fe–4S cluster synthesis depicted in the blue box. However, it is elusive whether the GSH-Grx5 is also required for 2Fe–2S cluster delivery to recipient
proteins, in this case, Sdh2. It is also unknown whether the preformed 4Fe–4S clusters are directly delivered to Sdh2 or another factor is in need for this
delivery step. All arrows with solid lines indicate transfer of components of Fe–S clusters or pre-formed Fe–S clusters.




holo-complex, but forms a stable subcomplex with Sdh1,
which hyper-accumulates in sdh2D and sdh4D backgrounds.
Consistent with this finding, Sdh8 steady-state protein levels
also increase in these conditions, presumably to occupy the
augmented pool of unbound and flavinylated Sdh1.
Furthermore, deletion of Sdh1 causes significant destabiliza-
tion of Sdh8, indicating that the stability of Sdh8 depends
upon its ability to form a complex with Sdh1. Taken
together, these data indicate that Sdh8 is a subunit-specific
chaperone that occupies flavinylated Sdh1 prior to the forma-
tion of the Sdh1–Sdh2-soluble dimer (Van Vranken et al.,
2014; Figure 3).
Why exactly does unbound Sdh1 require such a chaperone?
The first evidence came from assessing the steady-state levels
of SDH core subunits in the sdh8D mutant. While there was
little or no destabilization of Sdh1, the primary binding
partner of Sdh8, there was a marked decrease in the steady-
state abundance of Sdh2. This was accompanied by, and
probably a result of, a decrease in the Sdh1–Sdh2 soluble
dimer as assessed by co-immunoprecipitation. Although this
result is somewhat difficult to interpret, it suggests that the
interaction between Sdh1 and Sdh8 facilitates the formation
of the Sdh1–Sdh2 dimer by maintaining Sdh1 in a state that
is competent for Sdh2 binding. Therefore, in the absence of
Sdh8, Sdh1 does not interact as efficiently with Sdh2, which
is unstable on its own. Interestingly, studies focused on
Drosophila dSdhaf4 demonstrate that this assembly factor
is required for maintaining the stability of SdhA. Therefore,
it is possible that in higher eukaryotes Sdh8 orthologs support
the formation of the hydrophilic head by maintaining subunit
stability. Overall, this data suggests that the chaperone
activity of Sdh8 promotes SDH assembly by stabilizing
Sdh1 and maintaining it in an assembly-competent state prior
to interaction with Sdh2 (Van Vranken et al., 2014).
In addition to promoting formation of the Sdh1–Sdh2
dimer, Sdh8 might also function to prevent potentially
deleterious interactions of free and flavinylated Sdh1 with
the solvent. Indeed, studies focused on SDH have demon-
strated that impaired electron transport at the level of the FAD
can generate significant quantities of superoxide (Ishii et al.,
2005; Messner & Imlay, 2002; Yankovskaya et al., 2003).
Furthermore, previous studies in mammalian cells demon-
strate that silencing of SDHB (Sdh2 ortholog), but not SDHA
(Sdh1 ortholog) causes an increase in ROS levels (Guzy et al.,
2008; Ishii et al., 2005). This increase in oxidative stress
mediated by Sdh1 is thought to be dependent on the ability of
the exposed FAD cofactor to interact with the surrounding
solvent. In a phenomenon referred to as auto-oxidation, free
Sdh1 oxidizes succinate to fumarate independent of the SDH
holo-complex. This oxidation causes a reduction of the FAD
cofactor, which then reduces molecular oxygen to form
superoxide (Messner & Imlay, 2002). If Sdh8 functions to
prevent Sdh1 auto-oxidation then overexpression of Sdh1
should be toxic to sdh8D mutant cells. In fact, Sdh1
overexpression proved toxic to both WT and sdh8D mutant
cells; however, cells lacking Sdh8 were particularly sensitive
Figure 3. Model of the SDH assembly
pathway. Each SDH core subunit is trans-
lated in the cytosol and must be subsequently
translocated to the mitochondria. (1) Upon
mitochondrial import, apo-Sdh1 is rapidly
bound by the subunit-specific chaperone,
Sdh5, forming a dimeric complex that sup-
ports covalent attachment of the FAD cofac-
tor. (2) Following covalent flavinylation, the
Sdh1–Sdh5 dimer disintegrates resulting in a
pool of flavinylated Sdh1 that is unbound by
any other core subunits. This leads to the
formation of a complex comprised of Sdh1
and Sdh8, another subunit-specific chaper-
one. (3) The formation of this complex
supports the formation of the subsequent
Sdh1–Sdh2 soluble dimer and also prevents
the spurious production of superoxide by
flavinylated Sdh1. Meanwhile, apo-Sdh2
must also mature into a complex-competent
subunit. This process involves the insertion of
three Fe–S clusters generated by the ISU and
ISA complexes. (4) Following maturation of
Sdh2, it interacts with Sdh6 and Sdh7, which
serve to protect exposed Fe–S clusters during
the assembly process and (5) further associ-
ates with a mature Sdh1 subunit forming a
heterotetrameric assembly intermediate. (6)
Finally, the Sdh1–Sdh2 hydrophillic head
docks to the IMM via interactions with the
Sdh3–Sdh4 membrane anchor domain, which
may or may not pre-assemble at the IMM. In
the end, the concerted efforts of core sub-
units, dedicated assembly factors and other
ancillary factors facilitate the stepwise
assembly of SDH. (see colour version of this
figure at www.informahealthcare.com/bmg).




to this stress. Furthermore, overexpression of Sdh8 was
capable of partially rescuing the toxicity associated with
overexpressed Sdh1. Additional studies demonstrated that
sdh8D mutant cells exhibited higher levels of oxidative stress
and that the growth phenotype associated with sdh8D mutant
cells was predominantly the result of oxidative stress rather
than respiratory deficiency. Indeed, while overexpression of
YAP1, a transcription factor involved in mediating oxidative
stress, is capable of rescuing the sdh8D growth phenotype it
fails to have any impact on the SDH deficiency of these cells
(Van Vranken et al., 2014). Therefore, Sdh8 might have two
important functions related to Sdh1. It appears to facilitate
assembly with Sdh2 and may also function to seclude the
FAD cofactor from the solvent, thus preventing spurious
oxidation (Van Vranken et al., 2014).
Sdh2 – the electron wire
Architecture of Sdh2
Sdh2 (SDHB in mammals) is the Fe–S cluster-containing
subunit of SDH. The crystal structure of porcine heart SDH
demonstrates that SDHB contains two distinct domains (Sun
et al., 2005; Figure 1). The N-terminal domain (residues
37–142; human sequence) consists of a single small a-helix
and a five-strand b-sheet. This domain harbors the FAD-
proximal 2Fe–2S center, which is ligated by Cys93, Cys98,
Cys101 and Cys113. The C-terminal domain (residues 142–
280) consists of six a-helices and harbors the 4Fe–4S and
3Fe–4S centers, which are coordinated by Cys186, Cys189,
Cys192 and Cys253 and Cys196, Cys243 and Cys249,
respectively. These three Fe–S centers essentially act as a
wire that carries electrons from FAD to ubiquinone. SDHB
also serves to connect the catalytic subunit, SDHA, with the
hydrophobic anchor domain. Both the N-terminal domain and
the C-terminal domain mediate the interaction with SDHA.
Meanwhile, the C-terminal domain is mainly responsible
for the interaction with the hydrophobic anchor domain.
Importantly, SDHB contributes several residues to the
ubiquinone-binding site, which otherwise is mediated by the
hydrophobic anchor domain. In this way, the terminal 3Fe–4S
center is poised adjacent to the ubiquinone to enable the final
electron transfer (Sun et al., 2005).
Iron–sulfur cluster biogenesis
The aforementioned Fe–S clusters are key cofactors required
for electron transfer from FAD to the QP site. Fe–S clusters
are preformed in the mitochondrial matrix on a scaffold
complex (ISU) consisting of four proteins, Nfs1, Isd11, Yfh1
and Isu1 (or Isu2; yeast nomenclature) (Lill et al., 2012;
Schmucker et al., 2011; Tsai & Barondeau, 2010). The sulfide
ions necessary for cluster biogenesis are provided by the Nfs1
cysteine desulfurase, along with its effector proteins Isd11
and Yfh1 (Pandey et al., 2012, 2013) and the Yah1 ferredoxin
reductant (Sheftel et al., 2010). Fe(II) and sulfide ions form
2Fe–2S clusters on the Isu1 (or Isu2) scaffold proteins prior to
transfer to client proteins. The preformed cluster is transferred
to the monothiol Grx5, an Fe–S shuttle protein, through the
binding of the DnaJ protein Jac1 to Isu1, which dissociates
the ISU complex (Majewska et al., 2013) and the recruitment
of the Hsp70 enzyme Ssq1. The cluster is released from Isu1
by the ATPase activity of Ssq1 (Ciesielski et al., 2012;
Majewska et al., 2013; Uzarska et al., 2013). Grx5, which is
pre-associated with Ssq1, transiently binds the 2Fe–2S cluster
together with glutathione (GSH) for subsequent transfer steps
(Banci et al., 2014; Johansson et al., 2011; Uzarska et al.,
2013). The human ortholog of Jac1 was shown to also
bind Fe–S client proteins, so Grx5-mediated cluster transfer
may occur in pre-bound complexes with client proteins
(Maio et al., 2014). Clusters consisting of 4Fe–4S and
perhaps 3Fe–4S stoichiometries are matured on a downstream
ISA scaffold complex consisting of Isa1, Isa2 and Iba57
(Gelling et al., 2008; Muhlenhoff et al., 2011; Sheftel et al.,
2012) and perhaps Nfu1 (Cameron et al., 2011; Lill et al.,
2012; Navarro-Sastre et al., 2011). Nfu1 is likely a targeting
factor to Fe–S client proteins in bacteria (Py et al., 2012).
Yeast depleted of ISU components or the Fe–S targeting
factors Grx5, ISA components and Nfu1 are impaired in SDH
activity (Jensen & Culotta, 2000; Muhlenhoff et al., 2011;
Rodriguez-Manzaneque et al., 2002). Mutations in human
orthologs of Isd11, Isu1, Iba57 or Nfu1 (Ajit Bolar et al.,
2013; Cameron et al., 2011; Crooks et al., 2012; Ferrer-
Cortes et al., 2013; Hall et al., 1993; Lim et al., 2013;
Navarro-Sastre et al., 2011) or RNAi depletion of Isa1, or Isa2
lead to compromised SDH function (Sheftel et al., 2012;
Figure 2).
Recently, mutations in a novel mitochondrial protein
BolA3 were shown to result in defects in similar respiratory
complexes and 2-oxoacid dehydrogenases as mutations in
Nfu1 (Baker et al., 2014; Cameron et al., 2011), suggesting
that BolA3 may likewise function in late stages of mitochon-
drial Fe–S biogenesis or transfer. BolA proteins typically
function with glutaredoxins (Li & Outten, 2012), therefore,
one prediction is that BolA3 has a role in conjunction
with Grx5.
Sdh2 cofactor insertion
The architecture of Sdh2 raises several questions regarding
cofactor insertion and maturation. Analogous to Sdh1, which
receives its FAD cofactor within the mitochondrial matrix,
Sdh2 receives its three Fe–S clusters in the matrix after
import (Figure 3). Based on the Fe–S biogenesis pathway
outlined above, one prediction is that the 2Fe–2S center in the
N-terminal domain of Sdh2 is received from the Grx5:GSH
complex, whereas the clusters in the C-terminal domain may
be populated by the late-stage targeting factors ISA and Nfu1.
Recently, Maio et al. (2014) reported that the mammalian
Jac1 ortholog HSC20, the Ssq1 ortholog HSPA9 and the Isu1
scaffold, ISCU, form a complex with SDHB. This SDHB
assembly intermediate was visualized on BN-PAGE after co-
immunoprecipitation of SDHB. SDH activity appeared to be
attenuated upon depletion of HSC20 or HSPA9 using siRNA
knock down. Therefore, the study suggested that cluster
transfer to SDHB occurs within this complex. In vitro
synthesized SDHB is readily imported into isolated mito-
chondria. Co-immunoprecipitation of the imported SDHB at
different time points revealed that the interaction of SDHA
with SDHB comes later than the formation of the HSC20/
HSPA9/ISCU/SDHB complex, indicating that cluster transfer




may precede binding of SDHB to SDHA. However, the ISA
components and Nfu1 failed to be co-adsorbed with the
HSC20 pulldown. These results may imply that only the
2Fe–2S center is transferred within the HSC20/HSPA9/ISCU/
SDHB complex and a subsequent transfer step mediates
insertion of the C-terminal SDHB clusters. This process could
be either a zip-up from 2Fe–2S through 3Fe–4S or a zip-down
from 3Fe–4S through 2Fe–2S. Alternatively, SDHB may
remain associated with HSC20 during the insertion of the
4Fe–4S and 3Fe–4S centers, although the targeting factors
may not stably associate with the HSC20/HSPA9/ISCU/
SDHB complex (Maio et al., 2014).
It should be noted that reduced Cys thiolates are required
for Fe–S clusters to be assembled into Sdh2 as oxidized Cys
ligands cannot coordinate Fe–S clusters. However, it is
unknown whether cells depend on the thioredoxin/thioredoxin
reductase, glutathione/glutathione reductase or peroxiredoxin
to ensure the presence of thiolates for Fe–S coordination.
It is also intriguing how meta-stable Sdh2 intermediates are
protected specially from ROS after Fe–S cluster insertion.
It has been well known that Fe–S clusters are extremely
susceptible for damage upon exposure to oxygen (Imlay,
2006). Since 2Fe–2S and 3Fe–4S clusters are exposed to
solvent in Sdh2 prior to association with Sdh1 and the
membrane anchor domain, it is possible that specialized
chaperones are required to sequester these Fe–S clusters from
oxidative stressors present in the solvent.
In the following section, we discuss two recently reported
SDH assembly factors required for the maturation of Sdh2.
Sdh6 and Sdh7 are chaperone required for Sdh2
maturation
Sdh6 (SDHAF1 in human) is the first SDH assembly factor
reported. Mutations in human SDHAF1 compromise the
stable assembly of SDH, which leads to SDH deficiency
associated with infantile leukoencephalophaty (Ghezzi et al.,
2009, Ohlenbusch et al., 2012). Sdh6 is a small mitochondrial
matrix protein that belongs to the LYR motif protein family,
which is defined by the presence of a short
LX(L/A)YRXX(L/I)(R/K) motif. Previous studies showed
that the functions of several other LYR motif proteins are
related to Fe–S cluster metabolism. Ghezzi et al. reported that
yeast or human cells lacking wild-type Sdh6 (or its ortholog)
exhibited significantly reduced SDH activity, accompanied by
attenuation of SDH assembly (Ghezzi et al., 2009). They
suggested the possibility that Sdh6 is an assembly factor
required for the Fe–S containing subunit, Sdh2, based on the
fact that Sdh6 is an LYR motif protein. While prescient, this
hypothesis remained unproven as the biochemical data
supporting it were not yet available. We recently reported
that Sdh6 is indeed an assembly factor required for stable
Sdh2 maturation during SDH assembly (Na et al., 2014).
In yeast cells lacking Sdh6, Sdh2 steady-state levels were
significantly diminished, but Sdh1 steady-state levels and
covalent flavinylation remained unaffected. Moreover, Sdh6
appeared to accumulate in sdh3D or sdh4D cells lacking the
SDH membrane anchor domain where an Sdh1/Sdh2
subcomplex accumulated. Furthermore, immunoprecipitation
of Sdh6 in mitochondrial lysates from cells lacking Sdh4
resulted in co-precipitation of Sdh1 and Sdh2, but immuno-
precipitation of Sdh6 in WT or sdh2D mutants failed to yield
Sdh1 or Sdh2. Thus, these results suggested that Sdh6
interacts with an Sdh1/Sdh2 complex and the interface for the
interaction resides within Sdh2 (Figure 3). Indeed, Sdh6
overexpression in sdh1D mutants, in which Sdh2 is extremely
labile, increased Sdh2 accumulation, thus, corroborating the
postulate that Sdh6 acts on Sdh2 during SDH assembly.
Why does Sdh2 require the function of Sdh6 during
the process of SDH assembly? One possibility is that Sdh6
is a chaperone stabilizing Sdh2 prior to Sdh1 association.
However, Sdh2 overexpression failed to restore SDH activity
in sdh6D mutants. Thus, Sdh6 likely exerts its function on
Sdh2 maturation rather simply maintaining an apo-Sdh2 pool.
Unbiased high-copy genetic suppressor screening provided
a hint regarding Sdh6 function (Na et al., 2014). Yap1, a
transcription factor that increases expression of a repertoire
of genes required for oxidative stress tolerance was recovered
from this screen. Yap1 overexpression enhanced the respira-
tory growth of sdh6D mutants and restored SDH activity.
Conversely, artificially increased superoxide generation in the
presence of paraquat severely impaired the respiratory growth
of sdh6D cells. Moreover, Sdh2 protein levels under this
condition were dramatically decreased. Given that ROS levels
were not increased in sdh6D mutants, this exacerbated
phenotype with paraquat suggests that Sdh6 is important for
protecting Sdh2 from ROS-induced damage.
In the meantime, a genetic interaction between Sdh6 and
Acn9 (renamed Sdh7), another protein in the LYR motif
protein family, was observed. Sdh7 is also a small mitochon-
drial matrix protein, required for normal respiratory growth.
Overexpression of Sdh6 in sdh7D mutants slightly rescued the
respiratory growth defect although overexpression of Sdh7 in
sdh6D mutants failed to do so. Metabolite profiling suggested
an SDH deficiency in sdh7D mutant cells as succinate
accumulated in the mutants. BN-PAGE analysis and SDH
activity assay confirmed SDH deficiency with reduced SDH
complex levels in sdh7D mutants. Biochemical analysis of
sdh7D mutants suggested that Sdh7 function is similar to that
of Sdh6 (Na et al., 2014). Among the SDH structural
subunits, the steady-state levels of Sdh2 were the most
impaired in sdh7D mutants. Sdh7 exhibited increased abun-
dance and interaction with the Sdh1/Sdh2 subcomplex in cells
lacking the SDH membrane anchor. In addition, Yap1
overexpression restored SDH activity and paraquat supple-
ment markedly attenuated Sdh2 steady-state levels in sdh7D
cells. However, Sdh2 overexpression failed to restore SDH
activity in sdh7D cells. Thus, these results suggested that
Sdh7 is another assembly factor for protecting Sdh2 from
ROS damage. Deletion of the Drosophila melanogaster SDH7
ortholog, dSdhaf3, caused a dramatic SDH deficiency with
muscular and neuronal defects that are reminiscent of
neurodegeneration observed in humans with mutations in
SDHAF1 (Na et al., 2014).
It is clear that Sdh6 and Sdh7 support the assembly of SDH
under normal physiological conditions, although their defi-
ciencies do not result in total ablation of SDH biogenesis.
This might be due to a theoretical bypass pathway that can
substitute for Sdh6 and Sdh7 functions. Otherwise, the
importance of these two assembly factors is limited with




passive roles for Sdh2 maturation under certain circum-
stances. Our study shows that iron salt supplementation
enhances the respiratory growth of sdh6D cells and sdh7D
cells. It has been shown that ROS-inactivated aconitase under
aerobic conditions regains activity following iron salt supple-
mentation (Kennedy et al., 1983). The active site of aconitase
harbors a 4Fe–4S cluster, which loses one Fe atom upon
exposure to superoxide, resulting in inactivation. Increased
concentration of iron salts facilitates re-insertion of Fe(II) ion
back into the damaged 3Fe–4S center, leading to reactivation
of aconitase. Therefore, it is possible that Sdh6 and Sdh7
are involved in shielding the aforementioned solvent-exposed
Fe–S centers from ROS until an Sdh1/Sdh2 complex is fully
assembled with Sdh3 and Sdh4. A recent study on Fe–S
cluster insertion to SDHB has revealed that SdhB (Sdh2) can
be expressed as two separate domains in vivo and SDHAF1
(Sdh6) interacts with the C-terminal domain of SdhB, but
not with the N-terminal domain (Maio et al., 2014). The
C-terminal domain harbors 4Fe–4S and 3Fe–4S centers
(Sun et al., 2005). Therefore, it is possible that Sdh6 is
required for protecting the solvent-exposed 3Fe–4S center
from ROS damage. However, there is no data suggesting how
Sdh7 would exert its protection on Sdh2.
The origin of the damaging ROS is unclear, but a likely
source is either the 2-oxoacid dehydrogenases including
2-oxoglutarate dehydrogenase and pyruvate dehydrogenase or
the respiratory complexes (Quinlan et al., 2014). However,
it is also possible that ROS generated intrinsically within an
Sdh1/Sdh2 subcomplex might play a role. Like flavinylated
monomeric Sdh1, an Sdh1/Sdh2 subcomplex is also compe-
tent to catalyze succinate oxidation (Lemire & Oyedotun,
2002; Nihei et al., 2001). It is expected that the electrons
extracted from succinate oxidation can travel to Fe–S centers.
Once the electrons reach the solvent-exposed surface via Fe–S
centers, the electrons can react with oxygen to generate local
ROS that can damage Fe–S centers in the vicinity. Therefore,
one alternative role of Sdh6 and Sdh7 might be that they
interact with an Sdh1/Sdh2 complex to inhibit the electron
transfer to Fe–S centers within the subcomplex.
It has also been suggested that Sdh6 may be directly
involved in the process for Fe–S insertion into Sdh2 based on
the observation that the SDH assembly factor SDHAF1
(Sdh6) was recovered in the immunoadsorption of HSC20
(Maio et al., 2014). It remains unclear, however, whether
SDHAF1 is a dedicated Fe–S targeting factor for SDHB since
no additional evidence is available to show that Sdh6 has an
active role in Fe–S cluster formation.
Sdh3 and Sdh4 – the hydrophobic anchor
Architecture of the hydrophobic anchor
The SDH membrane anchor consists of an Sdh3–Sdh4
heterodimer and an intercalated heme b moiety. The structure
of mammalian SDH demonstrates that SDHC contains four
total helices while SDHD contains five (Sun et al., 2005;
Figure 1). The N-terminal helix of SDHD is localized to the
mitochondrial matrix and interacts with SDHB to promote
membrane localization of the hydrophilic dimer. Each subunit
contributes two transmembrane helices to the formation of a
four-helix bundle, which comprises the core of the membrane
anchor, while the remaining transmembrane helix from each
subunit flanks the core. The remaining helices from each
subunit protrude from the membrane and arrange in antipar-
allel fashion in the IMS essentially capping the transmem-
brane core. In addition to the helical arrangement of this
domain, the structure reveals that SDHC and SDHD coord-
inate a heme b cofactor at the interface of the core four-helix
bundle, which interacts with the porphyrin ring. Each subunit
contributes a conserved histidine residue that coordinates
the heme iron while two arginine residues, one from
SDHC and one from SDHD, as well as another histidine
residue from SDHC interact with the heme propionate groups
(Sun et al., 2005).
The membrane anchor domain contains the site of
ubiquinone binding and reduction, which ultimately facilitates
electron transfer from succinate to subsequent ETC com-
plexes (Sun et al., 2005). In fact, this domain contains two
ubiquinone binding sites that are distinguished by their
disparate affinities for ubiquinone (Oyedotun & Lemire,
2001; Silkin et al., 2007). The high-affinity site (QP-proximal)
lies on the matrix-proximal side of the IMM and is the
dominant ubiquinone binding site (Figure 1). The QP site is
composed of residues from SDHC, SDHD and SDHB
including the terminal 3Fe–4S cluster of SDHB (Sun et al.,
2005). The second binding site (QD-distal) lies closer to the
IMS side of the IMM and is a lower affinity site. This site is
composed entirely of residues from SDHD (Sun et al., 2005).
Ubiquinone reduction occurs in two stepwise single electron
transfers, in contrast to the two-electron reduction of FAD.
Importantly, the QP site stabilizes the partially reduced
semiquinone intermediate and facilitates full reduction of
ubiquinone to ubiquinol, thereby preventing the generation
of reactive oxygen species (ROS; Yankovskaya et al., 2003).
Assembly of the hydrophobic anchor
With respect to assembly of the hydrophobic anchor, there
remain more questions than answers. Sdh3 and Sdh4 are
translated in the cytosol and imported to mitochondria
through the TOM complex. They may then be transferred to
the TIM23 complex in the IMM and laterally released to the
final destination like other a-helical transmembrane IMM
proteins (Dudek et al., 2013). Unfortunately, membrane
insertion represents the bulk of our knowledge regarding
assembly of this dimer and thus many questions remain.
Do Sdh3 and Sdh4 folding and subsequent dimer formation
require a chaperone? How is the Sdh3–Sdh4 assembly
intermediate stabilized prior to formation of the holo-
complex? Although little is known about this process, it is
intriguing that stable Sdh3/Sdh4 dimerization requires the
hydrophilic domain as deletion of either Sdh1 or Sdh2 causes
near complete loss of both Sdh3 and Sdh4 (Kim et al., 2012;
Na et al., 2014). Thus, it appears that biogenesis of the
hydrophobic anchor is in some manner connected to the rest
of the assembly process.
Perhaps the most intriguing question regarding the hydro-
phobic anchor relates to the heme b cofactor. In fact, it is
unclear whether heme b is actually required for the electron
transfer from FAD to ubiquinone in the QP site. The heme b
lies further away from the 3Fe–4S (13.3 A˚) than the QP site




does (7.6 A˚; Sun et al., 2005; Yankovskaya et al., 2003).
Moreover, the redox potential of heme b (!185mV) is much
lower than the 3Fe–4S (+60mV) in SDH (Ha¨gerha¨ll, 1997).
Therefore, these two barriers would make the electron transfer
from 3Fe–4S to heme b thermodynamically unfavorable
compared to the direct electron transfer to ubiquinone
(+113mV). In fact, SDH complexes lacking heme b (from
yeast cells expressing Sdh3 H106A and Sdh4 C78A heme-
ligand mutants) appeared to be able to catalyze succinate-
dependent quinone reduction (Oyedotun et al., 2007).
It should be noted, however, that the heme b is important
for the structural integrity of the membrane anchor domain
in mammalian cells. SDH and SDHD steady-state levels were
decreased in cells expressing SDHC His-ligand mutants
(H127A or H127Y) in the absence of wild-type SDHC
(Lemarie et al., 2011).
Regardless of its precise function, the heme b cofactor is
present in SDH across all species, suggesting its importance
in either electron transfer or complex stability. However, it is
not yet known how Sdh3 and Sdh4 are assembled with heme b
in the IMM. Does an assembly factor deliver and/or insert the
heme b into a pre-existing Sdh3/Sdh4 dimer? It has been
shown that several assembly factors, including Coa1, Coa2
and Shy1, are required for proper heme insertion into the
complex IV subunit Cox1 in the IMM (Atkinson et al., 2010;
Mashkevich et al., 1997; Pierrel et al., 2007, 2008).
Therefore, one might expect that an assembly factor is
required for SDH hemylation. Overall, studies addressing the
assembly of this domain represent an important next step in
understanding SDH biogenesis.
Conclusion
Prior to the discovery of the assembly factors reviewed herein,
it was difficult to fully appreciate the complexity of the SDH
assembly pathway. This is perhaps best illustrated by the fact
that at least four and quite possible more, dedicated assembly
factors are required for the maturation of the two soluble
subunits alone. This does not even consider the process of
assembling the Sdh3–Sdh4 hydrophobic domain. In the end,
the assembly of SDH does not happen spontaneously, but is
rather the result of a highly intricate and stepwise process
facilitated by the concerted efforts of a number of accessory
assembly factors.
These discoveries have dramatically increased our under-
standing of the assembly process and allow us to propose a
more complete model of the SDH assembly pathway (Ghezzi
et al., 2009; Hao et al., 2009; Na et al., 2014; Van Vranken
et al., 2014; Figure 3). Following cytosolic translation, Sdh1
and Sdh2 are imported into the mitochondrial matrix as apo-
proteins. Each of these subunits must subsequently mature in
a process that is facilitated by subunit-specific assembly
factors. Upon import, Sdh1 must be flavinylated and is bound
by Sdh5, which enables this process. Although the precise
mechanism remains poorly defined, Sdh5 most likely main-
tains apo-Sdh1 in a confirmation that facilitates insertion and
covalent binding of FAD. Once Sdh1 has been covalently
flavinylated, Sdh5 is released and holo-Sdh1 binds another
subunit-specific chaperone, Sdh8. Sdh8 appears to serve dual
roles in the process of assembly. First, Sdh8 prevents the
generation of superoxide by Sdh1 through limiting the
spurious reduction of oxygen. In addition to this, Sdh8 also
appears to facilitate the formation of the Sdh1–Sdh2 soluble
dimer. Like Sdh1, apo-Sdh2 must also mature prior to
complex formation. The initial step in the maturation of this
subunit is the insertion of the three Fe–S clusters generated
by the ISU and ISA complexes. At this point, both Sdh1 and
Sdh2 have matured into holo-proteins and can proceed
through the assembly process. Sdh2 comes into association
with two additional chaperones, Sdh6 and Sdh7 as it forms a
soluble complex with Sdh1, thereby displacing Sdh8 and
generating a heterotetrameric assembly intermediate. This
intermediate, which is facilitated by Sdh6 and Sdh7, serves to
protect surface-exposed Fe–S clusters and possibly prevents
the spurious generation of superoxide by the redox active
Sdh1–Sdh2 dimer. Finally, the Sdh1–Sdh2 dimer is bound by
the Sdh3–Sdh4 hydrophobic domain, which may or may not
be pre-assembled in the IMM, bringing the hydrophilic head
in close association with the IMM and forming the active
holo-complex (Figure 3).
In general, the contribution of subunit-specific assembly
factors to the process of SDH assembly can be organized into
three distinct functions. First, they mediate the insertion of
essential cofactors. All ETC complexes utilize cofactors to
perform the redox chemistry necessary to oxidize and reduce
substrates and transfer electrons. Therefore, the maturation
of individual subunits and subsequent assembly of active
complexes is dependent on the post-translational insertion of
essential redox-active cofactors. This is highlighted by the
fact that eukaryotic genomes have maintained a specific Sdh1/
SDHA flavinylation factor, which is absolutely required for
the covalent attachment of FAD to this subunit. It remains to
be determined whether Sdh6 or Sdh7 also has an active role in
the insertion of one or more of the Fe–S clusters in Sdh2.
Second, assembly factors act as subunit-specific chaper-
ones that stabilize individual subunits and assembly inter-
mediates. The process of SDH, and more generally, ETC
assembly, relies on the step-wise assembly of potentially
dozens of individual subunits translated from two different
genomes to form a single intricately constructed complex. As
the structures of individual subunits are optimized to exist and
function in the context of fully assembled complexes, it is not
surprising that individual subunits and sub-complexes require
chaperones to maintain stability during assembly. In terms of
SDH assembly, this has been validated by discovery of
specific factors that mediate the stability of both individual
subunits and multimeric assembly intermediates. Indeed,
work in Drosophila has demonstrated that the fly ortholog of
Sdh8 is required for stabilization of holo-SdhA. Furthermore,
the requirement for stabilizing holo-assembly intermediates is
more manifested in the case of assembly intermediates
containing oxidatively labile cofactors such as Fe–S centers.
Sdh6 and Sdh7 appear to specifically bind and stabilize the
Sdh1–Sdh2 soluble dimer prior to membrane association via
Sdh3/Sdh4.
Third, assembly factors serve to prevent spurious and
potentially deleterious interactions between individual redox-
active subunits and the surrounding solvent. As a result of the
unique chemistry enabled by their cofactors, individual ETC
complex subunits are potentially toxic when not secluded




within a fully assembled complex. Indeed, the cell contains
numerous protein complexes that need to be assembled in an
organized fashion; however, dedicated assembly factors are
much more common for those complexes in which individual
subunits contain redox-active cofactors. This is highlighted by
the role of Sdh8 as a chaperone for covalently flavinylated
Sdh1. In isolation, flavinylated Sdh1 is capable of oxidizing
succinate, which results in the spurious generation of
superoxide upon reduction of molecular oxygen. By occupy-
ing free Sdh1, Sdh8 serves to minimize these deleterious
chemical reactions, thus protecting the matrix from ROS.
Sdh6 and Sdh7, which specifically bind the potentially redox-
active Sdh1–Sdh2 dimer, could potentially mediate similar
protection as Sdh8.
In addition to providing valuable insights into the SDH
assembly pathway the recent discovery of SDH assembly
factors has also facilitated a greater understanding of SDH-
deficient pathologies (Table 1). The literature has many
reports of patients with SDH deficiencies; however, it is clear
that only a subset of these cases can be explained by
mutations in the genes encoding the four core subunits. With
the discovery of a number of proteins intimately involved in
the SDH assembly pathway, this disparity may now start to be
resolved. Indeed, it is now clear that loss of function
mutations in SDH assembly factors are capable of causing
the same pathologies as the core subunits themselves.
Analogous to mutations in SDHA, mutations in SDHAF1,
the human ortholog of SDH6, were discovered as a cause of
leukoencephalopathy, a neurodegenerative disorder similar to
Leigh Syndrome (Ghezzi et al., 2009). Furthermore, muta-
tions in SDHAF2, the human ortholog of SDH5, were shown
to be the causative lesion in at least two families with familial
paraganglioma syndrome, mirroring the physiological conse-
quences of core subunit mutations (Hao et al., 2009).
Currently, there are no published reports describing human
mutations in SDHAF3 (SDH7) or SDHAF4 (SDH8); however,
these genes have only recently been implicated in the SDH
assembly pathway. We suspect that, in time, mutations in
these genes will ultimately be discovered in patients with
SDH-deficient pathologies, thus further clarifying the con-
nection between succinate dehydrogenase and human disease.
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Flavinylation and Assembly of Succinate Dehydrogenase Are
Dependent on the C-terminal Tail of the Flavoprotein
Subunit*
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Background: Succinate dehydrogenase (SDH) requires a covalent addition of FAD for catalytic function.
Results:Mutational analyses of Sdh1 implicate C-terminal region Arg residues involvement in covalent flavinylation and SDH
assembly.
Conclusion: SDH assembly is dependent on FAD binding to Sdh1 but not covalent binding.
Significance: These results document the basis for the SDH deficiency and pathology seen with mutations in human Sdh1.
The enzymatic function of succinate dehydrogenase (SDH) is
dependent on covalent attachment of FAD on the!70-kDa fla-
voprotein subunit Sdh1.We showpresently that flavinylation of
the Sdh1 subunit of succinate dehydrogenase is dependent on a
set of two spatially close C-terminal arginine residues that are
distant from the FAD binding site. Mutation of Arg582 in yeast
Sdh1 precludes flavinylation as well as assembly of the tetra-
meric enzyme complex. Mutation of Arg638 compromises SDH
function only when present in combination with a Cys630 sub-
stitution. Mutations of either Arg582 or Arg638/Cys630 do not
markedly destabilize the Sdh1polypeptide; however, the steady-
state level of Sdh5 is markedly attenuated in the Sdh1 mutant
cells. With each mutant Sdh1, second-site Sdh1 suppressor
mutations were recovered in Sdh1 permitting flavinylation, sta-
bilization of Sdh5 and SDH tetramer assembly. SDH assembly
appears to require FAD binding but not necessarily covalent
FAD attachment. The Arg residues may be important not only
for Sdh5 associationbut also in the recruitment and/or guidance
of FADandor succinate to the substrate site for the flavinylation
reaction. The impaired assembly of SDH with the C-terminal
Sdh1 mutants suggests that FAD binding is important to stabi-
lize the Sdh1 conformation enabling association with Sdh2 and
the membrane anchor subunits.
Succinate dehydrogenase (SDH),4 also known as succinate:
quinone oxidoreductase, is a citric acid cycle enzyme that links
directly to the aerobic respiratory chain. The enzyme catalyzes
the FAD-dependent oxidation of succinate to fumarate coupled
with the reduction of ubiquinone to ubiquinol. SDH is a hetero-
tetrameric integral membrane protein complex. The eukary-
otic enzyme is embeddedwithin themitochondrial innermem-
brane by a hydrophobic module associated with the catalytic
module protruding into the mitochondrial matrix (1). The
hydrophilic catalytic module consists of Sdh1 and Sdh2 sub-
units and the electron transfer cofactors. Succinate oxidation
occurs in the FAD-containing Sdh1 with the abstracted elec-
trons from the reaction shuttled via three iron-sulfur centers in
Sdh2 to the ubiquinone reduction site (QP -proximal) at the
interface of Sdh2 and the membrane anchor (1–4). The Sdh3/
Sdh4membrane domain contains a boundheme bmoiety at the
subunit interface of Sdh3 and Sdh4 with each providing one of
the two axial His ligands, although the role of the heme in
eukaryotic SDH is unresolved (5).
The FAD of Sdh1 is covalently attached at an active site His
residue (2). This covalent bond increases the FAD redox poten-
tial by !60 mV to permit succinate oxidation (6). SDH is the
major mitochondrial protein containing a covalent bound fla-
vin (7). Sdh1 containing a H90S substitution is enzymatically
inactive in succinate oxidation but assembles into a tetrameric
complex that exhibits fumarate reductase activity (8). Fumarate
reductase activity in SDH does not require covalent flavinyla-
tion. SDH is related to the bacterial fumarate reductase and
both enzymes can catalyze succinate oxidation and fumarate
reduction with different efficiencies (9). Flavinylation of Sdh1
was found to occur after import into thematrix and to be influ-
enced by the presence of the iron/sulfur cluster subunit Sdh2
but largely independent of the membrane anchor (10). The
presence of citric acid intermediates stimulated the flavinyla-
tion process (10).
The covalent addition of FAD was proposed to be autocata-
lytic (7), but recently, a dedicated assembly factor Sdh5 was
identified that is required for covalent flavinylation (11). The
role of Sdh5 in Sdh1 flavinylation was discovered by the inter-
action of the two proteins and the demonstration that sdh5"
yeasts were devoid of SDH activity and lacked flavinylated
Sdh1. The direct role of Sdh5 in Sdh1 flavinylation was shown
by the enhanced covalent addition of FAD to recombinant Sdh1
expressed in bacteria in the presence of Sdh5. However, the
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mechanism by which the 22-kDa Sdh5 protein mediates flavi-
nylation of Sdh1 remains unresolved.
The human Sdh5 ortholog, SDHAF2, was shown to have a
corresponding role in covalent flavinylation in human cells
(11). Mutations in SDHAF2 are associated with a neuroendro-
crine tumor designated as paraganglioma. Mutations in the
SDH structural genes are also detected in a range of tumors,
including paraganglioma, pheochromocytomas, gastrointesti-
nal stromal tumors, and renal cell carcinoma (12). Recently, the
bacterial ortholog of Sdh5 was identified in the bacterium Ser-
ratia. The factor designated SdhE was shown to interact with
the flavoprotein (SdhA) and independently associate with FAD
(13). This is the first suggestion that the assembly factor may
mediate Sdh1 flavinylation by presenting bound FAD.Whereas
sdh5! cells exhibited a specific defect in SDH, the bacterial
sdhE mutant showed a more pleiotropic defect, suggesting
SdhE may flavinylate other flavoproteins (13).
SDH is one of many flavoproteins with a covalently bound
cofactor. SDH has an 8!-N3-histidyl-FAD linkage, but other
flavoproteins use cysteinyl-FAD or tyrosyl-FAD linkages (14).
Two large families of covalent flavoproteins are the glucose
oxidase/methanol oxidase family and the vanillyl-alcohol oxi-
dase family. Within the vanillyl-alcohol oxidase family, FAD
linkages to histidine, cysteine, and tyrosine are known,
although no ancillary enzyme is known to catalyze the covalent
addition. Covalent flavinylation with FAD is known to proceed
nonenzymatically, albeit slowly.
In the present study, we identify essential arginines in the
C-terminal tail in yeast Sdh1 that are required for flavinylation
and SDH assembly. The impaired assembly of the tetrameric
enzyme with these Sdh1 mutants correlates with the lack of
FAD binding.
MATERIALS ANDMETHODS
Yeast Strains and Vectors—All Saccharomyces cerevisiae
strains used in this study were derivatives of Trp303 (Mata
ura3-1 ade2-1 trp1-1 his3-11,15 leu2-3 112). Deletion strains
sdh1!, sdh2!, sdh3!, and sdh4!, in addition to plasmid
pRS414 Sdh2-His6Myc2, were kindly provided byDr. JaredRut-
ter at the University of Utah. Additional deletion strains (flx!,
sdh5!, sdh3!sdh4! double) were constructed by homologous
recombination using either the KanMX4 or the HIS3MX6 dis-
ruption cassettes (15). The C-terminal mutants of SDH1 along
with SDH1 WT under the control of its own promoter and
CYC1 terminator were expressed in sdh1! strain or subcloned
into integrating pRS405 vectors for chromosomal expression.
The integrating constructs were further digested with AflII and
integrated at the leu2-3,112 locus of sdh1! to be able to express
wild type and mutants SDH1 chromosomally. All integrated
strains were confirmed by PCR analysis of the locus. The C-ter-
minal point mutations were introduced by QuikChange
mutagenesis PCR system (Agilent Technology). All mutations
were confirmed by DNA sequencing. Yeast strains were trans-
formed using lithium acetate. Strains were grown in synthetic
complete medium lacking the amino acid(s) to maintain plas-
mid selection with either 2% galactose or 2% glycerol/lactate as
the carbon source.
For carbon swap cultures overnight, 50-ml glucose-grown
cultures were used to inoculate 1 liter ofmedium containing 2%
galactose as the carbon source. Cells were grown to an A600 nm
" 0.4 to 0.5 and harvested in a sterile manner. The cell pellet
was resuspended in fresh medium containing 2% glycerol/lac-
tate as the carbon source and grown for "10 h ("3–4 dou-
blings) before harvesting.
Mitochondria Isolation—Intact mitochondria were isolated
using previously described methods of Glick and Pon (16) and
Diekert et al. (17). For HPLC experiments, isolated mitochon-
dria were further purified using ultracentrifugation through a
Histodenz (Sigma Aldrich) step gradient (14 and 22%). Total
mitochondrial protein was quantified using either the Bradford
(18) or the bicinchoninic acid assays (19).
Immunoblotting and Blue-native PAGE—Steady-state levels
of mitochondrial proteins were analyzed using the NuPAGE
Bis-Tris gel system (Invitrogen) usingMES as the buffer system.
Proteins were subsequently transferred to nitrocellulose mem-
brane and probed using the indicated primary antibodies and
visualized using enhanced chemiluminescence (ECL) reagents
with horseradish peroxidase-conjugated secondary antibodies.
Primary antibodies were obtained from the following: anti-
Sdh1, Sdh2, Sdh3, and Sdh5 were generated in this study (21st
Century Biochemicals). Anti-HA, anti-Myc, and anti-porin
were purchased from Rockland, Roche Applied Science, and
Molecular Probes, respectively. Anti-F1 ATP synthase was a
generous gift from Alex Tzagoloff.
Analysis of yeastmitochondrial nativemembrane complexes
was performed using the native PAGE gel system (Invitrogen)
that is based on the blue-native polyacrylamide gel electropho-
resis (BN-PAGE) technique developed by Schägger and von
Jagow (20). Solubilized mitochondria (1% digitonin for 20–40
"g of mitochondrial protein) were separated on either 3–12%
or 4–16% Bis-Tris native gels, transferred to PVDFmembrane,
and analyzed by immunoblotting.
Hemin-agarose Pulldown Assays and Immunoprecipitation—
Purified mitochondria (0.75 to 1 mg of total protein) were sol-
ubilized using either 0.1% DDM or 1% digitonin in PBS buffer
and clarified at 20,000 # g for 5 min. For hemin-agarose pull-
down assay, the clarified lysates were incubatedwith 20 to 40"l
of hemin-agarose beads (Sigma), which had been prereduced
using DTT. Binding was performed for 2 h or overnight at 4 °C.
Beads were subsequently washed (15min# 4) with PBS buffer,
0.1% DDM or 1% digitonin, $ DTT, and eluted with 2# SDS-
PAGE loading buffer. For immunoprecipitation, the clarified
lysates were incubated with anti-HA or anti-Myc beads for 2 h
or overnight at 4 °C, washed four times with PBS buffer% 0.1%
DDM or 1% digitonin, and eluted with 2# SDS-PAGE loading
buffer. The clarified lysate, final wash, and eluate fraction were
analyzed by SDS-PAGE and immunoblotting. Bands fromCoo-
massie-stained SDS-PAGE gel from hemin-agarose pulldown
assay were also excised for identification using MS analysis of
the tryptic digests.
SDH Activity Assay—SDH activities in isolated yeast mito-
chondria were measured spectrophotometrically at 22 °C fol-
lowing the succinate-dependent, phenazine methosulfate-me-
diated reduction of either 2,6-dichlorophenolindophenol or
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cytochrome c as the terminal electron acceptor described for
intact mitochondria (21).
Analysis of Sdh1-bound FAD and Total Mitochondrial FAD
Levels—Levels of covalently attached FAD to Sdh1 were ana-
lyzed as described previously (11, 22). Mitochondrial proteins
were resolved on SDS-PAGE, and the gel was placed in a 10%
acetic acid solution for 20 min to oxidize flavin. The FAD band
was visualized upon exposure to UV light using a Bio-Rad Gel
Doc transilluminator.
Freely soluble mitochondrial FAD levels were analyzed as
described previously (23). Purifiedmitochondria (500!g) were
pelleted at 20,000! g for 10 min and resuspended in 500 !l of
deionized water and boiled at 105 °C for 10–15 min to precip-
itate proteins. The resulting yellowish supernatant was clarified
at 20,000 ! g for 5 min and analyzed on a Waters Sunfire C18
HPLC column (5 !m 4.6 ! 150 mm) equilibrated with 15%
MeOH in 10 mM ammonium acetate, pH 6.4. Flavin was eluted
using a linear MeOH gradient to 75% in 10 mM ammonium
acetate, pH 6.4, for 25 min and monitored at 450 nm. Elution
times were compared with FAD and FMN flavin mononucle-
otide standards (Sigma). The concentration of FAD for the
peak area was determined using an extinction coefficient of
11,300 M"1 cm"1 at 450 nm (9).
RESULTS
Adsorption of Sdh1 on Heme Agarose—The focus on SDH
flavinylation initiated from a goal to isolate heme-binding pro-
teins within the mitochondria using affinity purification with a
heme-agarose matrix. Detergent-solubilized mitochondrial
lysates were chromatographed on heme-agarose affinity beads
either in the oxidized (Fe3#; hemin) or reduced (Fe2#; heme)
state (Fig. 1A). Proteins adsorbed on the heme matrix were
eluted by SDS treatment and analyzed by SDS-PAGE. With
reduced heme-agarose, a single major band was apparent with
Coomassie staining that was identified as Sdh1 by mass spec-
trometry. The 67-kDa band was further verified to be Sdh1 by
FIGURE 1. Subunit 1 of SDH (Sdh1) binds hemin in vitro, and truncation of its last 13 residues abrogates this heme binding and renders the cells
respiratory defective.A, Coomassie-stained SDS-PAGEgel of hemin-agarose purified Sdh1 fromDDM-solubilizedmitochondria$DTT (lane 4 versus 5) and in
the presence of increasing concentrations of free hemin as a competitor to the hemin-agarose beads (lanes 6–8). Activated agarose beads conjugated to a
six-carbon linker (minus hemin) failed to capture Sdh1 (lane 9) std, protein standards;wash, final wash of the resin concentrated 10-fold. B, the last 13 residues
of Sdh1 is a featureless strand (highlighted in red) located on the surface of the protein and away from the buried FAD cofactor (colored sticks). Sdh1 is shown
in light beige, Sdh2 is shown in light gray, and its iron-sulfur clusters are shown as dark gray spheres. PyMOLwas used to generate the figure from Protein Data
Bank code 2H88 (avian). C, WT and sdh1% strains transformed with vectors (Vec) encoding full-length and truncated Sdh1 were spotted on fermentable
(glucose) and non-fermentable (glycerol/lactate) mediumwith serial dilution and incubated at 30 °C. Cells with truncation of the last 13 residues in Sdh1 (Clip
K628) failed to grow on respiratory medium. D, SDS-PAGE and immunoblot analysis of mitochondria isolated from strains in B. Covalent flavinylation of Sdh1
is lost in cells with truncation of the last 13 residues in Sdh1 (Clip K629) as analyzed by UV illumination of SDS-PAGE gel. Immunoblots show that steady-state
levels of Sdh2 and Sdh3 are also affected by C-terminal truncation. E, immunoblot analysis of hemin-agarose purification of Sdh1 usingmitochondria isolated
from strains indicated in B shows that heme binding is lost in the Sdh1 C-terminal truncate (Clip K629). Flavo, flavoprotein. KanMX is the deletion cassette.
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immunoblotting using Sdh1 antisera. Subunits Sdh2 and Sdh3
were also detected with their respective antiseras but in less
abundance compared with Sdh1 (data not shown). The adsorp-
tion of Sdh1 on heme-agarose was competed by preincubation
of the lysate with free heme, and no Sdh1 was retained on acti-
vated agarose beads lacking the heme moiety.
The retention of Sdh1 on heme-agarose suggested Sdh1may
possess a heme-bindingmotif. Inspection of the yeast Sdh1pro-
tein sequence showed a single CP motif in the C-terminal tail
found in a subset of heme-binding proteins (Fig. 1B). This
C-terminal tail strand lies on the surface of Sdh1 and is located
far from the buried FAD cofactor. Deletion of a C-terminal
13-residue segment in Sdh1 generated a truncate (designated
ClipK628) that was stably expressed, although cells harboring
this truncate failed to propagate on non-fermentable carbon
sources (Fig. 1C). The presence of the Sdh1 truncate abrogated
assembly of the tetrameric SDH enzyme and steady-state levels
of Sdh2 and Sdh3 were markedly attenuated (Fig. 1D). The
truncated Sdh1 was not flavinylated as shown by the lack of a
FAD fluorescence band after SDS-PAGE (10). Chromatogra-
phy of detergent lysates on the mutant cells on heme-agarose
did not result in any retention of the Sdh1 truncate on the
column (Fig. 1E).
C-terminal Segment of Sdh1 Is Critical for Flavinylation—
Site-directed mutagenesis was carried out to map the residues
responsible for flavinylation and heme-agarose binding.
C630A,V633S, or a double P634A,P635Amutation in Sdh1 had
no effect of glycerol/lactate growth (Fig. 2A). Furthermore, the
C630A mutant in the CP motif did not attenuate SDH activity
or compromise steady-state protein levels (Fig. 2B). Heme-aga-
rose binding was also unaffected (Fig. 2C). However, cells har-
boring a mutant allele of Sdh1 with a R638A substitution were
compromised in glycerol/lactate growth (Fig. 2A) and SDH
activity (Fig. 2D). Flavinylation of the mutant Sdh1 was attenu-
ated by !60% relative to the WT subunit. Assembly of the
mutant Sdh1 into the tetrameric complex was not impaired as
seen by BN-PAGE (Fig. 2E). The R638A mutant Sdh1 retained
the ability to associate with the heme-agarose matrix (Fig. 2F).
A double C630A,R638A mutant revealed a more impaired
phenotype than the single R638A mutant. The double mutant
in Sdh1 failed to support SDH assembly of the tetrameric com-
plex (Fig. 2E), resulting in a marked drop in steady-state levels
of Sdh2 and Sdh3 (Fig. 2D). The mutant Sdh1 exhibited no
flavinylation, although the mutant Sdh1 was stably expressed.
Furthermore, the double mutant failed to associate with the
heme-agarose matrix (Fig. 2F).
FIGURE 2. Double mutation of C630A and R638A residues leads to loss of respiratory growth and assembly of the SDH complex and loss of heme
binding to Sdh1. A, growth test of strains with chromosomally integrated SDH1 C-terminal point mutants. Cells possessing R638A substitutions showed
growth impairment on fermentable medium with the double C630A,R638A mutant showing the greatest growth defect. B, upper panel: SDH activities of
isolatedmitochondria from sdh1" strains transformedwith vectors (vec) encodingWTandC630ASdh1mutant. Activities expressedas apercentageofWT (n!
3# S.D.). Lower panels, corresponding immunoblot analysis of mitochondria isolated from above strains showing steady-state levels of covalent flavinylation
(UV illumination) and SDH subunits. C, immunoblot analysis of hemin-agarose purification of Sdh1 usingmitochondria isolated from strains indicated in B. D,
upper panel: SDH activities of isolated mitochondria from strains expressing chromosomally integrated SDH1 C-terminal point mutants expressed as a per-
centage of WT (n! 3# S.D.). Lower panel: steady-state of flavinylated-Sdh1 and SDH complex subunits in corresponding mitochondria of upper panel. The
flavoprotein (Flavo) % WT is a relative comparison to WT based on band density as quantified by ImageJ software. E, BN-PAGE immunoblots of isolated
mitochondria from B. 20 "g of isolated mitochondria were solubilized in 1% digitonin and separated on 3–12% native PAGE. Native protein complexes were
transferred onto PVDFmembrane andprobedwith antibodies to Sdh1 and F1 (loading control). F, immunoblot analysis of hemin-agarose purification of Sdh1.
DDM-solubilized mitochondria lysates in B shows that heme binding is lost in the double C630A,R638A mutant.
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Sdh1-Sdh5 Interaction in the Sdh1 C-terminal Mutants—
The diminished flavinylation in the C-terminal Sdh1 mutants
raised the possibility that the mutations attenuated the known
interaction of Sdh1 and Sdh5 that is important in Sdh1 flaviny-
lation. The cellular level of Sdh5 has been observed to be
dependent on Sdh1 (11) (i.e. Sdh5 is destabilized in cells lacking
Sdh1). Steady-state levels of Sdh5 were tested in sdh1! cells
expressing Sdh1 mutant alleles (Fig. 3A). A significant diminu-
tion in Sdh5 levels was apparent in cells with the double
C630A,R638A Sdh1 mutant.
The interaction of Sdh1 and Sdh5 is apparent by co-immu-
noprecipitation. Mitochondria from cells containing
HA-tagged Sdh5 and wild-type Sdh1 were solubilized with dig-
itonin and incubatedwith anti-HA beads. The immunoprecipi-
tation of Sdh5 led to the co-purification of Sdh1 in the WT as
expected (Fig. 3B). This was also true with Sdh1 containing the
single R638Amutation. Attempts to test binding of Sdh5 to the
double C630A,R638A Sdh1 mutant were compromised by the
attenuated steady-state levels of Sdh5 in the Sdh1 mutant cells.
Although the IP of Sdh5-HA failed to show any Sdh1, the
reduction in input Sdh5 makes the absence of Sdh1 in the co-
immunoprecipitate difficult to interpret.
We evaluated whether the impaired SDH function observed
in sdh1! cells expressing Sdh1 mutant alleles was suppressed
by overexpressing SDH5 (Fig. 4A). Expression of SDH5 from a
low-copy vector in the Sdh1 mutant cells did not significantly
increase total Sdh5 levels as measured by immunoblotting with
antisera to Sdh5 (data not shown). However, the expression of
SDH5 gave a modest improvement in respiratory growth (Fig.
4A) as well as SDH activity (Fig. 4B) in cells harboring the
R638A mutant Sdh1. Sdh1 flavinylation was also partially ele-
vated by overexpression of Sdh5. The respiratory growth
enhancement was not further increased by overexpression of
SDH5 using a high-copy vector (data not shown). In contrast,
no rescue was observed in growth or SDH activity of cells con-
taining the double C630A,R638A Sdh1 mutant. The effect of
overexpression of Sdh5 in cells with the Sdh1 double mutant
actually led to a diminution in SDH activity rather than any
restoration.
Isolation of Intragenic SDH1 Suppressors—In the absence of a
more marked rescue of the respiratory defect of R638A Sdh1
mutant cells by overexpression of SDH5, we isolated genetic
suppressors in the mutant cells to gain possible insight into the
mechanism underlying the point mutants. In addition to focus-
ing on the R638A mutant, we analyzed a Sdh1 mutant in a
second conserved arginine residue (Arg582) that is spatially
adjacent toArg638. The corresponding residue in humanSDHA
is Arg589 and a R589W mutation was reported in a patient
afflicted with paraganglioma (24). We generated R582W and
R582A mutations in yeast Sdh1 and observed that both substi-
tutions resulted in lack respiratory growth (Fig. 5A).
Plating sdh1! cells expressing either R638A, R589A, or
R589W Sdh1 from high-copy plasmids at high density on glyc-
erol/lactate medium resulted in the appearance of papillae that
contained mutants proficient in respiratory growth. The sup-
pressors failed to respire in each casewhen the plasmid express-
ing the Sdh1 point mutation was shed, suggesting intragenic
suppression. Rescue of the plasmid in Escherichia coli and
retransformation in parent sdh1! cells resulted in glycerol/lac-
tate growth.
DNA sequencing of the R638Amutant SDH1 gene revealed a
second-sitemutation resulting in aG70V substitution. The res-
piratory competency of the G70V,R638A Sdh1 mutant is
shown in Fig. 5A. Gly70 is located 35 Å from Arg638 but is close
to the FAD. It is also on the opposite face from the His90 that
forms the covalent bond (Fig. 5B). SDH activity was restored in
these second-site mutant cells (Fig. 6A).
The cultures used for the studies in Fig. 6 were propagated
using a carbon swap protocol in which cultures initially grown
in glucose to anA600 nm" 0.5 were switched to glycerol/lactate
for the last 10 h of the experiment.Under these conditions, even
the sdh1! cells maintained viability during the last phase of
growth. Propagation of sdh1! cells with the R638A Sdh1
mutant on galactose medium rather than the carbon swap pro-
tocol resulted inmarkedly reduced SDH activity as seen in Figs.
2D and 4B; however, the presence of the G70V,R638A Sdh1
suppressor mutant did not exhibit enhanced SDH activity. The
abundance of wild-type and mutant SDH complexes is mark-
edly enhanced in glycerol/lactate medium relative to galactose
medium (data not shown).
The genetic suppressor screen carried out with the R582A
Sdh1 mutant cells resulted in the recovery of a second site sup-
pressor with aM599R Sdh1 substitution in addition to the orig-
inal R582A mutation (Fig. 5A). Met599 is spatially close to
Arg582 and Arg638 (Fig. 5, C andD). The double R582A,M599R
Sdh1 mutant was catalytically active unlike the R582A single
mutant (Fig. 6A). Steady-state levels of Sdh1, Sdh2, and Sdh3
were restored. The suppressor was able to partially assemble,
unlike the R582A single mutant, into a tetrameric SDH com-
plex that could be visualized upon extended exposure of the
blue-native immunoblot (Fig. 6B). In addition, the double
mutant was competent to bind the heme-agarose matrix
(Fig. 6D). The suppressor mutation resulted in a stabilized
Sdh5 polypeptide.
A second site suppressor was also found for the non-func-
tional R582W Sdh1 mutant (Fig. 5A). The suppressor mutant
consisted of a conversion of the Trp to a Cys residue (Fig. 5A).
FIGURE 3. The steady-state level of Sdh5 is diminished in the
C630A,R638A double mutant. A, steady-state immunoblot analysis of
endogenous Sdh5 from isolated mitochondria from strains expressing chro-
mosomally integrated SDH1 C-terminal mutants. B, immunoprecipitation of
HA-taggedSdh5. Isolatedmitochondria fromcells expressingexogenousHA-
tagged Sdh5 on top of the strains in Awere solubilized in digitonin and sub-
ject to IP. The Sdh1-Sdh5 interactionwas analyzed by SDS-PAGE immunoblot
analysis of the HA-agarose purification eluate and probed with antibodies to
HA (Sdh5) and Sdh1.
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FIGURE 4.Overexpression of Sdh5 partially restores growth of the single R638A mutant; the double C630A,R638A is unaffected. Similar effects
are observed for steady-state covalent flavinylation and protein levels. A, growth test of strains with chromosomally integrated SDH1 C-terminal point
mutantsminus (top panel) or plus (bottom panel) low-copy vector (vec) expressing Sdh5. Cells were grown on glucose (fermentable) and glycerol/lactate
(non-fermentable)media at 30 °C. B, upper panel: SDH activities of isolatedmitochondria from strains in A expressed as a percentage ofWT (n! 3! S.D.).
Lower panels: corresponding immunoblot analysis of mitochondria isolated from above strains showing steady-state levels of covalent flavinylation
levels (UV illumination) and SDH subunit. The flavoprotein (Flavo) "% is a relative band density (quantified using ImageJ software) comparison of the
Sdh5 overexpressing strain to that of the non-overexpressing strain.
FIGURE 5. Spontaneous intragenic second-site suppressors of the Sdh1 flavinylation defect shows restoration of growth. A, growth test of
intragenic second-site spontaneous suppressors to Sdh1 Arg mutants. The plasmid-borne SDH1 second site mutations were integrated chromosomally
into sdh1" strains at LEU2 locus along with the original Arg mutation and tested for growth on fermentable (glucose) and non-fermentable (glycerol/
lactate) medium at 30 °C. B, PyMOL-generated representation of avian SDH (Protein Data Bank code 2H88) showing the two critical Arg residues that are
located on (Arg638) or near (Arg582) the C terminus (red strand) that when mutated causes a covalent flavinylation defect. C, the second-site mutation
G70V that restores the growth defect of the R638Amutation lies on a helix that makes contact with the phosphate group of FAD but lies 35 Å away from
the Arg638 and 14 Å away from FAD. PyMOL generated representation of avian SDH (Protein Data Bank code 2H88). D, the second-site mutation M599R
is spatially close to the C-terminal tail (#6 Å) of Sdh1 and to the original R582A (#3.5 Å) mutation. In eukaryotes, the residue corresponding to Met599
in yeast has already been replaced to Arg. PyMOL generated figure using avian SDH (Protein Data Bank code 2H88). vec, vector.
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The R582C Sdh1 mutant is active and assembles into the tetra-
meric complex (Fig. 6C) and is capable of adsorption on heme-
agarose beads (Fig. 6D). Thus, Sdh1with either anArg or Cys at
sequence position 582 is functional.
Role of FAD in SDH Complex Assembly—The lack of assem-
bly in the R582A and the double C630A,R638A mutant Sdh1
and the lack of Sdh1 flavinylation in those mutants raised the
question of whether SDH assembly is dependent on flavinyla-
tion. Yeast lacking Sdh5 were reported to be impaired in SDH
assembly (11), but cells containing amutantH90S Sdh1mutant
with a replacement of the histidyl residue forming the covalent
FAD adduct was able to assemble into the tetrameric complex
(8). We confirmed the latter result; the H90S Sdh1 yeast lacked
any observable covalent FAD (Fig. 7A), yet it exhibited a tetra-
meric complex on BN-PAGE (Fig. 7B). Although no covalent
FAD was seen, Robinson et al. (8) reported that FAD was still
associated non-covalently with the enzyme. Sdh5 levels were
normal in cells containing the H90S mutant Sdh1 (Fig. 7A).
In the case of sdh5! cells, despite no covalent flavinylation
(Fig. 7A), we observed varying degrees of SDH assembly inmul-
tiple independent experiments with three different sdh5!
strains (Fig. 7C). This variability occurs within a given deletion
strain. The variable assembly states seen by BN-PAGE may
imply that the SDH complex is unstable and dissociates under
the Coomassie gel conditions. In these mitochondrial lysates,
we quantified steady-state Sdh2 and Sdh3 levels to assess the in
vivo stability of the SDH complex (Fig. 7D). The level of Sdh2
correlated with the abundance of the assembled SDH complex.
Thus, it appears likely that the complex is destabilized in vivo
and that an equilibrium exists between assembly and disassem-
bly in which some mutants are more prone to the latter step.
A correlation between SDH assembly and Sdh1 flavinylation
is also seen in flx1! cells. Flx1 is amitochondrial carrier protein
implicated in FAD utilization (23, 25, 26). Sdh1 flavinylation is
impaired in yeast lacking themitochondrial carrier Flx1 (23, 25,
26). Although some uncertainty exists on whether Flx1 func-
tions to import or export FAD from mitochondria, a careful
quantitation of matrix FAD levels in flx1! cells showed a
marked diminution (Fig. 7E) as was reported previously (23).
Steady-state levels of Sdh1 and Sdh2 were markedly attenuated
in the flx1! cells, yet Sdh5 levels were normal (Fig. 7F). As
expected from the reduced Sdh1 and Sdh2 levels, no assembled
SDH was observed on BN-PAGE (data not shown).
Role of Other SDH Subunits in Sdh1 Flavinylation—In the
pioneering work of Bernard Lemire on SDH assembly and fla-
vinylation, Sdh1 flavinylation was shown to occur upon mito-
chondrial import andproteolytic processing of Sdh1. In a pulse-
chase study, the flavinylation of Sdh1 was assessed (10) in
strains lacking one of the other SDH subunits to assess the
dependence of Sdh1 flavinylation on the presence of other sub-
units (10). Robinson and Lemire (10) reported that Sdh1 flavi-
nylation is independent of themembrane anchor subunits Sdh3
and Sdh4 and partially attenuated in cells lacking Sdh2. We
extended their observations and found that steady-state Sdh1
levels were normal in cells lacking Sdh2 and the membrane
anchor Sdh3 (Fig. 8A). Cells lacking Sdh4, or Sdh3 and Sdh4
double, possess a similar phenotype as cells lacking Sdh3 only
(data not shown). Sdh2 steady-state levels were near normal in
cells lacking Sdh3, but Sdh2 levels were absent in cells lacking
Sdh1. Sdh1 flavinylation was partially depressed in sdh2! cells.
However, flavinylation of Sdh1 occurred normally in sdh3!
(Fig. 8A). The Sdh1 and Sdh2 subunits persisting in double
sdh3!,sdh4!mutant formed a complex as indicated by affinity
purification (Fig. 8B). Thus, flavinylation of Sdh1 occurs to a
limited extent in the absence of other SDH subunits, but Sdh2 is
FIGURE 6. Spontaneous intragenic second-site suppressors of the Sdh1
flavinylation defect restores SDH activity, SDH assembly, and heme
binding toSdh1.A,upper panel: SDHactivities of isolatedmitochondria from
strains in Fig. 5A expressed as a percentage of WT (n! 3" S.D.) when cells
were grown initially on 2% glucose and swapped to 2% glycerol/lactate (car-
bon swap; see “Material and Methods”). Lower panels: corresponding immu-
noblot analysis of mitochondria isolated from above strains showing steady-
state levels of covalent flavinylation levels (UV illumination) and SDH subunit.
B, corresponding blue native immunoblot analysis of mitochondria isolated
from strains in A. The streaking in lane 3 (R638A) is likely a result of fractional
amounts of soluble aggregates of Sdh2 formed in thismutant background.C,
BN-PAGE immunoblot analysis ofmitochondria isolated from selected strains
in A but cultured in 2% glycerol/lactate showing the full restoration of com-
plex assembly under respiratory condition for the two spontaneous suppres-
sors (R582C and the double R582A,M599R). D, hemin-agarose purification of
Sdh1 from isolated mitochondria from selected strains in C showing the
restored heme-binding to Sdh1 in the spontaneous suppressors (R582C and
thedouble R582A,M599R) but not in theoriginal pointmutant (R582A). Flavo,
flavoprotein; vec, vector.
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important for efficient covalent FAD binding. Interestingly, the
Sdh5 steady-state levels were elevated in sdh2! or sdh3! cells
(Fig. 8A).
DISCUSSION
We show presently that flavinylation of the Sdh1 subunit of
succinate dehydrogenase is dependent on a set of two spatially
close Arg residues near the C terminus, which are distant ("20
Å) fromtheFADbindingsitebutarecritical in flavinylation.These
residues are also important for the assemblyof Sdh1 into the tetra-
meric enzyme complex. Mutant Sdh1 proteins with either a
R582A or double C630A,R638A substitution are neither flaviny-
lated nor assembled into the SDH complex (Table 1).
With each mutant Sdh1, second-site Sdh1 suppressor muta-
tions were recovered in Sdh1 permitting both flavinylation and
SDH assembly. In the case of the single R638A mutation, the
second site suppressor was a G70V substitution, whereas the
R582A second site suppressor was a M599R substitution. The
presence of the Arg at residue 599 restores a positively charged
residue in proximity to residue position 582. It is of interest that
the corresponding residue toMet599 in humans andmetazoans
is Arg.
In the human SDHA (Sdh1 equivalent), the Arg residue cor-
responding to yeast Arg582 is Arg589. Substitution of this Arg589
to a Trp (R589W) has been reported in a patient afflicted with
paraganglioma (24). Yeast harboring a corresponding R582W
mutant Sdh1 are compromised in SDH assembly and flavinyla-
tion, but a reversion mutant of R582C restores both Sdh1 flavi-
nylation and SDH assembly.
FIGURE 7. Covalent flavinylation of Sdh1 is not required for assembly of SDH as indicated by sdh5! and H90S Sdh1 mutants. However, Sdh1-FAD
binding is likely required for stability of Sdh1 and SDH assembly. A, steady-state immunoblot analysis of isolatedmitochondria from sdh1! strains expressing
eitherwild type Sdh1orH90S substitution (lanes 1 and 2) and sdh5! cells transformedwith the indicated vectors (vec; lanes 3 and 4).B, correspondingBN-PAGE
immunoblot analysis of mitochondria from A showing the assembly of SDH even in the absence of covalent flavinylation. C, BN-PAGE immunoblot analysis of
mitochondria fromWTand three different sdh5! cells showing the assembly of SDHeven in the absence of covalent flavinylation.D, steady-state immunoblot
analysis of isolatedmitochondria from C. E, HPLC analysis of FAD levels in purifiedmitochondria fromWT and flx! strains showing the#50% decrease in FAD
levels in the flx! strain. F, steady-state SDS-PAGE UV and immunoblot analysis of isolated mitochondria from strains in E. Note the dramatic decrease in Sdh1
and the absence of Sdh2 in the flx! strain likely resulting from the decrease in mitochondrial FAD levels. Abs., absorbance. prot, total mitochondrial protein.
FIGURE 8. Sdh1 is flavinylated in the absence of the membrane anchor
subunits and forms a stable dimeric complex with Sdh2. A, steady-state
immunoblot and Sdh1 flavinylation analysis (UV illumination). B, nickel-nitri-
lotriacetic acid purification of Sdh2-His6Myc2 in mitochondria isolated from
sdh3!sdh4! cells. UB, unbound; E, eluate; Flavo, flavoprotein.
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One major question emerging from the present studies con-
cerns the role of the C-terminal Arg residues in Sdh1 flavinyla-
tion. These mutations do not appear to destabilize the Sdh1
polypeptide; rather, they only impair Sdh1 maturation. Three
candidate roles for the C-terminal Arg residues may be envi-
sioned. One candidate link involves the binding of Sdh5 and its
importance in Sdh1 flavinylation. Sdh5 levels are dependent on
the presence of Sdh1. The reduced steady-state levels of Sdh5 in
the Sdh1 mutants may reflect attenuated binding. However,
cells harboring the mutant Sdh1 alleles are markedly impaired
in SDH assembly, whereas sdh5! cells are only partially atten-
uated in SDH stability as seen by the variable levels of the
assembled SDH complex in our series of isolates. Thus, the
phenotypes observed with either the R582A or double
C630A,R638Amutants appear distinct from that of sdh5! cells.
A second scenario is that the flavinylation may occur in a
nascent conformation of Sdh1 that is somewhat distinct from
the final mature conformation. In this scenario, the C-terminal
Arg residuesmay be in juxtaposition for FAD flavinylation. The
G70V second site suppressor mutation in the SDH-deficient
R638A Sdh1 mutant is consistent with this postulate of a dis-
tinct nascent conformation inwhich these two residues are now
in closer proximity. However, two observations argue against
this model. The observation that citric acid cycle intermediates
can stimulate the flavinylation process (10) suggests that a fla-
vinylation-competent conformation may have a preformed
native-like substrate binding site. The dependence of Sdh2 on
efficient Sdh1 flavinylation suggests that the flavinylation-com-
petent conformation of Sdh1 must be quite similar to the final
mature fold enabling Sdh2 association. In the flavoprotein
vanilly-alcohol oxidase containing a histidyl-linked FAD, struc-
tural similarity between the holo- and the apo-forms indicates
that FAD and substrate bind to a folded, highly preorganized
cofactor/active site cavity, followed by autocatalytic covalent
flavinylation (27).
A third candidate role for the C-terminal Arg residues may
relate to FAD binding. Although the C-terminal Arg residues
are distantly removed from the FAD or substrate site in the
mature Sdh1 structure, the Arg residues may be important in
recruitment and/or guidance of FAD and or succinate to the
substrate site. Asmentioned, flavinylation of Sdh1 is dependent
on succinate (10).
Another conserved Arg residue (human Arg408) stabilizes
succinate or inhibitor binding through two hydrogen bonds.
Mutations in the human gene yielding a R408C substitution
was reported in a patient with a late onset neurodegenerative
disease (28). Engineering the corresponding mutation in the
E. coli enzyme resulted in impaired covalent flavinylation and
the absence of membrane-associated enzyme (28).
The impaired assembly of SDH with the C-terminal Sdh1
mutants suggests that FAD binding is important to stabilize the
Sdh1 conformation enabling association with Sdh2 and the
membrane anchor subunits. To address the role of FAD bind-
ing in SDH assembly, we utilized a yeast flx1! deletion strain.
This mutant was reported to have attenuated levels of matrix
FAD levels (23), and we confirmed this observation. Cells lack-
ing Flx1 are known to be deficient in two FAD-containing
enzymes SDH and lipoamide dehydrogenase (22).We show the
mutant cells are also impaired in SDH assembly and stability of
Sdh2. The impaired SDH assembly in the FAD-deficient flx1!
cells suggests that FAD binding is important for Sdh1 matura-
tion enabling assembly of the tetrameric enzyme. Cells contain-
ing theH90S Sdh1mutant that precludes covalent flavinylation
assemble into the SDH complex consistent with a non-covalent
association of FAD as was reported previously (8).
The covalent addition of FAD to Sdh1 likely occurs in a spe-
cific folded conformation of Sdh1 that brings a set of amino
acids in juxtaposition for the autocatalytic addition. Sdh5 as
well as succinate as a substrate are proposed to stabilize the
flavinylation-competent conformation of Sdh1 for the reaction.
The conserved C-terminal Arg residues (Arg582 and Arg638)
could contribute to FAD recruitment and or its binding prior to
formation of the covalent attachment. The G70V second site
suppressormutation in the SDH-deficient R638A Sdh1mutant
may merely partially deform the Sdh1 conformation allowing
FAD binding in the absence of Arg638. The C-terminal Arg res-
idues may also have a secondary role in the binding of Sdh5.
The propensity of Sdh1 to adsorb onto heme-agarose beads
may relate to either a hydrophobic pocket that fortuitously
accommodates hemewith no physiological consequence of this
binding. Alternatively, the presence of the positively charged
Arg residues in the C-terminal segment could interact electro-
statically with the dianionic propionate groups of heme, facili-
tating the association of Sdh1 with heme-agarose. This interac-
tion may be analogous to the possible dianionic succinate or
phosphates of FAD. Thus, in this scenario, heme is acting
merely as a dianionicmimic of FAD or succinate. This notion is
supported by the fact that protoporphyrin IX (heme lacking the
iron center, but still possessing the dianionic propionates) can
compete for heme binding to Sdh1 (results not shown). This
observation argues that the iron center is not important for
binding to Sdh1. Thus, the increased affinity of Sdh1 to heme in
the presence of a reductant may bemore related to the reduced
state of Sdh1 than the heme iron.
TABLE 1
Molecular properties of strains with mutations or deletions that result in the loss of covalent flavinylation in Sdh1
The double C630A,R638A and the single R582W mutations at or near the C terminus lead to loss of SDH assembly as well as binding to heme-agarose beads. However,












H90S Yes Yes Down Stable Attenuated
sdh5! Yes Yes Down
ClipK No No Absent ND ND
C630A,R638A No No Absent Unstable Attenuated
R582A No No Absent Unstable Attenuated
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A third less likely scenario is that heme has an effector role in
the flavinylation reaction. We have no evidence that SDH bio-
genesis requires heme for Sdh1 maturation. Because heme is
essential for cell survival and important in yeast for Hap1-me-
diated gene expression of mitochondrial proteins, the investi-
gation of a role of heme in Sdh1 maturation is challenging and
will be the topic of future studies.
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Disorders arising from impaired assembly of succi-
nate dehydrogenase (SDH) result in a myriad of pa-
thologies, consistent with its unique role in linking
the citric acid cycle and electron transport chain.
In spite of this critical function, however, only a few
factors are known to be required for SDH assembly
and function. We show here that two factors, Sdh6
(SDHAF1) and Sdh7 (SDHAF3), mediate maturation
of the FeS cluster SDH subunit (Sdh2/SDHB). Yeast
and Drosophila lacking SDHAF3 are impaired in
SDH activity with reduced levels of Sdh2. Drosophila
lacking the Sdh7 ortholog SDHAF3 are hypersen-
sitive to oxidative stress and exhibit muscular and
neuronal dysfunction. Yeast studies revealed that
Sdh6 and Sdh7 act together to promote Sdh2 matu-
ration by binding to a Sdh1/Sdh2 intermediate, pro-
tecting it from the deleterious effects of oxidants.
These studies in yeast and Drosophila raise the pos-
sibility that SDHAF3 mutations may be associated
with idiopathic SDH-associated diseases.
INTRODUCTION
Succinate dehydrogenase (SDH) is an integral component of
both the mitochondrial respiratory chain and the tricarboxylic
acid (TCA) cycle. It catalyzes the two-electron oxidation of
succinate to fumarate with the reduction of ubiquinone to ubiq-
uinol (succinate:ubiquinone oxidoreductase). SDH is embedded
within the inner membrane (IM) of mitochondria and consists of
four nuclear-encoded subunits, designated Sdh1 through Sdh4
in yeast and SDHA through SDHD in mammalian cells. SDH
deficiency in humans results in infant encephalomyopathy,
myopathy, or tumorigenesis in the adult (Finsterer, 2008; Rustin
and Ro¨tig, 2002). Loss-of-function mutations in human genes
for SDHA, SDHB, SDHC, and SDHD are strongly linked with
susceptibility to familial paraganglioma, pheochromocytoma,
gastrointestinal stromal tumors, and renal cell carcinoma (Bar-
della et al., 2011; Baysal et al., 2000; Feichtinger et al., 2010;
Janeway et al., 2011). Tumorigenesis arising from SDH defi-
ciency is purportedly related to the deleterious effects of supra-
physiological levels of succinate, which is a known inhibitor of a
myriad of a-ketoglutarate (aKG)-dependent enzymes, including
prolyl hydroxylases, histone, and DNA demethylases (Selak
et al., 2005; Xiao et al., 2012).
This tetrameric enzyme contains five redox cofactors,
including a covalently bound FAD and three iron-sulfur (FeS)
clusters in a hydrophilic segment consisting of two subunits
(Sdh1 and Sdh2) and a heme-containing membrane anchor
domain consisting of Sdh3 and Sdh4 subunits (Robinson and
Lemire, 1996). The FeS clusters facilitate electron transfer to
the ubiquinone-binding site formed between Sdh2 and themem-
brane subunits (Sun et al., 2005).
Assembly factors are often used to facilitate cofactor insertion
in mitochondrial respiratory complexes and mitigate unwanted
reactions during biogenesis. Recently, two SDH assembly fac-
tors associated with human pathogenesis were identified. Succi-
nate dehydrogenase assembly factor 1 (SDHAF1) was found in a
study of infantile mitochondrial diseases in which two families
hadmultiple children afflicted with leukoencephalopathy (Ghezzi
et al., 2009). Biochemical analyses revealed a SDH deficiency in
muscle samples and fibroblasts from these patients along with
missense mutations in SDHAF1. Deletion of the yeast ortholog
ofSDHAF1 (SDH6) resulted in a respiratory deficiency and a spe-
cific reduction in SDH activity (Ghezzi et al., 2009). SDH defi-
ciency has subsequently been reported in other patients that
carry SDHAF1 mutations (Ohlenbusch et al., 2012). Succinate
dehydrogenase assembly factor 2 (SDHAF2 or yeast Sdh5)
was shown to be required for the covalent attachment of FAD
to the catalytic SDHA (Sdh1) subunit (Hao et al., 2009). Yeast
lacking Sdh5 were respiratory deficient due to an absence of
SDH activity. Germline loss-of-function mutations in SDHAF2
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were identified in SDH-deficient neuroendocrine paraganglioma
tumors (Hao et al., 2009). A number of SDH-deficient pathol-
ogies, including Leigh syndrome, gastrointestinal stromal tu-
mors, and neuroblastomas, have also been reported that lack
mutations in known SDH assembly factors or SDH structural
subunits (Feichtinger et al., 2010; Janeway et al., 2011).
Thus, additional SDH assembly factors may remain to be discov-
ered, potentially providing insights into the causes of idiopathic
SDH-associated diseases.
Sdh6 is amember of the LYR protein family that consists of ten
proteins in the human proteome and four in the yeast proteome
(Figure 1A). Within yeast, the founding member is the mitochon-
drial Isd11 protein that functions in the matrix FeS biogenesis
pathway as an effector of the Nfs1 cysteine desulfurase (Adam
et al., 2006; Wiedemann et al., 2006). We demonstrated that a
second LYR protein Mzm1 is a chaperone for the Rieske FeS
subunit of complex III (Atkinson et al., 2011; Cui et al., 2012).
The remaining yeast LYR proteins are Sdh6 and Acn9 (human
ortholog ACN9). Although Sdh6 is required for proper SDH activ-
ity, its molecular mechanism remains unknown. Moreover, Acn9
(designated Sdh7 in yeast and SDHAF3 in humans and flies) has
no known function. Here we show that these two factors are
required for SDH biogenesis in eukaryotes. Both Sdh6 and
Sdh7 protect Sdh2 maturation from the deleterious effects of
endogenous reactive oxygen species. We also report that loss
of SDHAF3 in Drosophila cells leads to a marked SDH deficiency
analogous to that in yeast, with defects inmuscular and neuronal
function in mutant flies. This study identifies functions of two
SDH assembly factors, providing a more complete understand-
ing of its critical role in cellular energy production and a potential
molecular framework for defining currently idiopathic SDH-asso-
ciated diseases.
RESULTS
Cells Lacking Sdh6 and Sdh7 Exhibit SDH Deficiency
As a first step toward characterizing Sdh6 and Sdh7 function, we
examined the growth phenotypes of sdh6D or sdh7Dmutants on
nonfermentable carbon sources using S. cerevisiae. Compared
to wild-type cells, cells lacking Sdh6 or Sdh7 exhibited a partial
growth defect on glycerol/lactate medium and a severe growth
defect on acetate medium (Figure 1B), which is consistent
with previous studies (Ghezzi et al., 2009; McCammon, 1996).
We confirmed that the respiratory growth defects of sdh6D
and sdh7D mutants were attributed to deletions of SDH6 and
SDH7, as respiratory growth of sdh6D and sdh7D cells
was restored with epitope-tagged Sdh6 and Sdh7, respectively
(Figure S1A, available online). Since both Sdh6 and Sdh7
belong to the LYR motif protein family (Figure 1A), we looked
for genetic interactions between their encoded proteins. The
sdh6D sdh7D double-deletion strain exhibited a marked syn-
thetic growth defect on glycerol/lactate medium (Figure 1B). In
addition, the overexpression of SDH6 partially suppressed the
respiratory growth defect of sdh7D cells (Figure 1C); however,
overexpression of SDH7 failed to restore respiratory function of
sdh6D cells.
Metabolomic profiling was used to identify the biological
process impaired in sdh6D and sdh7D mutants, assaying the
levels of approximately 100 polar metabolites. We cultured cells
in synthetic minimal medium with 2% raffinose and 0.2%
glucose to stationary phase. Metabolites extracted from cells
were analyzed using gas chromatography-mass spectrometry
(GC-MS) (Figure 1D). Cells lacking either Sdh6 or Sdh7 exhibited
elevated succinate levels and attenuated fumarate and malate
levels, consistent with impaired conversion of succinate to
fumarate by SDH in the citric acid cycle. These observations in
sdh6D cells are consistent with the previous study in fibroblasts
harboring a mutated SDHAF1 gene (Ghezzi et al., 2009). More-
over, the sdh6D sdh7D double mutant showed an enhanced
accumulation in succinate, consistent with the synergistic respi-
ratory growth defects in these cells.
To confirm that the increased succinate/fumarate ratio in
sdh7Dmutants was due to impaired SDH function, we quantified
SDH activity in mitochondria purified from wild-type (WT) and
mutant cells lacking Sdh6 or Sdh7. Mitochondria isolated from
sdh6D and sdh7D cells harvested at mid-log phase exhibited
modest diminutions of SDH activity, but the deficit was magni-
fied in stationary-phase cells (Figure 1E). The sdh6D sdh7D dou-
ble mutant showed markedly decreased SDH activity in mid-log
cultures (34% of WT; Figure S1B) relative to the single mutants,
in accordance with the synergistic respiratory growth defect
and TCA cycle intermediates in sdh6D sdh7D double mutants.
Enzymatic activities of pyruvate dehydrogenase, a-ketoglutarate
dehydrogenase, aconitase, malate dehydrogenase, and bc1
complex III were unaffected in cells lacking Sdh6 or Sdh7 (Fig-
ures S1B and S1C).
Amoderate diminution of the assembled tetrameric SDH com-
plex was seen in mitochondria isolated from late-log cultures of
sdh6D or sdh7Dmutants as visualized by blue native (BN)-PAGE
(Figure 1F). The abundance of the SDH complex was further
Figure 1. Succinate Dehydrogenase Deficiency in Cells Lacking Two LYR Motif Family Proteins, Sdh6 and Sdh7
(A) LX(L/A)YRXX(L/I)(R/K) motif conserved in four LYR motif family proteins in yeast. Isd11, a chaperone required for cysteine desulfurase activity in FeS
biogenesis pathway (Adam et al., 2006); Mzm1, a protein facilitating the Rieske FeS protein insertion into bc1 (Cui et al., 2012); Sdh6 (SDHAF1); and Sdh7.
(B) Serial dilutions (10-fold) of cells starting from optical density 600 (OD600) = 0.5 were spotted on synthetic complete (SC) media containing different carbon
sources, as indicated, and incubated at 30!C.
(C) Serial dilutions (10-fold) of cells were spotted on SC media lacking uracil and incubated at 30!C. EV, empty vector.
(D) Metabolites extracted from cells cultured in synthetic minimal media containing 2% raffinose/0.2% glucose were analyzed using GC-MS. Cells were
harvested at OD600 = 2. Relative levels of metabolites to WT are represented as mean ± SEM (nR 4 biological replicates; *p < 0.05; **p < 0.005).
(E) Relative SDH activity in isolated mitochondria compared toWT. Mitochondria were isolated from cells grown in SCmedia plus 2% raffinose/0.2% glucose for
24 hr (mid-log) and 48 hr (stationary). Data are shown as mean ± SD (n = 3; **p < 0.05).
(F) Blue native (BN)-PAGE analysis to visualize protein complexes. Mitochondria isolated from the strains harvested at late-log phase were solubilized with 1%
digitonin. After clarification, soluble fractions were separated on BN-PAGE and then transferred to membranes for immunoblotting. Sdh1, a FAD-containing
subunit of SDH; F1b, a subunit of ATP synthase (complex V, CV) in oxidative phosphorylation. The band highlighted by ** is the Sdh1 assembly intermediate. This
band is visualized by antisera to Sdh1, but not Sdh2. See also Figures S1 and S2.
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Figure 2. Sdh6 or Sdh7 Functions Are Linked to the Fe/S Sdh2 Subunit
(A) FAD-containing Sdh1 was visualized by UV excitation. Other proteins visualized by immunoblotting include Mdh1 (malate dehydrogenase) and Por1 (porin)
(loading control).
(B) 35S-methionine-labeled proteins were incubated with isolated mid-log versus stationary phase mitochondria for 30 min (pulse), followed by blocking protein
import with valinomycin for 30 and 60 min (chase), respectively. Radiolabeled proteins were resolved on SDS-PAGE and detected by autoradiography.
(legend continued on next page)
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attenuated in sdh6D sdh7D double-mutant cells. Thus, Sdh6 and
Sdh7 are required to maintain normal SDH levels and activity
in yeast. In addition to reduced levels of tetrameric SDH in the
mutant cells, a Sdh1 subcomplex is evident, and the same sub-
complex is seen in cells lacking Sdh2 or Sdh4 (** in Figures 1F
and S2). Therefore, Sdh6 and Sdh7 appear to function in SDH
assembly rather than in the regulation of SDH activity.
Maturation of Sdh2 Is Impaired in the Absence of Sdh6
or Sdh7
To characterize the roles of Sdh6 and Sdh7, the steady-state
levels of SDH subunits were quantified in mitochondria isolated
from mutant cells. The levels of Sdh2 were attenuated in both
sdh6D and sdh7D mutants and further diminished in the sdh6D
sdh7D double mutant (Figure 2A). In contrast, Sdh1 levels were
unchanged in the mutant cells, and covalent flavinylation of
Sdh1 was not significantly altered (Figure 2A). Cells lacking
Sdh5 are compromised in Sdh1 flavinylation, leading to a
reduced stability of Sdh1 (Hao et al., 2009; Kim et al., 2012).
A mitochondrial in vitro protein import assay was used to
address a role for Sdh6 and Sdh7 in Sdh2 maturation. The
import assay consisted of the in vitro import of 35S-methio-
nine-labeled Sdh2 into purified mitochondria isolated from
sdh2D cells. Sdh2-deficient mitochondria were used to ensure
that a pool of unassociated Sdh1 would be available for a stabi-
lizing interaction with imported Sdh2. Furthermore, the use of
sdh2D cells negates any changes in the mitochondrial mem-
brane potential (which drives protein import) by the loss of
Sdh6 or Sdh7. The stability of 35S-Sdh2 as monitored during
the chase phase of the reaction was compromised in cells lack-
ing Sdh6 or Sdh7, especially in mitochondria isolated from sta-
tionary-phase cultures (Figure 2B). This result is consistent with
the exacerbated defect in SDH activity seen in mutant cells at
late stages of growth. Unlike Sdh2, radioisotope-labeled Rip1,
a target of the LYR protein Mzm1, remained unaffected by
loss of either Sdh6 or Sdh7.
Sdh1 and Sdh2 accumulate in cells lacking the membrane
anchor subunits Sdh3 and/or Sdh4 (Figure S3A) (Kim et al.,
2012). We observed that cells depleted of the membrane an-
chor contain increased steady-state levels of both Sdh6 and
Sdh7 (Figure 2C). These results suggest that Sdh6 and Sdh7
may form stalled preassembly intermediates with Sdh1 and/or
Sdh2. We performed coimmunoprecipitation on epitope-tagged
Sdh6 and Sdh7 in mitochondria from WT cells and cells stalled
in SDH assembly. A fraction of Sdh1 and Sdh2 was copurified
with either Sdh6 or Sdh7 from cells lacking the membrane an-
chor domain, but not in cells devoid of Sdh2 (Figures 2D, 2E,
and S3B). These interactions are seen in the presence and
absence of crosslinking prior to resin adsorption. These results
suggest that Sdh6 and Sdh7 interact with Sdh2 within a Sdh1/
Sdh2 subcomplex, which is known to accumulate in cells lack-
ing the membrane anchor domain (Kim et al., 2012). Moreover,
these interactions appear to occur in the mitochondrial matrix,
consistent with the known matrix location of Sdh1, Sdh2, and
Sdh6 (Ghezzi et al., 2009). Sdh7 is also a matrix protein, as
revealed by proteinase K treatment of purified mitochondria,
which degrades Sdh7 only in the presence of detergents and
not upon hypotonic disruption of only the outer membrane.
(Figure S3C).
The physical interactions of Sdh6 and Sdh7 with Sdh2 promp-
ted the hypothesis that Sdh6 and Sdh7 may be chaperones for
Sdh2. To test this, we first examined the ability of overexpressed
Sdh6 or Sdh7 to stabilize the highly labile Sdh2 present in sdh1D
cells (Kim et al., 2012). Elevated levels of Sdh6, but not Sdh7, led
to increased steady-state Sdh2 levels under these conditions
(Figure 2F). This result raised a possibility that Sdh6 may func-
tion as a chaperone for Sdh2 prior to its interaction with Sdh1.
We tested whether SDH2 overexpression in sdh6D mutants
or sdh7D mutants would restore SDH activity and suppress the
respiratory growth defects. However, SDH2 overexpression
neither restored SDH activity nor reversed succinate accumula-
tion or rescued respiratory growth of sdh6D mutants and sdh7D
mutants (Figures 2G, 2H, S4A, and S4B).
Once a holo-Sdh2/Sdh1 complex forms, the final step in SDH
biogenesis is the addition of the Sdh3/Sdh4 membrane anchor.
To address whether Sdh6 and Sdh7 are involved in the recruit-
ment of the membrane anchor, we tested whether co-overex-
pression of SDH3 and SDH4 would suppress the respiratory
defect in the sdh6D and sdh7D mutant cells. No restoration of
growth on acetate medium was observed with elevated cellular
levels of Sdh3 and Sdh4 (Figures S4C and S4D). Thus, Sdh6
and Sdh7 do not likely facilitate the recruitment of the Sdh3/
Sdh4 membrane anchor.
We conducted a series of studies to assess whether Sdh6 or
Sdh7 has an active role in FeS cluster insertion. These studies
failed to reveal a direct role of either factor in FeS cluster inser-
tion. First, affinity purification of Sdh2 in yeast leads to copurifi-
cation of Nfu1, Isu1, and Isa2, three key matrix proteins involved
in FeS biogenesis (data not shown). However, affinity purification
of Sdh6-His6-2Myc or Sdh7-His6-2Myc failed to adsorb Isu1 or
Isa2, whereas Sdh2 was associated. Second, whereas overex-
pression of ISA1 or ISA2 restores respiratory growth in grx5D
(C) Sdh6-His6-3HA or Sdh7-His6-3HA under their own endogenous promoters was expressed from plasmids in cells lacking either Sdh2 or Sdh4, along with
endogenous Sdh6 or Sdh7 depleted, respectively. Steady-state levels are shown by immunoblotting.
(D) Coimmunoprecipitation of Sdh6-His6-2Myc after crosslinking. Mitochondria were solubilized with 1% digitonin in the presence of 1 mM dithiobis(succini-
midylpropionate). The crosslinking reaction was stopped with Tris buffer (pH 7.4), and the supernatants were absorbed to anti-Myc antibody-conjugated
magnetic beads. Bound substances to Myc beads were resolved on SDS-PAGE and detected by immunoblotting. Input, 4% of total lysates; Aco1, FeS
aconitase.
(E) Standard coimmunoprecipitation of Sdh7-His6-2Myc was performed with isolated mitochondria without crosslinking. Input, 2% of total lysates.
(F) Steady-state levels of Sdh2 in sdh1D mutants with overexpression of proteins indicated. Yap1, transcription factor upregulating oxidative stress response
genes.
(G) SDH activity in sdh6Dmutants with SDH2 overexpression was detected as described in Figure 1E. Data are represented as mean ± SD (n = 3; **p < 0.05; ns,
not significant).
(H) Succinate levels in sdh7D mutants with SDH2 overexpression were measured as described in Figure 1D. Mean ± SEM is shown (n = 6; **p < 0.05; ns, not
significant). See also Figure S3.
Cell Metabolism
Maturation of the FeS Subunit of SDH




mutant cells (Kim et al., 2010; Rodrı´guez-Manzaneque et al.,
2002), overexpression of ISA1, ISA2, NFU1, or ISU1 failed to
suppress the respiratory defect of sdh6D or sdh7D cells (data
not shown). Third, 55Fe incorporation into Sdh2-His6-2Myc was
quantified in cells either containing or lacking Sdh6 or Sdh7. Im-
munocapture of Sdh2 failed to show any clear diminution in 55Fe
in the mutant cells (Figure S4E). However, interpretation of the
55Fe study is complicated, since Sdh2 has three distinct FeS
centers, and Sdh6 or Sdh7 may have a restricted role with one
cluster. In addition, ascorbate is used during 55Fe labeling and,
as a reductant, may mimic the exogenous reductants in sup-




Figure 3. Exogenous Antioxidants Rescue
the Growth Defect of sdh6D and sdh7D
Mutants
(A) Cells harboring either empty vector (EV) or
high-copy YAP1 plasmid were spotted on SC
media lacking leucine by 10-fold serial dilutions
and incubated at 30!C.
(B) Serial dilutions (10-fold) of cells were spotted on
SCmediumwith the indicated carbon sources with
or without 5 mM N-acetylcysteine or 2 mM gluta-
thione and incubated at 30!C.
(C) Succinate levels in cells overexpressing YAP1
were measured as described in Figure 1D. Cells
were harvested at OD600 = 1. Mean ± SEM is
shown (n = 6; *p < 0.005).
Antioxidants Ameliorate Defects in
sdh6D Mutants and sdh7D Mutants
Further clues to the function of Sdh6
emerged from a genetic suppressor
study in which extragenic suppressors
of the acetate growth defect of sdh6D
mutants were recovered. We generated
a high-copy plasmid library with partially
digested genomic DNA from sdh6D
mutants. This library was transformed to
sdh6D mutants, and the transformants
that exhibited enhanced growth on ace-
tatemediumwere collected. Interestingly,
multiple independent suppressors were
recovered that encoded Yap1, which is
a transcriptional activator that induces
the expression of a battery of antioxidant
genes, including thioredoxin, thioredoxin
reductase, and glutathione reductase,
in response tooxidative stress (Fernandes
et al., 1997). The overexpression of YAP1
in subcloned vectors robustly suppressed
the acetate growth defect of cells lacking
Sdh6 (Figure 3A). Consistent with the anti-
oxidant role of Yap1 expression, supple-
mental glutathione or N-acetylcysteine
also restored limited respiratory growth
in sdh6Dmutants (Figure 3B).
Sinceweobserved agenetic interaction
between SDH6 and SDH7 (Figure 1), we
tested whether overexpression of YAP1
could also restore respiratory growth in sdh7Dmutants. Indeed,
YAP1 overexpression suppressed the respiratory growth defect
of sdh7D mutants, although the suppression was less pro-
nounced compared to sdh6D mutants (Figure 3A). Moreover,
the addition of exogenous reductants restored limited respiratory
growth of sdh7Dmutants (Figure 3B). To confirm that YAP1 over-
expression restored SDH activity in sdh6D and sdh7D single-
mutant cells, we assessed SDH activity by measuring succinate
levels using metabolomics. Indeed, YAP1 overexpression
decreased succinate levels in both sdh6D and sdh7D mutants
significantly, while YAP1 overexpression did not affect succinate
levels in sdh2D mutants as a negative control (Figure 3C).
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Therefore, we conclude that YAP1 overexpression contributes to
the restoration of SDH activity in sdh6D and sdh7D mutants.
Elevated levels of Yap1, however, have no effect on the respira-
tory growth defects in sdh6D sdh7D double mutants (Figure 3A).
Sdh2 Is Stabilized by Sdh6 and Sdh7 under Oxidative
Stress Conditions
We hypothesized that Sdh6 and Sdh7 may be important for SDH
maturation under oxidative stress conditions. Initially, we tested
whether cells lacking Sdh6 or Sdh7 were hypersensitive to the
superoxide anion generator paraquat. The respiratory growth
defect of sdh6D and sdh7D single mutants was dramatically
exacerbated in the presence of paraquat (Figure 4A). Likewise,
steady-state levels of Sdh2 were markedly attenuated in para-
quat-treated sdh6D and sdh7D mutants compared to WT cells
(Figure 4B). In contrast, steady-state levels of other mitochon-
drial FeS containing proteins were not significantly altered by
paraquat in the mutant cells (Figure 4B).
The paraquat sensitivity of sdh6D and sdh7D mutants may
arise from either enhanced ROS damage or the accumulation
of a pro-oxidant in the mutants. We observed that ROS levels
were not changed in untreated sdh6D and sdh7Dmutants using
two different assays. First, we quantified aconitase (Aco1)
activity. The 4Fe-4S cluster in aconitase is susceptible to ROS
damage (Gardner, 2002); thus, aconitase activity is an indicator
of ROS stress in vivo. No diminution of aconitase activity was
seen in sdh6D and sdh7Dmutants compared to WT (Figure 4C).
Second, we tested the mutant cells for hydrogen peroxide
sensitivity on rich glucose medium. As cells accumulate ROS,
they become sensitized to exogenous ROS and subsequently
lose viability (Khalimonchuk et al., 2007). After 2 hour treatment
of cells with 6 mM H2O2, the viability of sdh2D, sdh3D, and
sdh4Dmutant strainswas significantly compromised (Figure 4D).
However, sdh6D and sdh7D mutant cells exhibited no
growth defects. The lack of impairment in aconitase activity
and hydrogen peroxidase sensitivity suggest that ROS levels
are not elevated in sdh6D and sdh7D mutants as compared to
WT cells. It is notable that sdh1D and sdh5D single mutants
and the sdh4D sdh5D double mutant did not show hydrogen
peroxide sensitivity compared to sdh2D, sdh3D, and sdh4D
strains, which suggests that an assembly intermediate contain-
ing FAD-Sdh1 may be the source for electron leakage for the
generation of ROS in sdh2D, sdh3D, and sdh4D single mutants.
Theobservedhypersensitivity of sdh6D and sdh7Dmutant cells
to paraquat may imply that Sdh6 and Sdh7 are shielding the FeS
clusters in Sdh2 prior to full assembly. Superoxide inactivation of
the 4Fe-4S center in aconitase leads to a dissociation of one iron
ion forming an inactive 3Fe-4S center that can be reactivated by
supplemental iron salts (Gardner and Fridovich, 1992). We tested
whether supplemental iron salts would restore respiratory func-
tion to sdh6D and sdh7D mutant cells. Supplemental FeCl2, but
not ZnCl2, restored limited glycerol growth to both mutant cells
(Figure 4E). These data are consistent with a candidate role of
Sdh6 and Sdh7 in FeS cluster protection in SDH maturation.
Drosophila Sdhaf3 Mutants Are Sensitive to Oxidative
Stress
The Drosophila genome encodes a close ortholog of Sdh7 (Fig-
ure S5A) but has only a weak candidate homolog of Sdh6.
Accordingly, we examined the functions of Sdh7 in Drosophila
to determine if its roles in SDH assembly and activity have
been conserved through evolution and to define its possible
physiological functions. Gene targeting was used to generate a
null mutation in the Drosophila sdh7 ortholog (CG14898), which
we refer to here as dSdhaf3 (Figures S5B and S5C). These mu-
tants were outcrossed for six generations to w1118, which was
used as a control for most studies. dSdhaf3 mutants progress
normally through development and have a normal lifespan
when maintained on standard growth media. These animals
are, however, sensitive to ethanol (Figure 5A) and oxidative
stress, resulting from either paraquat treatment (Figure 5B) or
hyperoxia (Figure 5C). The response to hyperoxia is most pro-
nounced, with a 50% reduction in lifespan relative to controls,
althoughSdhB12081 hypomorphic mutants display amore severe
effect (Walker et al., 2006). Interestingly, most dSdhaf3 mutants
exposed to 100%oxygen for 4 days held their wings erect, a hall-
mark of mitochondrial dysfunction and muscle degeneration
(DeSimone et al., 1996; Greene et al., 2003). A similar abnormal
wing posture was observed in SdhB12081 mutants maintained
under normal conditions (10%–15%) or exposed to hyperoxia
(80%–100%).
dSdhaf3 Mutants Display Reduced SdhB Protein Levels
and SDH Activity
If the function of dSdhaf3 has been conserved through evolution,
then dSdhaf3 mutants should display a specific defect in SDH
function. Consistent with this possibility, metabolomic profiling
of dSdhaf3 mutants revealed elevated succinate and reduced
levels of fumarate and malate (Figure 5D). Biochemical analysis
of mitochondrial extracts from dSdhaf3 mutants demonstrated
that dSdhaf3 mutants have normal levels of SdhA, but signifi-
cantly reduced levels of SdhB (Figure 5E), resulting in an approx-
imate 50% reduction in SDH enzymatic activity (Figures 5F and
5G), similar to the phenotypes of sdh7D yeast. SdhA is also
flavinylated normally in dSdhaf3 mutants, as expected (Fig-
ure S5E). Combining the hypomorphic SdhB12081 allele with
the dSdhaf3mutation resulted in a dramatic decrease in viability,
demonstrating a strong genetic interaction, consistent with the
reduced levels of SdhB in dSdhaf3 mutants and confirming the
functional interaction between dSdhaf3 and SDH (Figure S6A).
Interestingly, although dSdhaf3 mutants are fully viable and
fertile, they display a clear age-dependent reduction in move-
ment (Figure 5H). While mutants at 1 week of adult life show no
difference in motility relative to controls, mutants display an
approximately 50% reduction in movement by 2 weeks of age
and a more severe motility defect at later stages (Figure 5H).
Mutants are also significantly more sensitive to paralysis by
2 weeks of age, relative to controls (Figure S5F). Thus, like its
counterpart in yeast, dSdhaf3 is required to maintain normal
SDH levels and activity and proper wing muscle function and
motility in Drosophila.
Antioxidant and Genetic Rescue of dSdhaf3 Mutants
Consistent with the ability of antioxidants to suppress the
growth defects in sdh7D yeast mutants, either a dietary (N-ace-
tylcysteine) or genetic (Sod2 expression) reduction in oxidative
stress rescued the hyperoxia sensitivity of dSdhaf3 mutants
(Figures 6A and 6B). Unlike the yeast studies, however,
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Figure 4. sdh6D and sdh7D Mutants Are Sensitive to Oxidative Stress
(A) Serial dilutions (10-fold) of cells were spotted on SC media with or without 2 mM paraquat with indicated carbon sources and incubated at 30!C.
(B) Steady-state levels of proteins in mitochondria isolated from strains cultured in the presence of 2 mM paraquat. Yah1, ferredoxin of the mitochondrial matrix.
(C) Aconitase activity specific to cis-aconitate conversion in isolated mitochondria. Data are shown as mean ± SD (n = 3).
(legend continued on next page)
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overexpression of the putative Sdh6 homolog (encoded by
CG34229), using Act5C-GAL4 to drive a UAS-CG34229 trans-
gene in dSdhaf3mutants, had no effect on their sensitivity to hy-
peroxia (Figure S6B). This result, however, is difficult to interpret
because there is only limited sequence homology between
CG34229 and Sdh6. We conclude that this functional interac-
tion between Sdh6 and Sdh7 may not be conserved through
evolution or, alternatively, that CG34229 is not a functional ho-
molog of Sdh6.
The wing posture and motility defects in dSdhaf3 mutants
suggested that these animals suffer from muscular and
neuronal dysfunction. Consistent with this model, widespread
expression of WT dSdhaf3 (Act > dSdhaf3) in dSdhaf3 mutants
fully rescues their sensitivity to hyperoxia (Figure 6C), while
muscle-specific (C57 > dSdhaf3) or neuronal-specific (elav >
dSdhaf3) expression provides partial rescue (Figure 6D). Similar
effects are seen on the climbing defects in dSdhaf3 mutants
(Figures 6E and 6F). Genetic rescue in the fat body (Cg-GAL4)
or intestine (Mex-GAL4), however, provided no significant
rescue (data not shown). Widespread overexpression of
dSdhaf3 in wild-type flies has no significant effect on their
resistance to hyperoxia (data not shown). Taken together, we
conclude that dSdhaf3 function is conserved through evolution
and that proper SDH levels and activity are required for
resistance to oxidative stress as well as muscular and neuronal
function, consistent with their dependence on mitochondrial
oxidative phosphorylation.
SDHB Is Specifically Impaired in Human Cells Deficient
in Wild-Type SDHAF1
The human Sdh6 ortholog, SDHAF1, was shown previously to be
important for SDH activity and abundance in fibroblasts (Ghezzi
et al., 2009); however, its mechanism of action remained
undefined. We addressed whether SDHAF1 protects SDHB
(the human Sdh2 ortholog) from ROS damage similar to yeast
Sdh6. First, we determined steady-state levels of SDH structural
subunits in SDHAF1-depleted human embryonic kidney 293
(HEK293) cells by siRNA knockdown. SDHB and SDHC levels
were significantly reduced upon SDHAF1 depletion (Figure 7A).
SDHA levels, however, remained unaffected. Next, we tested
the effects of paraquat on SDHAF1-depleted HEK293 cells. In
accordance with the yeast and fly data, SDHB levels were further
attenuated in SDHAF1-deficient cells (Figure 7B). The sensitivity
to paraquat also suggests that SDHAF1 resembles Sdh6 in pro-
tecting holo-SDHB from ROS damage.
We also examined the steady-state SDHB levels in patient
fibroblasts with a known SDHAF1 mutation (Ohlenbusch et al.,
2012). Both SDHB and SDHC levels were diminished in mito-
chondria isolated from the patient fibroblasts, whereas SDHA
levels remained unaffected compared to controls (Figure 7C).
SDHB protein levels were <50% of wild-type controls, and
SDH enzyme activity was 52% and 40% in patients 1 and 2 rela-
tive to control values. Thus, the limited SDHB levels in the patient
cells likely contribute to reduced SDH function.
DISCUSSION
The present work demonstrates that maturation of the FeS sub-
unit of Sdh2 (SDHB) requires the participation of two assembly
factors, Sdh6 (SDHAF1) and Sdh7 (SDHAF3). These factors are
shown to guide Sdh2 maturation within the mitochondrial matrix
in the midst of endogenous oxidants. Yeast, flies, and mamma-
lian cells lacking one of these factors are impaired in SDH activity
and assembly, with Sdh2 exhibiting a heightened susceptibility
to oxidants. Normal oxidative metabolism in the mitochondria
leads to the formation of superoxide anions from the one-elec-
tron reduction of O2. Superoxide anions can readily dissociate
FeS clusters, rendering the assembly of FeS cluster centers
in mitochondrial enzymes susceptible to oxidative damage.
The present studies in yeast, flies, and mammalian cells suggest
that Sdh6 and Sdh7 shield one or more of the three FeS clusters
in Sdh2 from oxidants during assembly.
Yeast studies reveal that Sdh6 and Sdh7 act in concert in the
maturation of Sdh2 with a limited redundancy in function. Yeast
lacking either factor show a marked SDH deficiency in late-log
cultures that rely on oxidative metabolism. Under these condi-
tions, the mutant cells contain a reduced level of the assembled
tetrameric enzyme. These cells exhibit a hypersensitivity to the
superoxide generator paraquat. The respiratory defect of these
mutants is readily suppressed by overexpression of the Yap1
transcriptional activator of oxidative stress genes or exogenous
reductants. These studies highlight the role of Sdh6 and Sdh7 in
shielding Sdh2 maturation from deleterious effects of oxidants.
Flies lacking the Sdh7 ortholog SDHAF3, likewise, are hyper-
sensitive to paraquat and hyperoxia. The mutant flies show
diminished levels of active SDH and, as a result, accumulate suc-
cinate. The dSdhaf3 mutants are viable and fertile yet display
impaired movement that intensifies with age. The erect wing
phenotype exhibited under hyperoxic conditions and the motility
defects evident in agedmutant flies are consistent with muscular
and neuronal dysfunction. Moreover, neuronal or muscle-spe-
cific expression of wild-type dSdhaf3 is sufficient to partially
rescue the hyperoxia sensitivity of the mutants, demonstrating
the importance of SDH function in these tissues that rely heavily
on oxidative phosphorylation (OXPHOS). The hyperoxia sensi-
tivity of dSdhaf3 mutants is also partially suppressed by dietary
N-acetylcysteine or overexpression of the matrix mangano-
superoxide dismutase Sod2. These effects of antioxidantsmimic
the rescue of yeast sdh7Dmutant oxidative growth and demon-
strate the apparent close conservation of Sdh7/SDHAF3 func-
tion through evolution.
Conservation in Sdh6/SDHAF1 function between yeast and
humans also exists. Attenuation of SDHAF1 in HEK293 culture
cells leads to a hypersensitivity in the stability of the FeS SDHB
subunit to paraquat. SDHB instability is also seen in two SDHAF1
patient fibroblast lines. One implication of the observed antioxi-
dant rescue of the defect of sdh6D yeast cells and dSdhaf3
mutant flies is the potential use of antioxidant therapeutics
for patients afflicted with SDHAF1 (and perhaps SDHAF3)
(D) Precultures grown up to late-log phase in YPDmedia were diluted 2-fold, followed by addition of 6mMH2O2 and incubated for 2 hr at 30
!C. Cells were washed
with sterile water, and 10-fold serial dilutions were spotted on YPD plate, followed by incubation at 30!C.
(E) Enhanced respiratory growths of sdh6D mutants and sdh7D mutants with iron supplementation. Serial dilutions (10-fold) of cells were spotted on SC media
with or without FeCl2 or ZnCl2 with the indicated concentrations and then incubated at 30!C.
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Figure 5. dSdhaf3 Mutants Are Sensitive to Oxidative Stress and Display Reduced Levels of SdhB, Reduced SDH Activity, and Motility
Defects
(A–C) w1118 control (solid line) and dSdhaf3 mutant (dotted line) males (5 days old) were transferred to vials with (A) 5% ethanol, 1% agar in PBS, (B) 30 mM
paraquat in semidefined medium, or (C) 100% O2 with standard medium, and living animals were scored daily. Homozygous SdhB
12081 mutants (dashed line)
were included in the hyperoxia experiment. Each graph was compiled from 3–5 experiments, using a total of 15–21 vials with 20 animals per vial. Error bars
represent ±SEM. dSdhaf3 mutants are significantly more sensitive than controls under each condition; p < 0.001.
(D) GC-MS was used to compare the relative levels of small metabolites in wild-type controls (gray boxes) and dSdhaf3 mutants (white boxes). n = 12 samples
from two independent experiments with 20 flies/sample (5 days old). ***p < 0.001.
(E) Proteins were extracted frommitochondria isolated fromw1118 controls, dSdhaf3mutants, orUAS-dSdhaf3/+ transformants and analyzed by immunoblotting
to detect SdhA, SdhB, and ATPa (subunit of complex V).
(legend continued on next page)
Cell Metabolism
Maturation of the FeS Subunit of SDH




mutations. Patients with SDHAF1 mutations have presented
with SDH-deficient leukoencephalopathy (Ghezzi et al., 2009;
Ohlenbusch et al., 2012) and have a survival window that may
be amenable to antioxidant therapy. Two case studies were
reported that attempted to alleviate clinical symptoms in SDH-
deficient patients harboring SDHAF1 mutations by supplement-
ing riboflavin and CoQ10. The clinical outcomes, however, were
not significantly improved (Jain-Ghai et al., 2013). More recently,
a candidate therapeutic, EPI-743, is being tested for treatment
of Leigh syndrome patients (Martinelli et al., 2012). EPI-743 is
a vitamin E quinone that is orally bioavailable and crosses
the blood-brain barrier (Shrader et al., 2011). Future studies
will focus on the efficacy of antioxidants with SDHAF1 patient
fibroblasts. In addition, it is important to note that every gene
encoding an SDH subunit or known assembly factor is causally
associated with human disease. We thus anticipate that
SDHAF3 mutations will be associated with one or more previ-
ously idiopathic SDH-associated diseases and propose that
SDHAF1 and SDHAF3 are candidate susceptibility factors for
undefined SDH-deficient tumors.
The present work provides insights into the physiological func-
tion of Sdh6 and Sdh7 in Sdh2 maturation. Sdh6 and Sdh7 are
shown to bind to the Sdh1/Sdh2 assembly intermediate that
accumulates in mutants lacking the SDH membrane anchor. In
addition, both Sdh6 and Sdh7 accumulate in the membrane an-
chormutant cells. Sdh6was found to impart stabilization to Sdh2
in cells lacking the FAD subunit Sdh1, suggesting that at least
Sdh6 has a specific interface for Sdh2. These assembly factors
do not appear to be apo-Sdh2 chaperones, since elevated levels
of Sdh2 do not suppress the respiratory defects of sdh6D or
(F) A continuous colorimetric assay was used to measure SDH enzyme activity in extracts of purified mitochondria from w1118 controls, dSdhaf3 mutants, and
UAS-dSdhaf3/+ transformants. ***p < 0.001.
(G) Proteins from purified mitochondria were extracted from w1118 controls and dSdhaf3 mutants, fractionated by nondenaturing PAGE, and analyzed for SDH
and complex IV activity.
(H) Control w1118 flies and dSdhaf3 mutants were tested for motility in three independent experiments using a total of 18 vials with 20 adults/vial at 1, 2, 3, or
4 weeks of age. Climbing ability is reported as the number of flies that climbed above a line drawn 4 cm above the bottom of the vial 5 s after being tapped to the













































































































Figure 6. dSdhaf3 Function Is Required in
the Muscles and Nervous System
w1118 control (blue solid line) and dSdhaf3 mutant
(red dotted line) males (5 days old) were trans-
ferred to vials with 100% O2 with standard me-
dium, and living animals were scored daily.
(A) 0.1% N-acetylcysteine was added to the cul-
ture medium for a quarter of the vials.
(B) Expression ofSod2 using theubiquitousAct5C-
GAL4 driver (Act>Sod2; purple line) partially res-
cues the hyperoxia sensitivity of dSdhaf3mutants.
Both NAC treatment and Sod2 expression signifi-
cantly rescue the hyperoxia sensitivity of dSdhaf3
mutants; p < 0.001.
(C) Expression of wild-type dSdhaf3 using
the ubiquitous Act5C-GAL4 driver (Act>dSdhaf3;
purple line) rescues the hyperoxia sensitivity of
dSdhaf3 mutants (p < 0.001).
(D) The muscle-specificC57-GAL4 driver provides
minor, but significant (p < 0.01), rescue of the
hyperoxia sensitivity of dSdhaf3 mutants (purple
line) relative to the control that carries the UAS-
dSdhaf3 transgene alone (green line), while the
CNS-specific elav-GAL4 driver provides more
efficient rescue (orange line) (p < 0.001).
(E and F) Expression of wild-type dSdhaf3 by using
either (E) the ubiquitousAct5C-GAL4driver (purple),
(F) the muscle-specific C57-GAL4 driver (purple),
or (F) the CNS-specific elav-GAL4 driver ( orange)
rescues the climbing defect in dSdhaf3mutants.
The Act>dSdhaf3 rescue in (C) and (E) was per-
formed in females, and other rescue studies were
performed in males (A, B, D, and F). The apparent
partial rescue of dSdhaf3mutants by a single copy
of theUAS-dSdhaf3 transgene (CandD, green line)
appears to be due to genetic background since
UAS-dSdhaf3 transformants have normal levels of
SdhB and SDH activity (E and F). Each graph was
compiled from two experiments with a total of 10
vials with 20 animals per vial. ***p < 0.001.
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Figure 7. SDHB Is Destabilized in Human Cells with Reduced Levels of SDHAF1
(A) Relative SDHAF1 mRNA levels in HEK293 cells 72 hr after SDHAF1 knockdown using siRNA (left panel) and steady-state levels of proteins from total cell
lysates (right panel).
(B) HEK293 cells were treated with either control siRNA or SDHAF1 siRNA. Paraquat was added to cultures 24 hr after siRNA transfection. Total cell lysates were
obtained 48 hr after paraquat treatment.
(legend continued on next page)
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sdh7D mutants. Sdh6 and Sdh7 appear to be key chaperones
in holo-Sdh2 maturation during oxidative growth. However, a
recent report implicated SDHAF1 in an active role in FeS cluster
insertion (Maio et al., 2014).
Theobservation that the twoLYRproteinsSdh6andSdh7 func-
tionwith the FeS cluster Sdh2 subunit has significant implications
for the uncharacterized LYR proteins present in the human prote-
ome.Our studies raise thepossibility that future functional studies
of LYRM1, LYRM2, LYRM5, and LYRM9will reveal roles in matu-
ration of mammalian-specific FeS cluster enzymes.
EXPERIMENTAL PROCEDURES
Yeast Strains and Plasmids
All S. cerevisiae strains and plasmids used are listed in Tables S1 and S2,
respectively. Culture media and conditions are described in detail in the Sup-
plemental Experimental Procedures.
Mitochondrial Enzymatic Activity Assay
Succinate dehydrogenase (SDH) and aconitase activity assays were per-
formed as described previously (Atkinson et al., 2011). For SDH activity,
quinone-mediated reduction of dichlorophenolindophenol (DCPIP) upon suc-
cinate oxidation was measured with isolated mitochondria spectrophotomet-
rically at 600 nm. Aconitase activity wasmeasuredwith 100 mM cis-aconitate in
50 mM Tris (pH 7.4) at 240 nm in soluble fractions of mitochondria disrupted
by repetitive freeze-thaw. For malate dehydrogenase (MDH) activity, soluble
mitochondrial fractions were obtained using sonication. Oxidation of 0.2 mM
NADH was monitored in the presence of 2 mM oxaloacetate in 100 mM Tris
(pH 7.4) at 340 nm (Hayes et al., 1991).
Mitochondrial Protein Import Assay
Mitochondrial protein import assay was performed as described previously
(Wagener et al., 2011). Briefly, SDH2 and RIP1 open reading frames were
subcloned in pGEM-4Z for in vitro transcription and translation, respectively.
Radiolabeled precursor proteins were obtained using reticulocyte lysate
(Promega) in the presence of 35S-Met. Precursors were imported into 75 mg
of isolated mitochondria in 50 mM HEPES-KOH (pH 7.2) buffer containing
0.6 M sorbitol, 0.5 mg/ml BSA, 2 mM potassium phosphate, 75 mM KCl,
10 mM magnesium acetate, 2 mM EDTA, 2.5 mM MnCl2, 2 mM ATP, 2 mM
NADH, 10 mM creatine phosphate, 0.1 mg/ml creatine kinase, 2.5 mMmalate,
and 2.5 mM succinate for 30 min at 25!C for pulse. Import was stopped by
adding 5 mM valinomycin and then chased for the periods of time indicated.
Nonimported precursors were degraded by proteinase K on ice. Samples
were separated on SDS-PAGE and detected by autoradiography.
Coimmunoprecipitation
Mitochondria were solubilized in 10 mM sodium phosphate (pH 7.4), 500 mM
NaCl, 1mMEDTA, 1% digitonin, and 13 protease inhibitor cocktail (Roche) for
30 min on ice. Crosslinking was performed with solubilization by adding 1 mM
of dithiobis(succinimidylpropionate) (Pierce) for 30 min at room temperature
(RT). After centrifugation at 14,000 3 g, supernatants were incubated with
magnetic anti-Myc beads (Cell Signaling Technology) for 4 hr at 4!C. Beads
were washed with 10 mM sodium phosphate (pH 7.4), 500 mM NaCl, 1 mM
EDTA, 0.1% digitonin, and 1 mM PMSF. After washing three times, bound
substances were recovered by boiling with 23 SDS-PAGE sample buffer,
which was subjected to immunoblotting.
Drosophila Strains
Flies were maintained on standard Bloomington Stock Center medium with
malt at 25!C. The following stocks were obtained from the Bloomington Stock
Center: SdhAHP21216/CyO (Bloomington #22087), SdhB12081/CyO (Walker
et al., 2006), da-Gal4 (Wodarz et al., 1995), and Act5C-Gal4/CyO (Bloomington
#25374). The UAS-dSdhaf3 transformants were generated as described in the
Supplemental Experimental Procedures.
Statistics
Yeast data were analyzed using Microsoft Excel 2011. Data are presented as
mean ± SD or mean ± SEM, as indicated. Statistical significance was evaluated
usingStudent’s t test. p<0.05wasconsideredsignificant.Statistical analysisand
graphical presentation for Drosophila studies were performed using PRISM
software. Student’s t test was used for pairwise comparisons, and one-way
ANOVAwasused formultiplecomparisons.Flymetabolomicdataaregraphically
represented as box plots, with the box representing the lower and upper quar-
tiles, the horizontal line representing the median, and the bars representing the
minimumandmaximumdatapoints.All otherdataareshownas themean±SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.cmet.2014.05.014.
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SDH assembly factors have been identified as playing a role in maturation of 
individual SDH subunits and assembly of the functioning SDH complex. Using 
massively parallel sequencing, we identified a variant in SDH assembly factor 3 
(SDHAF3), c.157T>C (p.Phe53Leu), associated with increased prevalence in familial and 
sporadic pheochromocytoma and/or paraganglioma (6.6%) compared to a normal 
population (2.1% [Exome Aggregation Consortium]; p=0.0063). In silico prediction tools 
suggest this variant is probably damaging to protein function, hence we assessed 
functional consequences of the resulting amino acid change (p.Phe53Leu) in yeast and 
human cells. Through our analysis in yeast, we showed that introduction of SDHAF3 
p.Phe53Leu into Sdh7 null yeast (ortholog of SDHAF3 in humans) resulted in impaired 
function, as observed by its failure to restore SDH activity when expressed in Sdh7 null 
yeast relative to WT SDHAF3. As SDHAF3 is involved in maturation of SDHB, we 
tested the functional impact of SDHAF3 c.157T>C and various clinically relevant SDHB 
mutations on this interaction. Our in vitro studies in human cells show that SDHAF3 
interacts with SDHB (residues 46 and 242), with impaired interaction observed in the 
presence of the SDHAF3 c.157T>C variant. Our studies reveal novel insights into the 
biogenesis of SDH, uncovering a vital interaction between SDHAF3 and SDHB. We 
have shown that SDHAF3 interacts directly with SDHB (residue 242 being key to this 
interaction), and that a variant in SDHAF3 (c.157T>C [p.Phe53Leu]) is more prevalent in 
individuals with pheochromocytoma and/or paraganglioma, and is hypomorphic via 





Succinate dehydrogenase (SDH) plays an integral role in both the tricarboxylic 
acid (TCA) cycle, where it catalyses the oxidation of succinate to fumarate; and electron 
transport chain (ETC), where succinate oxidation is coupled to ubiquinone reduction. 
SDH is comprised of four nuclear encoded subunits (SDHA, B, C and D), and germline 
mutations in any of these SDH subunits are associated with a variable risk of developing 
neoplasia (1). Nevertheless, discordant phenotypes are observed both within and between 
families carrying the same SDH mutation, suggesting that other environmental, genetic or 
epigenetic factors influence the clinical phenotype. 
SDH genes (SDHA, SDHB, SDHC, SDHD) act as classical tumor suppressors, 
such that germline heterozygous inactivating mutations coupled with somatic loss of the 
remaining wild-type allele leads to complete loss of enzyme function and development of 
associated tumors. SDHx mutations have been linked to tumorigenesis as a result of a 
number of downstream consequences. SDH deficiency results in succinate accumulation, 
due to inability of SDH to catalyze the oxidation of succinate to fumarate. In turn, the 
elevated succinate can inhibit α-ketoglutarate-dependent dioxygenases, resulting in 
pseudo-hypoxia and hypermethylation of histones and DNA. Inhibition of the α-
ketoglutarate-dependent dioxygenase, prolyl hydroxylase (PHD), leads to HIF 
stabilization, increased expression of HIF targets and ultimately induction of a hypoxic 
response under normoxic conditions (pseudo-hypoxia). In line with this proposed 
mechanism of action, both increased stability of HIF and increased expression of HIF 
targets have been identified in SDHx-mutated paragangliomas and pheochromocytomas 
(2-4). Additionally, accumulated succinate inhibits other α-ketoglutarate-dependent 
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dioxygenases, such as histone demethylases of the Jumonji demethylase family and TET 
hydroxylases, resulting in hypermethylation of histones and DNA. This mechanism has 
been observed recently in SDHx-mutated paragangliomas, pheochromocytomas and 
gastrointestinal stromal tumors (5-7).  
Recently, SDH assembly factors (SDHAF1, SDHAF2, SDHAF3 and SDHAF4) 
have been identified as being crucial for maturation and effective functioning of SDH 
within mitochondria (8-10). To date, mutations affecting SDHAF1 (involved in 
maturation of SDHB) and SDHAF2 (required for covalent attachment of FAD to SDHA) 
have been associated with human diseases. SDHAF1 mutations have been identified in 
individuals with leukoencephalopathy (11, 12), but not yet in subjects with 
paragangliomas or pheochromocytomas. A SDHAF2 loss-of-function mutation 
(p.Gly78Arg) has been reported in two unrelated families with head and neck 
paragangliomas (8, 13, 14). In the tumors of affected individuals, this mutation was 
shown to impair flavinylation of SDHA. Additionally, in vitro experiments showed that 
the p.Gly78Arg mutant leads to complete loss of SDH activity, through impaired covalent 
flavinylation of SDHA and destabilization of the SDHAF2 protein. Subsequent studies in 
large cohorts of apparently sporadic paragangliomas and pheochromocytomas have failed 
to identify germline or somatic SDHAF2 mutations, suggesting that mutations within 
SDHAF2 may be rare (13, 14).  
Recently, yeast studies showed that two LYR motif proteins Sdh6 (SDHAF1, 
human ortholog) and Sdh7 (SDHAF3, human ortholog) act in concert to promote the 
maturation of Sdh2 (SDHB, human ortholog) by shielding one or more of the three Fe-S 
clusters in Sdh2 from the deleterious effects of oxidants during assembly (9). LYR motifs 
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were also observed in SDHB itself in residues 44-46 and 240-242. These were implicated 
in the insertion of Fe-S clusters (15). We therefore hypothesized that mutations within the 
newly identified SDH assembly factor, SDHAF3, may be associated with the 
pathogenesis of pheochromocytoma and/or paraganglioma syndromes. Furthermore, 
given SDHAF3 is involved in the maturation of SDHB, we hypothesized that mutations 
within either of these genes may impair this process.  
 
Materials and methods 
Subjects and samples 
DNA was extracted from peripheral blood leukocytes of 37 individuals (from 23 
families) with germline SDH mutations (16 SDHB, 1 SDHC and 6 SDHD families) and 
100 individuals with no known disease (i.e., unaffected control population). Additionally, 
DNA was extracted from 15 fresh-frozen pheochromocytoma/paraganglioma (PC/PGL) 
samples of apparently sporadic origin, as well as 3 paraffin embedded PC/PGL samples 
associated with familial disease. SDHB immunohistochemical assessment of the 3 
paraffin embedded PC/PGL samples was also performed, as previously described (16). 
Informed consent was obtained for the collection and study of all samples, with approval 
for research being granted by the Northern Sydney Local Health District Human 
Research Ethics Committee (Kolling Neuroendocrine Tumour Bank Protocol #11011-
361M, Australian SHD Consortium Protocol #1103-101M, and Kolling Institute Healthy 





Massively parallel sequencing 
A custom gene panel (TruSeq® Custom Amplicon Assay, Illumina) was 
developed, encompassing our candidate gene - SDHAF3 (NM_020186); as well as eight 
known PC/PGL suseptibility genes (MAX [NM_002382], SDHB [NM_003000], SDHC 
[NM_003001], SDHD [NM_003002], SDHAF2 [NM_017841], RET [NM_020975], 
TMEM127 [NM_017849] and VHL [NM_000551]). The panel included the protein-
coding exons and flanking intronic regions of each of the genes and was created using 
DesignStudio (Illumina). DNA libraries were prepared (using 250 ng of DNA from each 
sample) and sequenced on a MiSeq platform (using 2 x 150 bp paired end reads) 
according to the manufacturer’s instructions (Illumina). FASTQ files (containing reads 
and their base call quality scores) were generated for each sample, and alignment of reads 
(banded Smith-Waterman algorithm) and variant calling (GATK (17)) was processed by 
MiSeq Reporter (version 2.0, Illumina). Annotation of functional consequences to variant 
calls was performed using ANNOVAR (version 2013Jul (18)), which incorporates 
various in silico tools, including (but not limited to) PolyPhen-2, SIFT, MutationTaster. 
Visualisation of reads was performed using IGV (v2.1). 
 
Sanger sequencing 
SDHAF3 variants identified by massively parallel sequencing were confirmed by 
Sanger sequencing. Mutation analysis of the entire coding sequence, including exon-
intron boundaries, was performed for the two exons of SDHAF3. Primer sequences were 
as follows: exon 1-forward (5’-gtctgccttccggttcacta-3’), exon 1-reverse (5’-
gaacaggttgctgctctgttta-3’), exon 2-forward (5’-tccttaaccaaatgcttctgc-3’), exon 2-reverse 
  
47 
(5’-tgatcttgatccatatactgcaa-3’). In some instances, two rounds of PCR were required to 
amplify the DNA from paraffin embedded tissues; in such cases, each mutation was 
confirmed by sequencing of two independent PCRs.  
 
Strains and plasmids for studies in yeast 
S. cerevisiae strains used in this study were from a previous study (9). Yeast cells 
were grown in synthetic complete or minimal media containing 2% raffinose and 0.2% 
glucose, unless indicated otherwise. To clone SDHAF3 in yeast plasmids, the PCR-
amplified SDHAF3 ORF from a human cDNA library was ligated into pRS416 with 
MET25 promoter and CYC1 terminator. For SDHAF3 and SDH2 sequence variants, site-
directed mutagenesis was carried out using Phusion high-fidelity DNA polymerase 
(Thermo Fisher Scientific). The full-length SDH2 with its own promoter and terminator 
were cloned into pRS416. Plasmids expressing Sdh2-His6Myc2 and Rip-Myc were from a 
previous study (19). 
 
Co-immunoprecipitation of yeast proteins 
SDHAF3 immunoprecipitation with anti-SDHAF3 antibody was performed using 
protein A magnetic beads. Briefly, mitochondria were solubilized in 10 mM Tris-HCl 
(pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% digitonin and 1X protease inhibitor cocktail 
(Roche) for 30 min on ice. Supernatants after centrifugation at 14,000 x g were incubated 
with appropriate antibodies for 16 hours at 4°C. Protein A magenetic beads (New 
England Biolabs, Inc.) were added and incubated for 4 hours at 4°C. Beads were washed 
three times with 10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 0.1 % digitonin 
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and 1 mM PMSF. Beads were resuspended in 2X SDS-PAGE sample buffer, which was 
subjected to immunoblotting. 
 
Enzyme activity assay 
Succinate dehydrogenase (SDH) and succinate:quinone oxidoreductase (SQR) 
activity assays were performed as previously described, with slight modifications (23). 
Briefly, isolated mitochondria were incubated in 40 mM potassium phosphate (pH 7.4) 
buffer with 0.5% Tween 80, 20 mM succinate and 20 µM antimycin A for 5 min at room 
temperature. The reaction was initiated by adding 90 µM decylubiquinone for SQR or 
120 µM phenazine methosulfate for SDH with 120 µM dichlorophenolindophenol 
(DCPIP). The rate of reduction of DCPIP was measured spectrophotometrically at 600 
nm for 5 min. 
 
Plasmid constructs and site-directed mutagenesis for studies 
in mammalian cells 
Site-directed mutagenesis (QuikChange Lightning Site-Directed Mutagenesis Kit, 
Agilent) was used to produce the SDHAF3 variant (p.Phe53Leu [c.157T>C, 
NM_020186]) and SDHB mutants (p.Ala43Pro [c.127G>C, NM_003000], p.Arg46Gly 
[c.136C>G], p.Arg46Gln [c.137G>A], p.Cys101Tyr [c.302G>A], p.Ile127Ser 
[c.380T>G], p.Pro197Arg [c.590C>G], p.Arg242His [c.725G>A]). The SDHAF3 variant 
was generated in a commercially available plasmid, pCMV6-SDHAF3-Myc-DDK 
(RC204626, Origene); while the SDHB mutants were generated in a plasmid (pEGFP-N1; 
6085-1, Clonetech) containing wild-type SDHB. Briefly, normal SDHB cDNA was 
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generated from human adrenal total RNA and inserted into pEGFP-N1, using EcoRI and 
BamHI restriction sites, as previously described (24). Sanger sequencing was used to 
confirm the presence of wild-type or variant sequences, and that they were in-frame with 
the respective tag.  
 
Co-immunoprecipitation of mammalian proteins 
Human embryonic kidney 293 (HEK293) cells, cultured in DMEM with 10% 
fetal bovine serum, were seeded at 1.0 x 106 cells/25 cm2 flask and left to settle for 24 
hours. Co-transfections were then performed using 7.5 µg of DNA (pCMV6-SDHAF3-
Myc-DDK and pEGFP-N1-SDHB) using LipofectamineTM 2000 (Life Technologies) and 
Opti-MEM® (Life Technologies) according to the manufacturers’ instructions. Twenty-
four hours post transfection, cells were washed (PBS), pelleted and lysed using co-
immunoprecipitation (Co-IP) buffer (20 mM Tris pH7.5, 150 mM NaCl, 1 mM EGTA, 1 
mM EDTA, 0.1% Triton X100), which was also used for whole cell lysates. Dynabeads® 
M-280 sheep anti-mouse IgG (Life Technologies) were incubated with either mouse IgG 
antibody (dilution 1:2000, Thermo-Fisher, Waltham, MA, USA) for negative control or 
mouse monoclonal anti-DDK (dilution 1:2000, OriGene [TA50011], MD, USA) for 2 
hours prior to washing; then incubated overnight with cell extracts at 4°C under gentle 
rotation. Proteins not associated with DDK-tagged SDHAF3 were removed (3 x 10 
minutes gentle agitation washes) using Co-IP lysis buffer with a higher salt concentration 
(500 mM NaCl). To remove immunoprecipitated material from beads, cell lysates were 
mixed with NuPAGE® LDS sample buffer (Invitrogen) and dithiothreitol and incubated 
at 95°C for 5 min. Extracts were removed from beads, sonicated and separated by SDS-
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PAGE (4-12% NuPAGE Bis-Tris gels, Invitrogen) under reducing conditions. Proteins 
were transferred (nitrocellulose membrane) and the membrane blocked with 5% skim 
milk (in TBST) for 1 hour at room temperature. The membranes were probed with the 
following antibodies: GFP (dilution 1:2000, Roche [11814460001], Basel, Switzerland), 
DDK (dilution 1:2000, OriGene [TA50011], MD, USA), GAPDH (dilution 1:5000, Cell 
Signaling [D16H11], MA, USA) and incubated overnight at 4°C. Immunoblots were 
washed three times with TBST for 5-10 min and incubated with the relevant secondary 
antibody conjugated to horseradish peroxidase (HRP). Blots were then washed (three 
times in TBST for 5 minutes) and protein detected (ECL Plus Western Blotting Detection 




Isolation of yeast mitochondria was performed using the method of Glick and Pon 
(20). BN-PAGE was performed as described previously with mitochondrial lysates in 1 
% digitonin solution (21). Samples were separated on 4-16% NativePAGE Bis-Tris gels 
(Life Technologies) and transferred to PVDF membrane for immunodetection. Anti-
Sdh1, Sdh2 and Sdh3 were from a previous study (22). Antibodies to Por1 were from 
Molecular Probes. Protein concentration was determined by the Bradford assay. 
 
Statistical analyses 
Chi-squared tests were used to compare allele counts in the disease-affected and 
disease-free cohorts, with p<0.05 considered significant (GraphPad Software, Inc). Yeast 
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data were analyzed using Microsoft Excel 2011, with data presented as mean ± SD or 
mean ± SEM as indicated. Statistical significance was evaluated using Student’s test, 
with p<0.05 considered significant. 
  
Results  
Massively parallel sequencing identifies germline variants arising 
in SDHB and SDHAF3 in the same individual 
During validation of our targeted PC/PGL gene panel (MiSeq platform), we noted 
that one individual (S11_1) with a previously identified germline SDHB splice-site 
mutation (within intron 3 [IVS3]) also harbored a germline SDHAF3 c.157T>C 
(p.Phe53Leu) variant (rs62624461). Pheochromocytoma was first diagnosed in this 
individual at the age of 18 years, and subsequent recurrence and spinal metastasis was 
noted at 24 years of age. Although this SDHAF3 variant has been identified in population 
studies (minor allele frequency [MAF] 0.014 [1000 Genomes_Phase 1_ALL] and 0.021 
[Exome Aggregation Consortium, ExAC]), it is predicted to be damaging by several in 
silico tools (score of 0.777 [PolyPhen-2 v2.2.2r398], score of 0 [SIFT]). Since SDHAF3 
was recently shown to be involved in mediating SDHB maturation(9), we determined the 
prevalence of the SDHAF3 c.157T>C variant among other subjects either with SDH-
related PC/PGL or apparently sporadic PC/PGL, in comparison with normal controls.   
 
Analysis of SDHAF3 c.157T>C variant in a normal population  
The frequency of SDHAF3 c.157T>C in our Australian population was 
determined by direct sequencing of 100 healthy controls (48% males) with no known 
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familial association to SDH-related disease. Of 200 alleles assessed, 6 were found to 
exhibit the minor allele (c.157C [NM_020186], p.Phe53Leu, rs62624461), resulting in a 
minor allele frequency (MAF) of 0.03, which is consistent with the MAF reported in both 
1000 Genomes (Phase 1_ALL) and Exome Aggregation Consortium populations (Table 
4.1).  
 
Analysis of SDHAF3 c.157T>C in individuals with SDH-related 
familial pheochromocytoma and/or paraganglioma  
In addition to individual S11_1, an additional 22 unrelated individuals with SDH 
germline mutations and evidence of disease (i.e., presence of pheochromocytoma and/or 
paraganglioma) were assessed for the presence of SDHAF3 c.157T>C (Table 4.2). Of 
these, one additional individual was found to carry SDHAF3 c.157T>C (S55). This 
individual (S55) had multiple head and neck paragangliomas, the first (glomus jugulare 
tumor) being resected at the age of 48. A nodule at the left carotid bifurcation was noted 
at age 49 (MRI) and has subsequently been monitored, with no evidence of enlargement 
to date. Taken together, of 23 individuals with SDH-related familial pheochromocytoma 
and/or paraganglioma, two were heterozygous for SDHAF3 c.157T>C, giving a MAF of 
0.043 (Table 4.1) which was not significantly different from our Australian population of 
healthy controls (p=0.64) nor from the 1000 Genomes (Phase 1_ALL) (p=0.10) or 
Exome Aggregation Consortium (p=0.2855) populations (Table 4.1). Interestingly, both 
S11_1 and S55 had germline SDHB mutations in addition to the SDHAF3 c.157T>C 
variant; and if only SDHB-mutated individuals from our cohort were considered, then co- 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Genomes (Phase 1_ALL) population (p=0.025) but still not different from the Exome 
Aggregation Consortium (p=0.1005) (Table 4.1).  
 
Analysis of SDHAF3 c.157T>C in individuals with apparently 
sporadic pheochromocytoma and/or paraganglioma  
To further assess the potential role of SDHAF3 in pheochromoctyomas and/or 
paragangliomas, 15 tumors of apparently sporadic origin were assessed for the presence 
of the SDHAF3 c.157T>C (Table 4.3). Three samples were found to be heterozygous for 
this variant, giving a MAF of 0.1 (Table 4.1), which was significantly different from the 
1000 Genomes (Phase 1_ALL) (p=0.0002) and Exome Aggregation Consortium (p= 
0.0025) populations (Table 4.1).  
 
Extension of SDHAF3 c.157T>C analysis in Family S11  
In addition to individual S11_1, an additional 14 SDHB mutation carrying 
members of this family (S11) were assessed (Table 4.4). The SDHAF3 c.157T>C variant 
was identified in an additional seven SDHB mutation carrying family members. Five 
individuals in this family have (to date) presented with pheochromocytoma and/or 
paraganglioma (S11_1, S11_2, S11_3, S11_4 and S11_5). Of those with germline SDHB 
mutation and SDHAF3 variant (n=7), three (43%) have developed pheochromocytomas 
or paragangliomas (S11_1, S11_2 and S11_3); while two (25%) of those with germline 
SDHB mutation and wild-type SDHAF3 (n=8) have developed paragangliomas (p=0.47, 
Chi-squared test). Of note, the tumors of individuals S11_1, S11_2 and S11_4 all 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































splice-site mutation). Additionally, immunohistochemical assessment demonstrated loss 
of SDHB staining in all three tumors from individuals S11_1, S11_2 and S11_4.  
 
Functional characterization of SDHAF3 p.Phe53Leu in yeast 
To test whether the substitution of p.Phe53 residue with Leu is pathogenic, we 
exploited S. cerevisiae as a model organism to conduct biochemical and molecular 
biological characterization of the p.Phe53Leu variant. The expression of wild-type (WT) 
SDHAF3 in yeast cells lacking Sdh7, a yeast ortholog of SDHAF3, enhanced respiratory 
growth of mutant cells; however, the SDHAF3 p.Phe53Leu variant failed to fully rescue 
the respiratory growth defect (Fig. 4.1A). Cells lacking Sdh7 exhibit a modest diminution 
in SDH activity (9). Interestingly, the SDHAF3 p.Phe53Leu variant did not restore SDH 
activity in sdh7∆ cells, in contrast to the effect of WT SDHAF3 (Fig. 4.1B), suggesting 
that the p.Phe53Leu substitution in SDHAF3 is a hypomorphic mutation that contributes 
to SDH deficiency.  
Since SDHAF3 p.Phe53Leu appeared to be impaired functionally, we first 
examined whether expression of SDHAF3 p.Phe53Leu is compromised. We found that 
steady-state levels of SDHAF3 p.Phe53Leu were equal to those of WT SDHAF3 in 
sdh7∆ cells, consistent with stable expression of SDHAF3 p.Phe53Leu (Fig. 4.1C, Lane 1 
and 3). Meanwhile, substitution of residues in the LYR motif (p.Tyr13Ala and 
p.Arg14Ala) dramatically decreased SDHAF3 levels (Fig. 4.1C, Lane 5). Since SDHAF3 
p.Phe53Leu appeared to be well expressed compared to WT SDHAF3 in sdh7∆ cells, we 
next interrogated whether SDHAF3 p.Phe53Leu was competent to interact with Sdh2 (a 
yeast ortholog of SDHB) during SDH assembly. Previously, we showed that the steady-  
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Fig. 4.1. Phe53 substitution with Leu in SDHAF3 leads to the loss of function of 
SDHAF3 in yeast. (A) Respiratory growth of yeast cells expressing a human Sdh7 
ortholog, SDHAF3, and its sequences variants. Precultured cells in synthetic complete 
(SC) media were serially diluted and then spotted on SC media containing different 
carbon sources, as indicated. Cells were incubated at 30 °C. (B) Relative 
succinate:quinone oxidoreductase (SOQ) activity in isolated mitochondria. Mitochondria 
were isolated from cells grown until late-log phase in SC media plus 2% raffinose/0.2% 
glucose. Data are shown as mean ± SD (n = 3; **p < 0.05). (C) Steady-state levels of 
SDHAF3 proteins in sdh4∆ cells. Human SDHAF3 and its mutants under yeast MET25 
promoter were expressed from plasmids in cells. Por1 (porin) is a loading control. (D) 
Steady-state levels of SDHAF3 proteins in response to ectopic expression of Sdh2-
His6Myc2. Rip1 is the Fe-S cluster subunit of bc1 complex. (E) Co-immunoprecipitation 
of SDHAF3 was performed with mitochondrial isolated from cells expressing Sdh2-
His6Myc2 using anti-SDHAF3 antibody and protein A magnetic beads. Anti-HA antibody 
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state levels of Sdh7 increased in cells lacking the membrane anchor domain of SDH as a 
consequence of the enhanced interaction between Sdh7 and an Sdh1/Sdh2 pre-stalled 
intermediate (Sdh1, yeast ortholog of SDHA) (9). Therefore, we measured SDHAF3 
levels in sdh4∆ cells where an Sdh1/Sdh2 intermediate accumulates. SDHAF3 
p.Phe53Leu as well as WT SDHAF3 accumulated in sdh4∆ cells (Fig. 4.1C, Lane 2 and 
4), suggesting that SDHAF3 p.Phe53Leu may be capable of interacting with Sdh2. 
Recently, we observed that Sdh7 levels increased in response to an ectopic expression of 
Sdh2 in the presence of endogenous Sdh2 (data not shown). Therefore, we tested whether 
WT SDHAF3 and SDHAF3 p.Phe53Leu levels would also increase when Sdh2 is 
overexpressed in yeast cells. Indeed, an ectopic expression of Sdh2 or Sdh2-His6Myc2 in 
sdh7∆ cells harboring human SDHAF3 alleles resulted in increased levels SDHAF3, 
regardless of the p.Phe53Leu variation; however, the expression of Myc-tagged Rip1, a 
target of another LYR motif protein, Mzm1, failed to do so (Fig. 4.1D). We exploited this 
phenotype to further confirm the physical interaction between SDHAF3 p.Phe53Leu and 
Sdh2. We performed immunoprecipitation of SDHAF3 p.Phe53Leu with mitochondrial 
lysates from sdh7∆ cells wherein Sdh2-His6Myc2 is exogenously expressed. Indeed, 
Sdh2-His6Myc2 was co-precipitated with SDHAF3 p.Phe53Leu by anti-SDHAF3 
antibodies, indicating that SDHAF3 p.Phe53Leu can interact with Sdh2 (Fig. 4.1E). 
 
Functional characterization of SDHAF3 p.Phe53Leu 
in mammalian cells  
Physical interaction between SDHB and SDHAF3 was validated in mammalian 
cells by co-immunoprecipitation of overexpressed SDHB (GFP-tagged) and SDHAF3 
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(DDK-tagged) in HEK293 cells. Similar to our observations in yeast, WT SDHB and WT 
SDHAF3 were shown to interact (Fig. 4.2A). This interaction was impaired with the 
introduction of the SDHAF3 p.Phe53Leu variant (Fig. 4.2B).  
Further assessment of the interaction between SDHB and SDHAF3 was carried 
out using clinically relevant SDHB mutants. Introduction of SDHB mutants with wild-
type SDHAF3 impaired normal SDHB-SDHAF3 interaction to varying degrees (Fig. 
4.2A). Interestingly, complete abrogation of the SDHB-SDHAF3 interaction was seen 
with the SDHB p.Arg242His mutant; reduced interaction was observed for all other 
mutants, with the exception of the SDHB p.Ile127Ser mutant that appeared to be 
unaffected. Coupled with the stable SDHB expression observed in whole cell lysates 
(Fig. 4.2A), the complete loss of interaction observed on introduction of the SDHB 
p.Arg242His mutant is highly suggestive of this being a putative interaction site for 
SDHAF3.   
The interaction observed between WT SDHB and SDHAF3 p.Phe53Leu was also 
impaired, to varying degrees, with the introduction of SDHB mutants (Fig. 4.2B). 
Complete loss of interaction was not only observed with the SDHB p.Arg242His mutant 
but also with mutants affecting residue 46 (p.Arg46Gly and p.Arg46Gln). Interestingly, 
enhanced binding was observed with SDHB p.Ile127Ser and p.Cys101Tyr mutants; 
whereas no effect on interaction was evident with SDHB p.Ala43Pro and p.Pro197Arg 
mutants. Stable expression of SDHB in whole cell lysates (Fig. 4.2B) indicates these 
observed changes in SDHB levels, following immunoprecipitation with SDHAF3, are 
reflective of changes to the SDHB-SDHAF3 interaction. Complete abrogation of SDHB-
SDHAF3 interaction, following introduction of SDHB p.Arg46Gly and p.Arg46Gln  
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Fig. 4.2. SDHAF3 interacts with SDHB in vitro. SDHAF3-SDHB complexes pulled 
down by DDK-tagged SDHAF3, following 24 hours co-transfection with GFP-tagged 
SDHB in HEK293 cells, were immunoblotted for GFP and DDK. Stability of SDHB 
expression was assessed (whole cell lysates), following 24 hours co-transfection with 
DDK-tagged SDHAF3 and GFP-tagged SDHB in HEK293 cells, when immunoblotted 
for GFP and GAPDH. (A) Interaction of wild-type SDHAF3 with wild-type SDHB is 
evident (Lane 1); complete abrogation of this interaction can be seen when the SDHB 
p.Arg242His mutant is introduced (Lane 9); reduced interaction was observed for all 
other mutants (Lanes 3-5, 7-8) with the exception of SDHB p.Ile127Ser whose 
interaction was unaffected. Stable SDHB expression was observed in whole cell lysates. 
(B) Introduction of SDHAF3 p.Phe53Leu with wild-type SDHB leads to reduced 
SDHAF3-SDHB interaction (Lane 1); complete loss of interaction was observed with 
SDHB p.Arg242His (Lane 9), p.Arg46Gly (Lane 4) and p.Arg46Gln (Lane 5); interaction 
with SDHB p.Ala43Pro and p.Pro197Arg was unaffected; while binding was enhanced 
with SDHB p.Ile127Ser and p.Cys101Tyr mutants. Stable SDHB expression was 
observed in whole cell lysates. (C) Relative succinate dehydrogenase (SDH) and 
succinate:quinone oxidoreductase (SQR) activity with Sdh2 R235H in isolated 
mitochondria. Mitochondria were isolated from cells grown until late-log phase in SC 
media plus 2% raffinose/0.2% glucose. Data are shown as mean ± SD (n = 3; **p < 0.05). 
(D) Blue native-PAGE analysis to visualize mature SDH complexes. Mitochondrial 
lysates extracted with 1% digitonin were separated on BN-PAGE and then transferred to 
membranes for immunoblotting. III2IV2 is a supercomplex consisting of complex III and 
complex IV as a loading control. (E) Porcine succinate dehydrogenase (PDB: 1ZOY). 
SDHA (gray ribbon); SDHB (blue ribbon); SDHC (green ribbon); SDHD (Brown ribbon); 
Fe-S centers, [2Fe–2S], [4Fe–4S], [3Fe–4S] from the bottom (red and yellow sphere); 
Ubiquinone in the Q binding site (magenta stick); Arg242, corresponding to Arg235 in 
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mutants with SDHAF3 p.Phe53Leu (Fig. 4.2B), indicates that residue 46 of SDHB may 
also be involved in binding SDHAF3.  
Additional studies in yeast revealed that Sdh2 p.Arg235His, which corresponds to 
the SDHB p.Arg242His mutation, resulted in impairment of SDH function. Compared to 
Sdh2 WT, sdh2∆ cells expressing Sdh2 p.Arg235His exhibited reduced 
succinate:quinone oxidoreductase (SQR) activity (Fig. 4.2C). Interestingly, the 
substitution of p.Arg235 with His did not affect succinate dehydrogenase (SDH) activity 
(Fig. 4.2C) and SDH assembly (Fig. 4.2D). The 3Fe-4S cluster in SDHB is in close 
juxtaposition to p.Arg242 (Fig. 4.2E). The 3Fe-4S cluster in SDHB is essential for 
electron transfer to ubiquinone in the Q binding site in between SDHB and SDHC. 
Previously, we have shown that SDHAF3 confers protection on SDHB against reactive 
oxygen species (ROS) during SDHB maturation with Fe-S clusters (9). Given that 
p.Arg242 in SDHB (p.Arg235 in Sdh2) is critical for the interaction between SDHB and 
SDHAF3 (Fig. 4.2A, lane 9), it is possible that the 3Fe-4S cluster may become more 
susceptible to ROS-related damage in SDHB p.Arg242His mutants. However, we cannot 




In this study, we have identified a variant in the SDH assembly factor 3 
(SDHAF3, c.157T>C [p.Phe53Leu]) associated with increased prevalence of 
pheochromocytoma and/or paraganglioma. Studies in yeast confirm this to be a loss-of-
function variant, leading to reduced SDH activity. Furthermore, our in vitro studies in 
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human cells show that SDHAF3 interacts with SDHB (residues 46 and 242), and that 
interaction between SDHAF3 p.Phe53Leu and SDHB is impaired.      
SDH plays an integral role in both the tricarboxylic acid cycle and electron 
transport chain. Germline mutations within any of its four subunits (SDHA, B, C and D) 
have been associated with development of a number of tumors, including 
pheochromocytoma and/or paraganglioma, gastrointestinal stromal tumors, renal cancer 
and pituitary adenomas (1). Recently, SDH assembly factors (SDHAF1-4) have been 
identified as playing a role in maturation of individual SDH subunits and assembly of the 
functioning SDH complex as a whole (25). To date, loss-of-function mutations in 
SDHAF1 (biallelic) and SDHAF2 have been associated with infantile 
leukoencephalopathy (11, 12) and head and neck paragangliomas (8, 13, 14), 
respectively. More recently, the yeast orthologs for SDHAF1 (Sdh6) and SDHAF3 
(Sdh7) were shown to shield the Fe-S clusters of the yeast ortholog for SDHB (Sdh2), 
thereby promoting maturation of SDHB (9). Further, two LYR motifs within SDHB 
(residues 44-46 and 240-242) have been speculated to play a role in the incorporation of 
its Fe-S clusters (15). Taken together, we hypothesized that mutations within the newly 
identified SDH assembly factor, SDHAF3, may be associated with the pathogenesis of 
pheochromocytoma and/or paraganglioma syndromes.In this study, we identified a 
SDHAF3 c.157T>C (p.Phe53Leu) variant in familial and sporadic cases of 
pheochromocytoma/paraganglioma (PC/PGL), observing a minor allele frequency (MAF) 
of 0.066. Although this variant (rs62624461) is reported with a MAF of 0.021 in the 
Exome Aggregation Consortium (ExAC) database (http://exac.broadinstitute.org/), 
reflecting exome variant data from over 60,000 individuals, the prevalence is 
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significantly higher in PC/PGL (6.6% versus 2.1%, p=0.0063). This prompted us to 
perform additional studies to clarify the role that the SDHAF3 p.Phe53Leu variant may 
play in the pathogenesis of PC/PGL. Through yeast studies, we were able to show that 
introduction of the SDHAF3 p.Phe53Leu variant into Sdh7 null yeast (ortholog of 
SDHAF3 in humans) resulted in impaired function, observed by its failure to fully restore 
SDH activity when expressed in Sdh7 null yeast relative to wild-type (WT) SDHAF3. 
Taken together, these findings indicate that although SDHAF3 p.Phe53Leu is at best a 
very low penetrance allele for PC/PGL per se, it may play a modifying role as observed 
by its hypomorphic activity. Hypomorphic alleles of SDHAF3 may contribute to the 
pathology in SDH-deficient tumors with residual SDH subunits, or alternatively through 
a secondary unidentified function of SDHAF3. In this study, two PC/PGL tumors from 
patients harboring germline SDHB (IVS3 splice-site) mutation and SDHAF3 (c.157T>C) 
variant showed loss of SDHB staining by immunohistochemistry. This raises the question 
of how SDHAF3 c.157T>C can play a role in PC/PGL tumorigenesis, in SDH-deficient 
tumors. Clearly, by the time that inactivation of both SDHB alleles has occurred in the 
tumor, SDHAF3 c.157T>C presumably has no additional role, as SDHAF3 appears to 
interact specifically with SDHB. Nevertheless, we conjecture that the germline presence 
of this hypomorphic SDHAF3 c.157T>C allele may over time lead to instability of SDH. 
Further, as SDHB is a known tumor suppressor and hence requires inactivation of both 
alleles for tumorigenesis, the timeframe between SDHB germline (first hit) and somatic 
loss of the normal SDHB allele (second hit) provides a means by which the SDHAF3 
c.157T>C allele could act. Further research is needed to resolve this issue.  
To further understand the role of SDHAF3, and the impact of p.Phe53Leu in 
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greater detail, we assessed its ability to interact with SDHB. Our in vitro studies in 
human cells, confirmed previous findings in yeast (9), with wild-type SDHAF3 shown to 
interact with SDHB. Interestingly, this interaction was attenuated on introduction of the 
p.Phe53Leu variant. We wanted to assess SDHAF3-SDHB interaction further by 
introducing clinically relevant SDHB mutations. Interaction between wild-type SDHAF3 
and SDHB p.Arg242His mutant was not observed, implicating this region of SDHB as a 
direct binding site for SDHAF3. This finding is supported by observations in yeast, 
whereby Sdh6 and Sdh7 (orthologs of human SDHAF1 and SDHAF3, respectively) have 
been shown to interact with Sdh2 (ortholog of human SDHB) (9), although the specific 
binding site(s) enabling these interactions were not identified. Interestingly, Maio et al 
(2014) recently showed that the LYR motif of SDHB, affecting residues p.240-242, was 
not an SDHAF1 binding site, as substitution of these three residues with alanines failed to 
disrupt SDHBs ability to bind to SDHAF1 (15). Our study shows that SDHAF3, in fact, 
is a direct binding partner for the LYR motif of SDHB (p.240-242). Reduced interaction 
was observed in all other SDHB mutants, with the exception of p.Ile127Ser in which 
interaction between SDHAF3 and SDHB appeared to be unaffected, indicating that this 
residue has no bearing on SDHB interaction with SDHAF3.  
On introduction of the SDHAF3 p.Phe53Leu variant, SDHAF3-SDHB interaction 
was completely lost for SDHB p.Arg46Gln and p.Arg46Glyn mutants, implicating 
residue 46 as another region of SDHB that may interact with SDHAF3. Although these 
two regions are spatially separated in two distinct sub-domains, SDHAF3 may bind 
residues in each domain. Alternatively, the impaired binding may arise from secondary 
consequences of the p.Arg46 mutation. Interestingly, our previous structural modeling of 
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these SDHB mutations had not identified the functional impact on SDHB, as both glycine 
and glutamine are capable of fitting within the space left by arginine, and the electron 
path is not nearby (24). The findings of our current study suggest that mutations affecting 
residue 46 of SDHB are pathogenic via preventing maturation of SDHB. A similar effect 
was noted by Maio et al. (2014), whereby the SDHB p.Arg46Gln mutation did not impair 
SDHB interaction with HSC20, although reduced binding to the HSC20 complex and 
SDHA were noted, suggestive of an effect on formation of a mature SDH complex (15). 
Interestingly, introduction of the SDHAF3 p.Phe53Leu variant resulted in a 
stronger SDHAF3-SDHB interaction in the presence of the SDHB p.Cys101Tyr mutant. 
Since Cys101 is a ligand to the 2Fe-2S center in the N-terminal domain of SDHB, the 
enhanced interaction is suggestive that SDHAF3 interacts with apo-SDHB. Consistent 
with this prediction is the observation that over-expression of SDH2 in yeast lacking 
Sdh1 results in a profound stabilization of Sdh7 (SDHAF3) (U.N., unpublished data). 
SDHAF3 may, therefore, contribute to the Fe-S cluster insertion process in SDHB.  
Our studies have revealed novel insights into the biogenesis of SDH, uncovering a 
vital interaction between SDHAF3 and SDHB. We have shown that SDHAF3 interacts 
directly with SDHB (residue 242 being key to this interaction), and that a variant in 
SDHAF3 (c.157T>C [p.Phe53Leu]) is more prevalent in individuals with 
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A severe syndrome characterized by the dysfunction of multiple mitochondrial 
enzymes has been described for a series of patients with mutations in three mitochondrial 
proteins IBA57, NFU1 and BOLA3 (1-7). These patients presented with lactic acidosis, 
nonketotic hyperglycinemia and infantile encephalopathy, typically leading to death in 
their first year of life. The biochemical phenotype was associated with an impairment of 
the 2-oxoacid dehydrogenases arising from defective lipoate synthesis and defects in 
respiratory complexes I and II in select tissues, including muscle and liver. The syndrome 
presents due to defective iron-sulfur (Fe-S) cluster synthesis within the mitochondria. The 
defect in protein lipolyation is due to impaired activity of lipoic acid synthetase, which 
requires a [4Fe-4S] cluster cofactor (8). The hyperglycinemic phenotype arises from 
failed lipolyation of the glycine cleavage enzyme. IBA57 is a known component of the 
ISA complex that functions in the formation of [4Fe-4S] clusters in mitochondria (9, 10). 
Yeast cells lacking Nfu1 are partially compromised in mitochondrial [4Fe-4S] cluster 
formation, but the defect is not as pronounced as in cells lacking the components of the 
ISA complex (Isa1, Isa2 and Iba57) (3, 11). As in patient cells with mutations in NFU1, 
yeast nfu1∆ cells have diminished protein lipoylation levels (3). Humans and yeast have 
two mitochondrial BolA proteins BolA1 (Bol1 in yeast) and BolA3 (Bol3 in yeast) (12), 
but little is known concerning their physiological function. The similarities in phenotypes 
of patients with mutations in NFU1 and BOLA3 suggest that BOLA3 may likewise 
function in mitochondrial Fe-S biogenesis.  
Fe-S cluster synthesis within the mitochondria occurs on a scaffold complex and 
preformed clusters are subsequently transferred to recipient proteins (13). The initial 
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cluster formed is a [2Fe-2S] cluster assembled on the ISU complex consisting of four 
proteins, Nfs1, Isd11, Yfh1 and Isu1 (or Isu2; yeast nomenclature) (13-15). The sulfide 
ions are provided by the Nfs1 cysteine desulfurase, along with its effector proteins Isd11 
and Yfh1 (15-21). Assembled [2Fe-2S] clusters on Isu1 are transferred to the monothiol 
glutaredoxin Grx5 through the action of the Ssq1 ATPase and DnaJ protein Jac1 (22-24). 
Two [2Fe-2S] clusters are condensed into a [4Fe-4S] cluster on the downstream ISA 
complex (Isa1, Isa2 and Iba57) (9, 10, 25, 26).  
Nfu1 has been implicated to act as a late Fe-S maturation factor in bacteria and 
yeast (3, 27), but also suggested to be an alternate scaffold protein (2, 28). The lack of 
NfuA in E. coli and Azobacter vinelandii is associated with decreased viability under 
stress conditions (27, 29, 30). BolA proteins typically function with glutaredoxins (31); 
therefore, one prediction is that BolA3 and/or BolA1 has a role in conjunction with Grx5 
downstream of [2Fe-2S] formation.  
Nfu proteins from most species are multidomain proteins. One common feature of 
Nfu proteins is a conserved domain containing a functionally important CxxC sequence 
motif. The E. coli NfuA and human Nfu1 proteins consist of two domains with the C-
terminal domain containing the key CxxC motif (28, 29). The N-terminal domains differ 
between the E. coli and human proteins and lack a conserved CxxC motif. The conserved 
CxxC-containing domain is known to bind a [4Fe-4S] cluster, likely at a homodimer 
interface (28-30). Recombinant expression and purification of Azobacter NfuA or human 
Nfu1 did not result in Fe-S cluster bound to the purified protein, but in vitro Fe-S 
reconstitution studies followed by Mössbauer spectral studies demonstrated the presence 
of a [4Fe-4S] cluster (28-30). The ability of Nfu1 to bind a [4Fe-4S] cluster supported the 
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suggestions that Nfu1 was either an alternative scaffold protein involved in Fe-S cluster 
formation or involved in a late cluster transfer step. The ability of bacterial NfuA to 
transfer its cluster to apo-aconitase is consistent with a role in late step cluster transfer 
(29, 30). 
BolA proteins are also known to coordinate Fe-S clusters in conjunction with 
monothiol glutaredoxins. Arabidopsis thaliana contain three BolA proteins, one of 
which, BolA1, binds a [2Fe-2S] cluster in a complex with glutaredoxin (Grx) (32). In this 
BolA:Grx complex two thiolates, one each from Grx and an associated glutathione, and 
two histidyl residues from BolA1 coordinated the cluster. Likewise, the cytosolic BolA2 
proteins of yeast and humans coordinate [2Fe-2S] clusters at the heterodimer interface 
with monothiol glutaredoxins (31, 33). Little is known about the physiological function 
of mitochondrial BolA proteins. BolA proteins are found only in aerobic species (12). 
Depletion of the mitochondrial BolA1 in HeLa cells caused an oxidative shift in the 
mitochondrial thiol/disulfide redox ratio (12).  
We set out to define the functional steps of Nfu1 and the two mitochondrial BolA 
proteins in yeast. We report that Nfu1 and BolA3 function in late step transfer of Fe-S 
clusters from the ISA complex to mitochondrial client proteins. In contrast to BolA3, the 
related mitochondrial BolA1 shows an interaction with Grx5 but not Fe-S client proteins. 
 
Results 
Nfu1 is associated with mitochondrial [4Fe-4S] cluster formation 
S. cerevisiae cells lacking the mitochondrial Nfu1 protein (nfu1∆ cells) are 
markedly impaired in growth on synthetic complete medium with acetate as a carbon 
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source (Fig. 5.1A). However, the cells exhibit only a modest growth impairment on 
glycerol/lactate medium, suggesting a partial defect in respiratory growth that is 
exacerbated with acetate as the carbon source. It was previously reported that nfu1∆ cells 
exhibit specific but partial defects in formation of [4Fe-4S] clusters analogous to 
phenotypes seen in patients with mitochondrial dysfunctions syndrome (3). We 
confirmed the defects in [4Fe-4S] enzymes reported for nfu1∆ cells showing that 
aconitase and succinate dehydrogenase (SDH) activities are markedly impaired, but 
residual active enzymes persist (Fig. 5.1B). Whereas aconitase activity is markedly 
attenuated in nfu1∆ yeast cells, its level is not significantly depleted in human nfu1 
patients (2, 3). No defect was observed in the yeast mutant in respiratory complex III, 
cytochrome bc1, which requires a [2Fe-2S] cluster in its Rieske subunit (Fig. 5.1B). 
Consistent with the known defects of nfu1∆ yeast cells and human nfu1 patients, lipoic 
acid (LA) conjugates on pyruvate dehydrogenase and oxoglutarate dehydrogenase were 
attenuated in nfu1∆ cells (Fig. 5.1C). As mentioned, lipoic acid formation is dependent 
on the [4Fe-4S] lipoic acid synthase Lip5 (8). Steady-state protein analysis by SDS-
PAGE showed diminished Sdh2 levels, the Fe-S subunit of SDH. Sdh2 contains three 
distinct Fe-S clusters ([2Fe-2S], [4Fe-4S] and [3Fe-4S] clusters), which transfer electrons 
from the catalytic Sdh1 subunit to ubiquinone. In the absence of Fe-S cluster insertion, 
the Sdh2 stability is compromised (Fig. 5.1C). In contrast, aconitase protein stability is 
not as sensitive to the presence of its [4Fe-4S] cluster.  
Two enzymes involved in yeast lysine biosynthesis Aco2 and Lys4 contain [4Fe-
4S] clusters (34). Whereas yeast lacking the ISA complex are auxotrophic for lysine and 
accumulate homocitrate as a metabolic intermediate, nfu1∆ cells propagate normally in  
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Fig. 5.1. Cells lacking Nfu1 exhibit defects in [4Fe-4S] cluster enzymes in mitochondria. 
(A) Respiratory growth defects revealed by yeast drop-test. Cells harboring empty 
vectors (EV) or high-copy plasmids expressing designated genes were precultured in 
liquid synthetic complete (SC) glucose media lacking uracil. Serially diluted cells (10-
fold) were spotted on SC media plates supplemented with different carbon sources, and 
then incubated at 30°C. (B) Relative activity of aconitase, SDH, cytochrome bc1, 
cytochrome c oxidase (CcO), and malate dehydrogenase were measured in isolated 
mitochondria from cells cultured in SC media with 2% raffinose. Data are shown as mean 
± SE (n=3). (C) Steady-state protein levels measured by SDS-PAGE followed by 
immunoblotting in isolated mitochondria. Anti-LA antibody is an antibody specific to 
lipoic acid (LA) that is conjugated to proteins. (D) Restoration of Sdh2 protein shown by 
SDS-PAGE followed by immunoblotting in isolated mitochondria from nfu1∆ cells over-
expressing suppressors from panel A. Grx5 is a monothiol glutaredoxin. Isa1, Isa2 and 
Iba57 are subunits of the ISA scaffold complex required for [4Fe-4S] cluster synthesis. 
PDH is pyruvate dehydrogenase and KDH is α-ketoglutarate dehydrogenase. Sdh2 is the 
Fe-S cluster subunit of SDH. Aco1 is mitochondrial aconitase. Por1 is a mitochondrial 
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medium lacking lysine and do not accumulate homocitrate as shown by GC-MS 
metabolomic studies (data not shown). Thus, sufficient [4Fe-4S] cluster synthesis and 
distribution occurs in nfu1∆ cells for lysine synthesis.  
The growth defect of nfu1∆ yeast cells on acetate medium was severe, creating an 
opportunity to conduct screens for genetic suppressors of the respiratory defect. In a 
screen using transformants with a yeast high-copy cDNA library, we isolated respiratory 
competent vector-borne clones of nfu1∆ BY4741 cells containing NFU1, ISA2, and 
YAP2. Each gene was recloned into yeast vectors and nfu1∆ transformants of both 
BY4741 and W303 genetic backgrounds were analyzed for growth on acetate medium 
and respiratory function. Although Isa2 is a component of the mitochondrial ISA 
heterotrimeric complex comprised of Isa1, Isa2 and Iba57, overexpression of Isa2 was the 
only ISA component capable of restoring respiratory growth of nfu1∆ cells on acetate 
medium (Fig. 5.1A) and glycerol/lactate (data not shown). ISA2 transformants of nfu1∆ 
cells showed restoration of SDH levels, suggesting that the respiratory capacity of the 
mutant cells was partially restored by elevated Isa2 levels (Fig. 5.1D). Thus, the 
respiratory function of Nfu1 can be partially replaced by super-physiological levels of the 
Isa2 component of the ISA complex.  
 
Nfu1 is necessary for protecting Fe-S clusters from oxidative damage 
Partial respiratory function of nfu1∆ cells was also restored by overexpression of 
Yap2 or its paralogue Yap1 (Fig. 5.1A). Yap1 and Yap2 are transcriptional activator that 
induces the expression of a battery of antioxidant genes, including thioredoxin, 
thioredoxin reductase and glutathione reductase, in response to oxidative stress (35). To 
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confirm that the suppression of nfu1Δ cells by the YAP transcription factors was 
specifically due to a recovery of the [4Fe-4S] centers, we analyzed mitochondria from the 
transformants to test for restoration of respiratory function. A modest restoration of LA 
conjugates of PDH and KDH was seen (Fig. 5.2A). The identification of YAP1 and YAP2 
as high copy suppressors of nfu1Δ cells suggested the potential importance of Nfu1 
during oxidative stress. 
To further understand the importance of Nfu1 function during oxidative stress, we 
grew nfu1Δ cells on glycerol/lactate medium with or without paraquat, a superoxide 
generator. Interestingly, nfu1Δ cells with Isa2 overexpression, unlike the presence of 
Nfu1, did not exhibit any enhanced resistance to paraquat. The presence of paraquat in 
the growth medium exacerbated the respiratory growth defect of nfu1Δ cells (Fig. 5.2B). 
In addition, respiratory growth of nfu1Δ cells is partially restored with the addition of the 
antioxidants, GSH and N-acetyl cysteine (NAC) to the growth medium (Fig. 5.2C). These 
results support an important role for Nfu1 during oxidative metabolism.  
If Nfu1 is important during oxidative cell conditions, we tested whether Nfu1 is 
expendable during anoxic growth.  WT and nfu1Δ cells were cultured to mid-log growth 
in normoxic or anoxic conditions. Mitochondria isolated from the cells were analyzed by 
steady-state protein analysis and enzymatic function of various [4Fe-4S] cluster enzymes. 
Whereas normoxic nfu1Δ cells exhibited the expected marked attenuation in SDH and 
aconitase activities and reduced lipoic acid adducts, the anoxic cells did not exhibit a 
significant difference between WT and nfu1Δ cells (Fig. 5.2, D and E). It should be noted 
that anoxic WT cells showed a marked reduction in mitochondrial enzymatic activities 






Fig. 5.2. Defects in cells lacking Nfu1 are pronounced under oxidative stress conditions. 
(A) Steady-state levels of proteins in isolated mitochondria from nfu1∆ cells harboring 
high-copy NFU1 plasmids or YAP1 plasmids. (B) Yeast drop-test with paraquat 
supplementation. (C) Yeast drop-test with n-acetyl cysteine (NAC) and glutathione 
(GSH). (D) Steady-state levels of proteins in isolated mitochondria from cells cultured 
under normoxic conditions or anaerobic conditions. (E) Relative activity of SDH and 
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did not show a marked further attenuation in SDH and lipoic acid conjugates. Thus, cells  
are more dependent on Nfu1 in oxidative metabolism. 
 
Nfu1 binds the ISA complex and [4Fe-4S] client proteins 
An association of Nfu1 with the mitochondrial ISA complex (involved in [4Fe-
4S] clusters) was suggested by the observed suppression of the respiratory defect of 
nfu1Δ cells by Isa2 overexpression along with defects in 4Fe-4S mitochondrial enzymes. 
We tested if Nfu1 physically interacts with the ISA complex by co-immunoprecipitation 
studies using a functional C-terminal Strep tagged chimera of Nfu1.  Affinity purification 
of Nfu1-Strep with Strep-Tactin beads showed co-purification of Isa1 and Isa2 (Fig. 
5.3A). In addition to the interaction with Isa1 and Isa2, Nfu1 associated with three [4Fe-
4S] client proteins: Aco1, Aco2 and Lys4 (Fig. 5.3, B and C).  
 
The NifU domain of Nfu1 harbors a CxxC motif required for function 
Nfu1 consists of two domains in addition to the N-terminal mitochondrial target 
sequence based on sequence homologies (Fig. 5.4A). The N-terminal domain (NfuN, 
residues 22-126) is only conserved within eukaryote species, while the C-terminal NifU-
like domain (residues 143-256) is widely conserved in all species and contains the 
important Fe-S cluster binding CxxC motif (Fig. 5.4B). Both candidate domains were 
separately expressed with the endogenous mitochondrial targeting sequence of Nfu1 (1-
21) to ensure proper delivery to the mitochondrial matrix.  
Cells containing only the Nfu1 C-terminal NifU domain were capable of 





Fig. 5.3. Nfu1 interacts with the ISA complex and [4Fe-4S] cluster proteins. (A) Strep-
tag affinity purification of Nfu1-Strep revealed the Nfu1 interaction with Isa1 and Isa2. 
Mitochondria were solubilized with 0.1 % n-dodecyl maltoside (DDM). Clarified lysates 
were incubated with Strep-Tactin superflow beads for 16 hours. After washing, proteins 
were eluted with 2.5 mM desthiobiotin, and then analyzed by immunoblotting. (B) Strep-
tag affinity purification of Nfu1-Strep in the presence of ectopically expressed Aco2-HA. 




Fig. 5.4. The CxxC motif is critical for Nfu1 function. (A) A schematic representation of 
Nfu1 domains. MTS, the mitochondrial targeting sequence; NfuN, the N-terminal domain 
of Nfu1; NifU, the C-terminal domain harboring the highly conserved CxxC motif. (B) 
The human NifU tertiary structure (PDB: 2M5O) and primary sequences showing the 
CxxC motif (red) and adjacent amino acids indicated in partial sequences (green). (C) 
The respiratory growth defect of nfu1∆ cells was rescued with NifU. Nfu1, NfuN, and 
NifU were all fused with a C-terminal Strep-tag and expressed exogenously using low-
copy plasmids. (D) Restoration of Nfu1 target proteins by NifU expression in nfu1∆ cells. 
(E) Respiratory growths of nfu1∆ cells that express Nfu1 sequence variants were tested. 
All variants were fused with a Strep-tag and expressed on low-copy plasmids. (F) Strep-
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harboring only the Nfu1 N-terminal domain failed to propagate. Additionally, cells with 
the C-terminal, but not the N-terminal Nfu1 domain, showed normal Sdh2 and lipoic acid 
levels. Although the N-terminal Nfu1 domain failed to restore Nfu1 function, the 
fragment was well expressed in cells, unlike the functional C-terminal domain that was 
markedly attenuated in expression level (Fig. 5.4D).  
To further address the functional importance of the C-terminal NifU domain, we 
generated a series of amino acid substitutions within and near the conserved CxxC motif 
(Fig. 5.4, B and E). One Nfu1 variant generated had the two cysteinyl residues in the 
CxxC motif (highlighted in red in Fig. 5.4B) replaced with alanines. Cells harboring Nfu1 
with the two CxxC cysteinyl residues replaced by alanines exhibited a respiratory growth 
defect analogous to nfu1Δ cells, suggesting a loss-of-function phenotype. The critical role 
of the CxxC motif cysteines was previously shown in the E. coli NfuA (29). 
A conserved glycine just upstream of the CxxC motif is commonly mutated to a 
cysteine in European patients with Multiple Mitochondrial Dysfunctions Syndrome 
(MMDS). We generated mutants with G>C or G>H substitutions and replaced the 
conserved threonine between the two cysteinyl residues by a histidyl residue. Each 
mutant of Nfu1 was expressed in nfu1Δ cells and tested for function. The most striking 
mutant was the G194C mutant that mimics the MMDS patient allele, which displayed a 
severe synthetic sick phenotype (Fig. 5.4E). This dominant negative phenotype was 
reversed when cells were plated on medium containing 5-fluoroorotic acid (5-FOA) to 
shed the URA3-containing plasmid harboring the G194C Nfu1 mutant (data not shown). In 
addition, co-expression of a wild-type Nfu1 with the G194C Nfu1 mutant failed to restore 
respiratory growth, demonstrating the dominant negative nature of this mutant (Fig. 
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5.4E). 
We tested whether the dominant negative effect arises from changes in 
interactions between Nfu1 and client proteins. We performed affinity purification of 
Nfu1-Strep on Step-Tactin beads for the WT and mutant alleles. The loss-of-function 
AxxA Nfu1 mutant failed to show a detectable interaction with Aco1. In contrast, the 
G194C Nfu1 mutant exhibited an enhanced interaction with Aco1 (Fig. 5.4F). An 
interaction with Sdh2 is unclear, since Sdh2 levels are markedly depleted in G194C Nfu1 
cells. These data show the importance of Nfu1’s C-terminal NifU domain and the CxxC 
motif in [4Fe-4S] cluster transfer to client proteins.  
 
The two BolA proteins of the mitochondria function in Fe-S cluster 
biogenesis 
Patients presenting with MMDS have also been reported to have mutations in the 
mitochondrial BOLA3 protein (1, 2, 6). The clinical phenotypes of patients with 
mutations in NFU1 or BOLA3 were similar with neurological regression, infantile 
encephalopathy and hyperglycinemia (2, 3). In addition, related biochemical defects in 
protein lipolyation and succinate dehydrogenase were observed.  
Due to the clinical and biochemical similarities in NFU1 or BOLA3 patients, we 
elected to evaluate the function of the yeast BOLA3 homolog, Bol3 and the related Bol1 
protein (Fig. 5.5A). In human cells, BOLA1 and BOLA3 were shown to be mitochondrial 
proteins. We confirmed that Bol1 and Bol3 were likewise localized within the 
mitochondria of yeast cells (data not shown). Yeast lacking either Bol1 or Bol3 lack a 
clear respiratory phenotype, but a double bol1Δbol3Δ null strain displayed a growth  
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Fig. 5.5. Bol1 and Bol3 play roles in Fe-S cluster biogenesis in mitochondria. (A) Partial 
sequences of yeast and human mitochondrial BolA proteins. Boxed are conserved motifs 
with proposed ISC ligands that were mutated in this work. (B) Respiratory growth defects 
of bol1∆ cells, bol3∆ cells and bol1∆bol3∆ double mutants and complementation by 
plasmid-borne BOL1 or BOL3. (C) Steady-state levels of LA-conjugated proteins and 
Sdh2 in cells lacking Bol1 and/or Bol3. (D) Relative activity of SDH, cytochrome bc1 
complex and aconitase were measured. Data are shown as mean ± SE (n=3). (E) Steady-
state levels of LA-conjugated proteins and Sdh2 in response to overexpression of Grx5 or 
the ISA components in cells lacking Bol1 and Bol3. (F) Respiratory function of Bol1 and 
Bol3 sequence variants in conserved residues were examined by yeast drop-test. All Bol1 
variants were fused with a C-terminal Strep-tag and expressed on low-copy plasmids. All 
Bol3 variants were fused with a N-terminal Strep-tag between the MTS and the 











































































































defect on acetate medium, but to a lesser extent on glycerol/lactate medium (Fig. 5.5B). 
Mitochondria isolated from single mutants and the double null was used for biochemical 
characterization studies. As with nfu1Δ cells, protein lipolyation was partially impaired in 
PDH in the bol3∆ null, but markedly in the bol1Δbol3Δ null strain (Fig. 5.5C). SDH and 
aconitase activities were depressed in the double null strain and partially done in the 
individual single mutants (Fig. 5.5D). The attenuation of aconitase activity in both bol3∆ 
and nfu1Δ cells is in contrast to BOLA3 and NFU1 patient mutant cells. A modest 
attenuation was seen in bc1 activity in the bol1Δbol3Δ null strain and this was not 
observed in nfu1Δ cells.  
Since the respiratory growth defect of nfu1Δ cells was partially suppressed by 
overexpression of Isa2, we tested whether overexpression of a series of late 
mitochondrial Fe-S cluster assembly genes would likewise rescue the respiratory defect 
of bol1Δ bol3Δ cells. As can be seen in Fig. 5.5E, only a marginal restoration of LA and 
Sdh2 levels was observed with overexpression of Grx5, Isa1 and Isa2. 
BolA proteins, like Nfu1, are implicated in binding Fe-S clusters. Whereas Nfu1 
is known to bind a [4Fe-4S] cluster at the homodimer interface, BolA proteins have been 
shown to bind [2Fe-2S] clusters in association with glutaredoxins as heterodimer (31-33). 
We evaluated the roles of potential Fe-S cluster ligands in Bol1 and Bol3. Bol1 has 
conserved His56 and His93 residues, which in the case of an Arabidopsis thaliana BolA1 
are apparent ligands to a [2Fe-2S] cluster in association with a monothiol glutaredoxin 
(32). Bol3 has conserved Cys64 and His101 residues in corresponding loops to that of 
Bol1 and are expected to serve as ligands for a Fe-S cluster. We converted the conserved 
histidyl residues to alanines or cysteines to test for phenotypic effects. We observed that 
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the C-terminal His in each BolA protein was important for the respiratory growth of cells 
(Fig. 5.5F). Whereas the H101A Bol3 mutant was nonfunctional, the variant containing a 
H101C substitution exhibited a dominant negative phenotype in that the respiratory defect 
was more pronounced than the starting bol1Δ bol3Δ null strain (Fig. 5.5F). The Bol3 
C64A mutant was only a partial loss-of-function allele. The Bol1 H93A or H93C mutants 
exhibited similar loss-of-function phenotypes without any observed dominant negative 
effects. The upstream Bol1 H56A mutant retains function, but the H56C allele was a partial 
loss-of-function mutant (Fig. 5.5F). These data show a functional importance of Bol1 and 
Bol3 in mitochondrial Fe-S cluster biogenesis and highlights the need for one of the two 
putative Fe-S ligands for physiological function. The BolA proteins, like Nfu1, are not 
essential for mitochondrial Fe-S biogenesis, as a bypass exists enabling limited 
respiratory growth on glycerol/lactate medium.  
 
Nfu1 and Bol3 physically interact with [4Fe-4S] client mitochondrial 
proteins 
To glean further insights into the function of Nfu1, Bol1 and Bol3 in 
mitochondrial Fe-S cluster biogenesis, we performed proteomic analyses on affinity 
purified Nfu1, Bol1 and Bol3 proteins each expressed as C-terminal Strep fusions. 
Purification of each protein was accomplished on Strep-Tactin resin and protein eluates 
were analyzed by mass spectrometry. Multiple independent proteomic analyses were 
conducted on WT proteins as well as mutant proteins of each (a double G/T>C Nfu1, 
H93C Bol1 and H101C Bol3) (Fig. 5.6, A and B). Of the mutant proteins, both the Nfu1 
and BolA3 were dominant negative mutants, whereas the Bol1 H93C variant was a loss-  
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Fig. 5.6. Proteomic analyses reveal Nfu1 and BolA proteins interacting partners. (A and 
B) Percentages of peptides identified by MS proteomics. Percentages were calculated by 
the number of peptides identified for a denoted protein in an individual Strep-tagged 
protein divided by the total number of peptides for that protein identified from all seven 
samples. Strep-tagged proteins were expressed from low-copy plasmids in corresponding 
single deletion mutants. Samples were Strep-affinity purified as in Fig. 5.3. Bol1m is the 
H93C variant. Bol3m is the H101C variant. Nfu1m is the G/T>H variant. All were fused 
with a C-terminal Strep-tag. WT is BY4741 wild-type harboring a low-copy empty 






of-function mutant without a dominant negative characteristic. Inspection of datasets of 
protein interactors revealed a common set of [4Fe-4S] client proteins associating with 
both Nfu1 and Bol3. These include Aco1, Aco2, Lys4, Sdh2, Lip5 and Bio2 (Fig. 5.6A). 
For all client proteins except Sdh2, the observed peptide count was markedly higher for 
clients purified with mutant Nfu1 and Bol3 variants. The lack of stalling of Sdh2 with 
mutant proteins may arise from depressed levels of Sdh2 in cells with the mutants as 
shown in Fig. 5.4F for G194C Nfu1. Additionally, the mutant forms of Bol3 and Nfu1 
both co-purified the ISA complex component, Isa2 (Fig. 5.6B). The physical interactions 
of Nfu1 with the clients, Aco1, Lys4, Aco2 and Sdh2, and with the ISA complex are 
consistent with the results shown by affinity purification experiments followed by SDS-
PAGE and immunoblotting (Fig. 5.3, A, B and C). We observed the co-purification of 
Nfu1 and Bol3 in cells containing Bol3-Strep (Fig. 5.6B). 
The Nfu1 and Bol3 proteomics experiments did not identify any novel 
mitochondrial [4Fe-4S] cluster client proteins. However, the [2Fe-2S] enzyme 
dihydroxyacid dehydratase (Ilv3) was recovered in multiple independent mass 
spectrometry analyses in Nfu1 and Bol3 samples. However, we were unable to verify that 
interaction when using a FLAG-tagged Ilv3 chimera in Nfu1-Strep affinity capture (Fig. 
5.6C). In addition, we were unable to observe a defect in Ilv3 function in nfu1Δ cells 
(data not shown).  
Unlike Bol3, Bol1 purification did not lead to appreciable co-purification of [4Fe-
4S] client proteins, but Grx5 was isolated as a reproducible interactor with WT but not 
the loss-of-function H93C Bol1 mutant (Fig. 5.6B). Grx5 was a significantly less 
abundant interactor with Bol3 or Nfu1. Human BOLA1 was previously shown to 
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associate with Grx5 in HEK293 cells (12), but a comparison with BOLA3 was not done. 
 
Nfu1 and Bol3 function together in [4Fe-4S] cluster transfer from 
the ISA complex to apo-client proteins 
The distinct overlap of [4Fe-4S] client protein interactors between Bol3 and Nfu1 
suggested a potential overlap or partnership in the function of the two proteins in late step 
[4Fe-4S] cluster transfer. We tested whether a genetic linkage exists between the proteins 
by evaluating whether a synthetic phenotype exists in cells lacking Bol1, Bol3 and Nfu1. 
The triple deletion cell (bol1Δbol3Δnfu1Δ) exhibited a strong synergistic growth defect 
on glycerol/lactate medium (Fig. 5.7A). The synergistic defect can also be seen in protein 
lipolyation, Sdh2 steady-state levels and enzymatic activities of SDH and aconitase (Fig. 
5.7, B and C). The growth defect of the triple mutant can be partially rescued by re-
expression of BOL1 or NFU1, but not by BOL3 (Fig. 5.7D). This may suggest that Bol3 
requires Nfu1 for its function.  
Affinity purification of Nfu1-Strep expressed in the bol1Δbol3Δnfu1Δ triple null 
mutant was conducted to test the effect of loss of the two BolA proteins on the interaction 
of Nfu1 with [4Fe-4S] client proteins. As can be seen in Fig. 5.7E in the absence of Bol1 
or Bol3, there was enhanced copurification of Aco1. Likewise, a similar enhanced 
interaction between client proteins and Nfu1 was apparent in cells lacking a functional 
ISA complex (Fig. 5.7F). These data are consistent with a role of Nfu1 in [4Fe-4S] 
cluster transfer from the ISA complex to client proteins.  
Given the strong genetic interaction between the mitochondrial BOLA genes and 
NFU1 (Fig. 5.7A), we attempted to substantiate the linkage. The proteomic results  
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Fig. 5.7. Nfu1 and Bol3 function together in [4Fe-4S] cluster transfer. (A) Exacerbated 
respiratory growth defects of bol1∆bol3∆nfu1∆ triple mutants compared to nfu1∆ single 
mutants and bol1∆bol3∆ double mutants on nonfermentable carbon sources. (B) Steady-
state levels of LA-conjugated proteins and Sdh2 in the absence of Bol1, Bol3 or Nfu1. (C) 
Relative activity of SDH and aconitase in the absence of Bol1, Bol3 or Nfu1. Data are 
shown as mean ± SE (n=3) (D) Respiratory growths of bol1∆bol3∆nfu1∆ triple mutants 
harboring plasmid-borne BOL1, BOL3 and NFU1, respectively. (E) Strep-tag purification 
of Nfu1-Strep in the absence of Bol1 and Bol3. (F) Strep-tag purification of Nfu1-Strep 
in the absence of Isa2. (G) Steady-state levels of Bol1-Strep (upper panel) and Bol3-Strep 
(bottom panel) in response to overexpression of genes as indicated. (H) A working model 















































































































































suggested an association of Bol1 and Grx5, whereas Bol3 was associated with Nfu1 
function. Mitochondrial BolA proteins are low abundance molecules making co-immuno- 
precipitation studies challenging (data not shown). Because of this, we tested whether 
increasing the levels of candidate interacting proteins would alter the abundance of Bol1 
or Bol3. As can be seen in Fig. 5.7G, the steady-state levels of Bol3, but not Bol1, were 
dramatically increased in cells with elevated levels of Nfu1. Additionally, ISA1 and ISA2 
overexpression resulted in a modest increase in Bol3, but not Bol1, protein levels. In 
contrast, Grx5 overexpression led to a marked enhancement in Bol1 levels without 
altering Bol3. In these studies, Strep-chimeras of Bol1 and Bol3 were expressed with 
heterologous promoters, so the change in protein level is likely occurring through post-
transcriptional stabilization. These stabilization experiments corroborate the genetic and 
proteomic experiments, all of which suggest that Bol3 (BOLA3) functions with Nfu1 in 
[4Fe-4S] cluster transfer to client proteins and Bol1 functions with Grx5 for a yet to be 
determined purpose.  
 
Discussion 
A role of Nfu1 in Fe-S cluster biogenesis has long been implicated (36, 37); 
however, its molecular mechanism has not been definitely established. Patients harboring 
mutations in NFU1, as well as BOLA3, exhibit biochemical abnormalities in a set of 4Fe-
4S enzymes leading to speculation that Nfu1, and BolA3, function as a late Fe-S 
maturation factor (3, 27) or that Nfu1 is an alternate Fe-S cluster synthesis scaffold 
protein used for a subset of specific Fe-S client proteins (2, 28). The phenotypic 
similarity between Nfu1 mutations and BolA3 mutations suggests the two proteins 
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function in a common pathway. 
We demonstrate in studies using yeast as a model system that the yeast orthologs 
of human NFU1 and BOLA3 function in a late step of transfer of [4Fe-4S] clusters to 
client proteins. Yeast lacking Nfu1 are partially deficient in the [4Fe-4S] enzymes 
aconitase, succinate dehydrogenase and lipoic acid synthase. The defect in lipoic acid 
synthase is highlighted by the pronounced defect in protein lipolyation in mitochondria. 
The defect in yeast lacking Bol3 is modest, but is exacerbated in cells lacking both 
mitochondrial Bol3 and Bol1. The double null cells shows related partial defects in [4Fe-
4S] enzymes aconitase, succinate dehydrogenase and lipoic acid synthase, although the 
defects are not as pronounced as in nfu1∆ cells. Yeast lacking all three proteins, Nfu1, 
Bol1 and Bol3, show an exaggerated phenotype approaching the defect seen in cells 
lacking the ISA complex required for [4Fe-4S] cluster synthesis. Clearly, nfu1∆ cells do 
not exhibit any defects in enzymes dependent on [2Fe-2S] centers, suggesting that Nfu1 
functions in the [4Fe-4S] cluster transfer pathway.  
Our systematic approach to identify endogenous binding partners of Nfu1, Bol1 
and Bol3 revealed their molecular function. Affinity purification of Nful1 coupled with 
mass spectrometry led to the identification of [4Fe-4S] client proteins as physically 
associating proteins of Nfu1. It is of interest that the G194C Nfu1 variant exhibiting a 
partial dominant negative effect showed enhanced interaction with the same client 
proteins. This yeast mutant mimics the known G208C patient mutation in human NFU1 
that causes the severe infantile encephalopathy. Nfu1 is implicated in Fe-S cluster 
binding. Recombinant Nfu1 has been shown competent to associate with a [4Fe-4S] 
cluster and 55Fe in vivo labeling studies showed iron binding by Nfu1, with enhanced 
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55Fe binding by the patient mimic G194C Nfu1 yeast variant (3). Moreover, It is also 
noteworthy that Gly194 is in juxtaposition to the CxxC motif, which has been proposed 
to bind Fe-S clusters. Therefore, it is plausible that the dominant negative effect of the 
G194C Nfu1 variant may result from the inefficient release of [4Fe-4S] clusters from the 
Nfu1 variant to client proteins. 
The dramatic phenotype of cells harboring G194C Nfu1 is likely due to secondary 
effects of impaired lipoic acid formation. As mentioned, yeast lacking enzymes involved 
in octanoic acid formation or the Lip5 lipoic acid synthase are deficient in tRNA 
processing by RNase P, leading to attenuation in mitochondrial translation (38, 39).  
The physical interactions of Nfu1 with Isa1 and Isa2 corroborate our model that 
Nfu1 is implicated in [4Fe-4S] cluster transfer to client proteins. Interestingly, we 
isolated Isa2 as a suppressor of the respiratory defect of nfu1∆ cells. Whereas the 
condensation of two [2Fe-2S] to form a single [4Fe-4S] cluster requires the participation 
of Isa1, Isa2 and Iba57, Isa2 is capable of forming homo-dimers that may exert a transfer 
function as proposed for Nfu1. 
The same 4Fe-4S client proteins were pulled down in affinity purification of 
Bol3, but not Bol1, compared to proteins interacting with Nfu1. In the case of Bol3, the 
dominant negative H101C Bol3 variant also showed enhanced interactions with [4Fe-4S] 
client proteins. BolA proteins are known to bind [2Fe-2S] clusters in association with 
monothiol glutaredoxins (31). Current results are consistent with both proteins 
participating in Fe-S cluster binding in vivo. The double C>A variant in the conserved 
Nfu1 C-terminal domain is a loss-of-function allele that is impaired in binding Aco1. The 
dominant negative phenotype of the H101C Bol3 mutant (putative Fe-S ligand) but only 
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loss-of-function phenotype for the H101A mutant is consistent with a model that a Fe-S 
cluster may associate with Bol3. Thus, both Nfu1 and Bol3 may function in the context 
of Fe-S cluster binding.  
The partial deficiency of [4Fe-4S] enzyme activity suggests that function of Nfu1 
may be conditionally important in [4Fe-4S] cluster transfer and that a bypass mechanism 
exists in yeast. We demonstrate that Nfu1 in yeast has a heightened importance in cells 
undergoing oxidative metabolism as opposed to anoxic metabolism. In addition, the 
protein lipolyation defect in nfu1∆ cells is partially suppressed in mutant cells with 
elevated expression of either Yap1 or Yap2, which are paralogous transcriptional 
activators of antioxidant genes, or supplemental GSH in the growth medium. Yap1- or 
Yap2-containing nfu1∆ cells do not recover significant levels of SDH, suggesting that 
elevated redox capacity is limited in its restoration of function in the mutant cells. 
One curiosity is that human patients with mutations in NFU1 or BOLA3 lack 
defects in mitochondrial aconitase, whereas the yeast mutants, nfu1∆ and the double 
bol1∆ bol3∆, exhibit a partial aconitase defect. There are two implications of this result. 
First, since partial respiratory function persists in nfu1∆ cells, Nfu1 may facilitate cluster 
transfer in oxidative growth conditions. Second, Nfu1 may exhibit client selectivity in the 
actual transfer of [4Fe-4S] clusters. Although Nfu1 binds all [4Fe-4S] client proteins, it 
may facilitate cluster transfer to select clients and this may differ between human and 
yeast cells as in the case of aconitase. This postulate is supported by selectively enhanced 
interaction of the Nfu1 HxxC mutant with Aco1, Aco2 and Lys4, but not with Sdh2, 
compared to WT Nfu1. The binding of [4Fe-4S] client proteins by Nfu1 is analogous to 
the function of Mms19 in the cytosolic Fe-S cluster transfer step in which Mms19 
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associates with apo-client proteins prior to Fe-S cluster transfer (40). 
One dramatic phenotype in human and yeast Nfu1 mutant cells is impaired 
protein lipoylation. Yeast and human cells require lipoylation on E2 subunits of pyruvate 
dehydrogenase, 2-oxoglutarate dehydrogenase and the glycine cleavage enzyme complex. 
In addition, the human branched chain 2-oxoacid dehydrogenase require lipolyation for 
function. The enzyme catalyzing formation of the lipoate coenzyme lipoic acid synthase 
binds two [4Fe-4S] clusters, one of which serves as the sulfur donor for lipoic acid 
formation in a radical S-adenosylmethionine dependent reaction (41, 42). Two sulfide 
ions from this auxiliary cluster are used for formation of lipoate resulting in disassembly 
of the cluster. Each catalytic cycle of the enzyme requires repair of the auxiliary cluster 
(43). Nfu1 may have a specialized role in cluster repair in lipoic acid synthase. Each 
catalytic cycle of the synthase liberates Fe(II) ions that may catalyze deleterious ROS 
species in oxidative cells, so Nfu1 may have evolved to shield its [4Fe-4S] prior to 
transfer. In addition, endogenous oxidants are generated by the 2-oxoacid 
dehydrogenases including 2-oxoglutarate dehydrogenase and pyruvate dehydrogenase as 
well as the respiratory complexes (44). Nfu1 may exert its facilitatory role in shielding its 
bound cluster from endogenous oxidants as well as being a reservoir of [4Fe-4S] clusters 
for lipoic acid synthase function. 
Bol3 but not Bol1 was found to associate with [4Fe-4S] client proteins, whereas 
Bol1 reproducibly associated with Grx5. These binding studies suggest that Bol1 and 
Bol3 have specialized functions, yet yeast mutants lacking only one of these proteins 
have only modest respiratory phenotypes. Since the double bol1∆ bol3∆ mutant has a 
respiratory defect with similarities to nfu1∆ cells but more modest, some redundancy 
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must exist between Bol1 and Bol3. It remains unclear if the role of Bol3 in late [4Fe-4S] 
transfer requires the participation of Grx5. However, the known BolA:glutaredoxin 
complexes that have been studied only bind [2Fe-2S] clusters (31). 
In summary, the present work suggests that Nfu1 has a significant role in a late 
step transfer of [4Fe-4S] clusters to select client proteins. Nfu1 binds the client proteins 
independent of the ISA complex and its association with the ISA complex may serve to 
recruit apo-clients to the ISA complex where [4Fe-4S] clusters are formed. Some [4Fe-
4S] client proteins may get their [4Fe-4S] cluster directly from the ISA complex, whereas 
others may derive their clusters after prior transfer of a [4Fe-4S] cluster to Nfu1. In these 
cases, Nfu1 facilitates the process as an adapter protein in oxidatively grown cells. 
Additional work is required to discern the client selectivity in [4Fe-4S] cluster transfer by 
Nfu1. This model of eukaryotic Nfu1 function resembles the role of E. coli Nfu1 ortholog 
NfuA, which binds a subset of Fe-S apo-client proteins and facilitates cluster transfer 
especially under oxidative stress conditions (27, 29). Likewise, the Azobacter NfuA is 
reported to be critical under oxidative growth conditions (30). In the case of E. coli, NfuA 
cluster transfer is likely mediated directly by NfuA (27). Bol3 may function at a similar 
step in cluster transfer, but its role is more nebulous considering some apparent 
redundancy with Bol1. Clearly, interaction studies separate Bol1 and Bol3 into two 
separate classes, with Bol3 working with Nfu1 in [4Fe-4S] client binding and Bol1 
working with Grx5, which has its known function upstream of the ISA complex (24, 45, 
46). However, Bol1 appears to have a compensatory redundancy with Bol3, since a 
phenotype is exposed only in the absence of both proteins. The BolA proteins may have a 
role in [4Fe-4S] cluster dissociation from either the ISA complex or Nfu1 in [4Fe-4S] 
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cluster transfer. Additional work will be required to discern their mechanisms. 
 
Materials and methods 
Yeast strains and plasmids 
BY4741 Strains were used unless indicated otherwise. Deletion strains were 
generated by homologous recombination and confirmed by PCR analyses of loci as 
described earlier (47). Plasmids used in this study were constructed using general 
subcloning techniques. For mutagenesis or adding epitope tags, Phusion DNA 
Polymerases (Thermo Fisher Scientific) were used. All plasmid-borne genes were 
expressed under the MET25 promoter and the CYC1 terminator unless indicated 
otherwise. 
 
Enzymatic activity assay 
Activity assays for aconitase, succinate dehydrogenase (SDH), cytochrome bc1 
complex and cytochrome c oxidase were performed as described previously (48, 49). 
Aconitase activity was determined by measuring the initial rate of conversion of 100 mM 
cis-aconitate to isocitrate in 50 mM Tris (pH 7.4) at 240 nm. Soluble fractions of 
mitochondria were obtained by repetitive freeze-thaw. SDH activity was measured by 
quinone-mediated reduction of dichlorophenolindophenol (DCPIP) upon succinate 
oxidation at 600 nm. For cytochrome bc1 complex activity, the reduction rate of 
cytochrome c was measured upon the oxidation of reduced decylubiquinol at 550 nm. 
Cytochrome c oxidase activity was determined by measuring the initial rate of oxidation 
of cytochrome c oxidation (50). 
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Miscellaneous procedures 
Yeast mitochondria isolation was performed using the method of Glick and Pon 
(51). Standard procedures were performed for SDS-PAGE and immunoblotting. Anti-
Sdh2 was from the previous study (52). Anti-Strep was purchased from Qiagen. 
Antibodies against LA-conjugated proteins were from Calbiochem. Anti-Myc and anti-
HA were from Santa Cruz Biotechnology. Anti-Por1 was purchased from Molecular 
Probes and anti-FLAG was from Sigma-Aldrich. Each polyclonal antibody against Aco1, 
Isa1, Isa2 and Nfu1 was a generous gift from Dr. Roland Lill. Protein concentration was 
determined by the Bradford assay. 
 
Strep-tag affinity purification 
Affinity purifications of Strep-tagged proteins were conducted using Strep-Tactin 
superflow beads (Qiagen) following the manufacturer’s instruction with slight changes. 
Briefly, isolated mitochondria were solubilized with 0.1 % n-dodecyl maltoside (DDM) 
in the lysis buffer, 50 mM NaH2PO4 (pH 8.0), 300 mM NaCl and 1x protease inhibitor 
(cOmplete mini, Roche), for 30 min on ice. After clarification of solubilized 
mitochondria by high-speed centrifugation, supernatants were incubated with Strep-
Tactin superflow beads for 16 hours at 4°C. The beads were washed five times with the 
lysis buffer. Strep-tagged proteins bound to the beads were eluted with 2.5 mM 
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One of the major challenges during the assembly of electron transport chain 
(ETC) complexes is handling redox-labile cofactors such as copper centers, iron-sulfur 
clusters and hemes. These redox-labile cofactors are deleterious for cells as pro-oxidants 
and/or susceptible for oxidative damage in forms exposed to solvent. Therefore, in order 
to transfer intact redox cofactors under the oxidative environment, one can expect that 
biology has evolved with means to minimize the possibility of cofactors to contact 
oxygen species in the process of cofactor delivery and insertion to target proteins. In the 
case of cofactor delivery to target proteins, one can expect machinery that ensures fast 
and efficient delivery of cargos to correct positions in recipients. A specialized protein 
would also play a role in protecting cofactors that are incorporated in assembly 
intermediates. In addition, unprotected assembly intermediates may result in generation 
of reactive oxygen species (ROS) as they can catalyze incomplete redox reactions. 
Therefore, a chaperone might be required to block unwanted incomplete reactions by 
assembly intermediates with redox cofactors. 
In the field of ETC complex biogenesis, we define assembly factors as proteins 
that mediate and facilitate assembly of ETC complexes. These assembly factors are 
different from auxiliary subunits of ETC complexes as they are not normally seen in the 
mature forms of ETC complexes. In the last decade, numerous assembly factors for 
ubiquinol-cytochrome c reductase (complex III) and cytochrome c oxidase (complex IV) 
have been identified: Mzm1 for maturation of Rip1 (the [2Fe-2S] Rieske subunit of 
complex III) (1), Cyc2 and Cyc3 heme lyases for hemylation of Cyt1 (the heme c subunit 
of complex III) (2, 3), Coa1, Coa2 and Shy1 for hemylation of Cox1 (a complex IV core 
subunit) (3), Cox11, Cox17 and Sco1 metallochaperones for Cox1 and Cox2 (another 
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complex IV core subunit) maturation with copper centers (4), etc. However, the 
mechanism for SDH biogenesis, which involves an assembly process of four subunits and 
five redox cofactors, was poorly understood until the recent years when two novel SDH 
assembly factors were identified. SDHAF1 (Sdh6 in yeast) mutants were identified in 
leukoencephalopathy patients that presented with SDH deficiency (5). However, the 
molecular function of SDHAF1 remained undefined. Another SDH assembly factor, 
SDHAF2 (Sdh5 in yeast), was shown to mediate insertion of FAD cofactor into SDHA 
(6). The same study also revealed that mutations in SDHAF2 were associated with 
paraganglioma. 
In Chapter 2, we expanded our understanding of SDH assembly that FAD 
binding, but not covalent attachment of FAD to Sdh1, is sufficient for SDH assembly. 
Interestingly, the study provided additional information on pre-stalled SDH assembly 
intermediates. We showed that Sdh2 (the Fe-S subunit of SDH) was quickly degraded in 
the absence of Sdh1 (the FAD subunit), but not in the absence of Sdh3 and Sdh4 that 
form the membrane anchor domain of SDH. Moreover, Sdh2 appeared to form a 
hydrophilic intermediate with Sdh1 in the absence of the membrane anchor domain. This 
result led us to a proteomic study to discover novel SDH assembly factors during the 
assembly of an Sdh1/Sdh2 subcomplex. 
Chapter 3 treats the main objective of this dissertation: defining the mechanism by 
which the Fe-S cluster subunit, Sdh2, is matured. Although a significant amount of 
information on Sdh2 structure with three different Fe-S clusters ([2Fe-2S], [4Fe-4S] and 
[3Fe-4S]) has been collected in the last decade, the entire process of Sdh2 maturation, 
especially the process of Fe-S cluster incorporation, remained elusive. In order to 
	 115 
understand the mechanism for Sdh2 maturation with Fe-S clusters, we initiated a study to 
elucidate the molecular function of Sdh6, which belongs to the LYR motif protein family. 
Previously, it has been shown that function of most LYR proteins is related to Fe-S 
cluster proteins. In the meantime, we identified another functionally uncharacterized 
LYR protein, Acn9 (now designated Sdh7), using an in silico method. Genetic studies 
and biochemical characterizations led to relating the molecular function of Sdh7 as well 
as Sdh6 to Sdh2 maturation. Metabolite profiling revealed that as in sdh6∆ deletion 
mutants, succinate accumulates in sdh7∆ mutants compared to WT, indicating impaired 
SDH in cells lacking Sdh7. Overexpression of Sdh6 in sdh7∆ mutants suppressed the 
respiratory growth defect, suggesting that Sdh7 might be a novel SDH assembly factor 
exerting a similar function to Sdh6. The physical interaction of Sdh6 and Sdh7 with 
Sdh2, as well as a specific attenuation of Sdh2 levels in sdh6∆ mutants and sdh7∆ 
mutants among SDH subunits, indicates that Sdh6 and Sdh7 are assembly factors 
required for Sdh2 maturation. 
To understand the exact biochemical mechanism by which Sdh6 and Sdh7 
facilitate Sdh2 maturation, we exploited high-copy genomic suppressor screening, 
resulting in the identification of Yap1, a transcription activator that induces expression of 
antioxidant genes. Antioxidant supplementation as well as Yap1 overexpression restored 
SDH activity in cells lacking Sdh6 or Sdh7. ROS levels were not increased in sdh6∆ cells 
and sdh7∆ cells. Therefore, the identification of Yap1 suppressor suggests that Sdh6 and 
Sdh7 are required for protecting the Fe-S subunit of SDH from oxidative damage during 
SDH assembly. 
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Several studies have suggested that some metabolic enzymes would be tumor 
suppressors. It has been shown that gain-of-function mutations in isocitrate 
dehydrogenase and loss-of-function mutations in fumarate hydratase and succinate 
dehydrogenase are associated with a subset of tumors (7). Mutations in these metabolic 
enzymes result in abnormal accumulation of succinate in cells. Subsequently, 
accumulation of succinate leads to inhibition of proteins that belong to the dioxygenase 
family, including proline hydroxylase responsible for degradation of hypoxia inducible 
factor 1 (HIF1) and DNA and histone demethylases regulating chromatin remodeling (7-
9). Up-regulation of HIF1 levels and dysregulation of chromatin remodeling are well-
known features of tumor progression. In the case of SDH, loss-of-function mutations in 
SDH structural subunits have been linked to paraganglioma, pheochromocytoma, renal 
cell carcinoma, neuroblastoma and gastrointestinal stromal tumor (10). Pathogenic 
mutations in SDHAF1 and SDHAF2 have also been exhibited in the context of 
neurodegenerative diseases and endocrine-related tumors. However, there has been a 
subset of SDH-deficient tumors reported without any mutation in genes encoding SDH 
subunits and two SDH assembly factors. Therefore, it has been thought that the study on 
SDH assembly could help to discover tumorigenic alleles of novel SDH assembly factors. 
Indeed, the genetic study using massively parallel sequencing in Chapter 4 revealed a 
higher rate of occurrence of sequence variation (c.157T>C, p.Phe53Leu) in SDHAF3 (a 
human ortholog of Sdh7) in patients presenting familial and sporadic paraganglioma or 
pheochromocytoma, compared to a normal population. We confirmed that SDHAF3 
F53L is less competent to bind SDHB (a human ortholog of Sdh2) in mammalian cells 
compared to WT and is a loss-of-function mutant leading to SDH deficiency when 
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expressed in yeast. However, the impact of heterozygote alleles of SDHAF3 F53L on 
tumorigenesis via SDH deficiency remains unclear, considering the coexistence of 
SDHAF3 WT alleles. We are currently testing whether SDHAF3 F53L is a dominant 
negative allele. 
The aforementioned study to discover putative SDH assembly factors interacting 
with an Sdh1/Sdh2 subcomplex led to a study to understand Fe-S cluster delivery 
pathways, especially [4Fe-4S] cluster delivery to target proteins. Using a proteomics 
approach coupled with affinity purification of Sdh2 in cells lacking Sdh3 and Sdh4, we 
identified several components in Fe-S cluster biosynthesis including Isa2 and Nfu1. In 
Chapter 5, we revealed that Nfu1 plays a role in [4Fe-4S] cluster transfer to 
mitochondrial [4Fe-4S] cluster proteins by pursuing our previous observation on the 
interaction between Nfu1 and Sdh2. The fact that importance of Nfu1 function was 
pronounced under oxidative stress conditions implies that adequate means of protection 
need to be provided during transfer of Fe-S clusters from Fe-S cluster synthesis 
machineries to recipient proteins. In this case, Nfu1 facilitates delivery of [4Fe-4S] 
clusters from the ISA complex to target proteins such as Aco1, Aco2, Lys4 and Sdh2. 
Interestingly, it has been proposed that Grx5 could play a role in [2Fe-2S] cluster 
transfer, implying that biology might have evolved with dedicated factors for each type of 
Fe-S cluster delivery as well as synthesis. 
Although it has been shown that Sdh6 and Sdh7 are important for protecting Fe-S 
clusters from oxidative damage during Sdh2 maturation, the mechanism for initial Fe-S 
cluster insertion into Sdh2 remains elusive. Sdh2 is a small subunit with a complex ligand 
geometry to accommodate three different types of Fe-S clusters as it contains a total of 11 
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cysteines coordinating three Fe-S clusters. Thus, there are several key aspects to be 
interrogated among all details in order to establish a near complete model for initial Fe-S 
cluster insertion. One potential challenge for Fe-S cluster insertion is keeping 11 thiol 
groups from oxidation until they coordinate Fe-S clusters in the mitochondrial matrix. It 
is of interest whether a reductase is required to keep thiol groups reduced during Sdh2 
maturation. 
Another aspect of Fe-S cluster insertion into Sdh2 is whether Fe-S cluster 
insertion is a step-wise process. Recently, Maio et al. have shown that a human ortholog 
of Sdh2, SDHB, has two domains that can be expressed separately in mammalian cells 
(11). The N-terminal domain contains a [2Fe-2S] cluster, and the C-terminal domain has 
a [4Fe-4S] cluster and a [3Fe-4S] cluster. It is interesting whether maturation of one 
domain is a prerequisite for maturation of the other domain. Reflecting on the putative 
step-wise mechanism for Fe-S cluster insertion, it is also intriguing how many Sdh2 
interacting proteins, such as Fe-S cluster biogenesis components as well as dedicated 
SDH assembly factors, are orchestrated during Sdh2 maturation. Despite well-defined 
function of each protein interacting with Sdh2, our understanding about the interplay 
among these proteins is still limited. We have recently initiated a study to understand a 
possible interplay among Sdh6, Sdh7 and Nfu1 during a [4Fe-4S] cluster insertion into 
Sdh2. Preliminary results suggest that Sdh7 may interact with Sdh2 prior to Nfu1, and 
Sdh7 could be important for the recruitment of Nfu1 to Sdh2, which is under 
examination. 
It remains unclear how exactly the protection by Sdh6 and Sdh7 is accomplished 
although we have demonstrated that Sdh6 and Sdh7 impart protection for holo-Sdh2 
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during SDH assembly. A simple scenario is that Sdh6 and Sdh7 bind in the vicinity of an 
Fe-S cluster in Sdh2 to shield the cluster. Another possibility is that Sdh6 and Sdh7 may 
play roles in repairing damaged Fe-S clusters in Sdh2. It is also interesting whether Sdh6 
and Sdh7 are important for a specific Fe-S cluster among three Fe-S clusters in Sdh2. 
Maio et al. have shown that SDHAF1 preferentially interacts with the C-terminal domain 
of SDHB, but not with the N-terminal domain (11). In addition, we have shown the loss 
of interaction between SDHAF3 and SDHB R242H, compared to WT SDHB in Chapter 4. 
Arg242 is located in juxtaposition to [3Fe-4S] center in the C-terminal domain. Taken 
together, it is attractive to speculate that function of SDHAF1 and SDHAF3 might be 
related to Fe-S clusters in the C-terminal domain of Sdh2. 
 Previous studies about Fe-S cluster biogenesis have identified the ISU scaffold 
complex for [2Fe-2S] cluster synthesis and the ISA scaffold complex for [4Fe-4S] cluster 
synthesis. However, no dedicated machinery has been identified yet; thus, little is known 
about [3Fe-4S] cluster formation in Sdh2. The active site [4Fe-4S] cluster in aconitase is 
coordinated by three cysteine ligands. Interestingly, the release of the uncoordinated Fe 
atom from the [4Fe-4S] cluster by oxidative damages leaves the [3Fe-4S] cluster in 
inactivated aconitase (12). Since the [3Fe-4S] cluster in Sdh2 is also coordinated by three 
cysteine ligands, it is interesting whether a [4Fe-4S] cluster is initially incorporated into 
Sdh2 and subsequently transformed to the [3Fe-4S] cluster. If it is the case, it is also 
interesting whether any specialized factor would be in need of this conversion. 
We have established a better model depicting the mechanism for the assembly of 
the hydrophilic domain of SDH with identification of novel SDH assembly factors and a 
good understanding of Fe-S cluster biogenesis. However, the assembly of the 
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hydrophobic domain containing a heme b remains barely studied. It is of interest whether 
there are novel SDH assembly factors required for the assembly of the hydrophobic 
domain, especially factors for hemylation and stabilization of this domain. A proteomic 
study will be of use for identification of these putative assembly factors. For this, it is 
required to establish a condition that ensures stable expression of nonaggregated Sdh3 
and Sdh4 to some extent in the absence of Sdh1 and Sdh2. As we progress research to 
elucidate the mechanism for Sdh3 and Sdh4 maturation, we will have a better 
understanding of SDH biogenesis in great detail.  
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